<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>1800</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="1800"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=1800&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=1700&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=1900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927751042"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927751042?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927751042&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927751042&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014483515001189"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927751042</prism:url><dc:identifier>SCOPUS_ID:84927751042</dc:identifier><eid>2-s2.0-84927751042</eid><dc:title>Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival</dc:title><dc:creator>Ma S.</dc:creator><prism:publicationName>Experimental Eye Research</prism:publicationName><prism:issn>00144835</prism:issn><prism:eIssn>10960007</prism:eIssn><prism:volume>135</prism:volume><prism:pageRange>1-13</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exer.2015.04.006</prism:doi><pii>S0014483515001189</pii><dc:description>© 2015 The Authors. Cones are the primary photoreceptor (PR) cells responsible for vision in humans. They are metabolically highly active requiring phosphoinositide 3-kinase (PI3K) activity for long-term survival. One of the downstream targets of PI3K is the kinase mammalian target of rapamycin (mTOR), which is a key regulator of cell metabolism and growth, integrating nutrient availability and growth factor signals. Both PI3K and mTOR are part of the insulin/mTOR signaling pathway, however if mTOR is required for long-term PR survival remains unknown. This is of particular interest since deregulation of this pathway in diabetes results in reduced PR function before the onset of any clinical signs of diabetic retinopathy. mTOR is found in two distinct complexes (mTORC1 &amp; mTORC2) that are characterized by their unique accessory proteins RAPTOR and RICTOR respectively. mTORC1 regulates mainly cell metabolism in response to nutrient availability and growth factor signals, while mTORC2 regulates pro-survival mechanisms in response to growth factors. Here we analyze the effect on cones of loss of mTORC1, mTORC2 and simultaneous loss of mTORC1 &amp; mTORC2. Interestingly, neither loss of mTORC1 nor mTORC2 affects cone function or survival at one year of age. However, outer and inner segment morphology is affected upon loss of either complex. In contrast, concurrent loss of mTORC1 and mTORC2 leads to a reduction in cone function without affecting cone viability. The data indicates that PI3K mediated pro-survival signals diverge upstream of both mTOR complexes in cones, suggesting that they are independent of mTOR activity. Furthermore, the data may help explain why PR function is reduced in diabetes, which can lead to deregulation of both mTOR complexes simultaneously. Finally, although mTOR is a key regulator of cell metabolism, and PRs are metabolically highly active, the data suggests that the role of mTOR in regulating the metabolic transcriptome in healthy cones is minimal.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011715</affiliation-url><afid>60011715</afid><affilname>Tianjin Medical University</affilname><name-variant>Tianjin Medical University General Hospital</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000986</affiliation-url><afid>60000986</afid><affilname>University of Massachusetts Medical School</affilname><name-variant>Univ. of Massachusetts Med. School</name-variant><affiliation-city>Worcester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029833</affiliation-url><afid>60029833</afid><affilname>University of Oklahoma Health Sciences Center</affilname><name-variant>Univ. of Oklahoma Hlth. Sci. Center</name-variant><affiliation-city>Oklahoma City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015184</affiliation-url><afid>60015184</afid><affilname>Biozentrum University of Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55802766700</author-url><authid>55802766700</authid><authname>Ma S.</authname><surname>Ma</surname><given-name>Shan</given-name><initials>S.</initials><afid>60011715</afid><afid>60000986</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55802766700</author-url><authid>55802766700</authid><authname>Ma S.</authname><surname>Ma</surname><given-name>Shan</given-name><initials>S.</initials><afid>60011715</afid><afid>60000986</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55328253100</author-url><authid>55328253100</authid><authname>Venkatesh A.</authname><surname>Venkatesh</surname><given-name>Aditya</given-name><initials>A.</initials><afid>60000986</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37077474200</author-url><authid>37077474200</authid><authname>Langellotto F.</authname><surname>Langellotto</surname><given-name>Fernanda</given-name><initials>F.</initials><afid>60000986</afid><afid>60002746</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37077474200</author-url><authid>37077474200</authid><authname>Langellotto F.</authname><surname>Langellotto</surname><given-name>Fernanda</given-name><initials>F.</initials><afid>60000986</afid><afid>60002746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8683638500</author-url><authid>8683638500</authid><authname>Le Y.</authname><surname>Le</surname><given-name>Yun Z.</given-name><initials>Y.Z.</initials><afid>60029833</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25651688600</author-url><authid>25651688600</authid><authname>Hall M.</authname><surname>Hall</surname><given-name>Michael N.</given-name><initials>M.N.</initials><afid>60015184</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005214351</author-url><authid>7005214351</authid><authname>Rüegg M.</authname><surname>Rüegg</surname><given-name>Markus A.</given-name><initials>M.A.</initials><afid>60015184</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14043932300</author-url><authid>14043932300</authid><authname>Punzo C.</authname><surname>Punzo</surname><given-name>Claudio</given-name><initials>C.</initials><afid>60000986</afid></author><authkeywords>Cone survival | Diabetic retinopathy | MTOR | Neuroprotective | Photoreceptors | PI3K | Retinitis pigmentosa | Visual function</authkeywords><intid>1035661275</intid><source-id>13866</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927591067"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927591067?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927591067&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927591067&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002233"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927591067</prism:url><dc:identifier>SCOPUS_ID:84927591067</dc:identifier><eid>2-s2.0-84927591067</eid><dc:title>PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1</dc:title><dc:creator>Ann S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>389-397</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.005</prism:doi><pii>S0021915015002233</pii><dc:description>© 2015 Elsevier Ireland Ltd. Background: Effects of peroxisome proliferator-activated receptor alpha (PPARα) agonists on cardiovascular outcome have been controversial. Although these agents primarily affect lipoprotein metabolism, their pleiotropic anti-inflammatory effect is one of the potential anti-atherosclerotic mechanisms. This study aimed to evaluate the effect of fenofibrate and gemfibrozil on inflammation in macrophages and reveal pathways these agents may affect. Methods and results: The two PPARα agonists inhibited secretion of CXCL2, TNF-α, IL-6, activation of p65 of NF-κB, ERK, and TLR4 expression. These changes occurred simultaneously with upregulation and secretion of β-defensin 1, an inflammation-modulating peptide. To demonstrate the role of β-defensin 1, it was knocked-down by target-specific siRNA. The effects of PPARα agonists on TLR4 expression and chemokine secretion were obviously abrogated with this treatment. In experiments investigating whether β-defensin 1 acts extracellularly, inflammatory chemokines decreased significantly after the addition of recombinant β-defensin 1 or conditioned media to cells. In experiments designed to clarify if the effects of the two agents are PPARα-dependent, induction of mRNA and secretion β-defensin 1 and inhibition of chemokine release were clearly reduced with GW6471, a PPARα blocker. Conclusions: Our results reveal the pathways by which fenofibrate and gemfibrozil inhibit LPS-induced inflammatory activation of macrophages. This study elucidated a novel anti-inflammatory mechanism that acts through PPARα, β-defensin 1, and TLR4 pathways.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60095571</affiliation-url><afid>60095571</afid><affilname>Severance Hospital</affilname><name-variant>Yonsei University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005389</affiliation-url><afid>60005389</afid><affilname>College of Medicine, Pochon CHA University</affilname><name-variant>CHA University</name-variant><affiliation-city>Pocheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016728</affiliation-url><afid>60016728</afid><affilname>Yonsei University College of Medicine</affilname><name-variant>Yonsei University College of Medicine</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60094974</affiliation-url><afid>60094974</afid><affilname>Yonsei University Health System</affilname><name-variant>Yonsei University Health System</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56592425500</author-url><authid>56592425500</authid><authname>Ann S.</authname><surname>Ann</surname><given-name>Soo jin</given-name><initials>S.j.</initials><afid>60095571</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591097300</author-url><authid>56591097300</authid><authname>Chung J.</authname><surname>Chung</surname><given-name>Ji Hyung</given-name><initials>J.H.</initials><afid>60005389</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591130900</author-url><authid>56591130900</authid><authname>Park B.</authname><surname>Park</surname><given-name>Byung Hee</given-name><initials>B.H.</initials><afid>60095571</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56590668400</author-url><authid>56590668400</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Soo Hyuk</given-name><initials>S.H.</initials><afid>60095571</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56591177600</author-url><authid>56591177600</authid><authname>Jang J.</authname><surname>Jang</surname><given-name>Jiyoung</given-name><initials>J.</initials><afid>60016728</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56364231800</author-url><authid>56364231800</authid><authname>Park S.</authname><surname>Park</surname><given-name>Sungha</given-name><initials>S.</initials><afid>60095571</afid><afid>60094974</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56364231800</author-url><authid>56364231800</authid><authname>Park S.</authname><surname>Park</surname><given-name>Sungha</given-name><initials>S.</initials><afid>60095571</afid><afid>60094974</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56141506400</author-url><authid>56141506400</authid><authname>Kang S.</authname><surname>Kang</surname><given-name>Seok Min</given-name><initials>S.M.</initials><afid>60095571</afid><afid>60094974</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56141506400</author-url><authid>56141506400</authid><authname>Kang S.</authname><surname>Kang</surname><given-name>Seok Min</given-name><initials>S.M.</initials><afid>60095571</afid><afid>60094974</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55716473900</author-url><authid>55716473900</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Hak</given-name><initials>S.H.</initials><afid>60095571</afid><afid>60094974</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55716473900</author-url><authid>55716473900</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Hak</given-name><initials>S.H.</initials><afid>60095571</afid><afid>60094974</afid></author><authkeywords>Atherosclerosis | Beta-defensins | Fenofibrate | Gemfibrozil | Toll-like receptor 4</authkeywords><intid>1785647313</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929995153"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929995153?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929995153&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929995153&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929995153</prism:url><dc:identifier>SCOPUS_ID:84929995153</dc:identifier><eid>2-s2.0-84929995153</eid><dc:title>The role of concentration-effect relationships in the QT&lt;inf&gt;c&lt;/inf&gt; interval prolongation: Case sotalol</dc:title><dc:creator>Neuvonen P.</dc:creator><prism:publicationName>British Journal of Clinical Pharmacology</prism:publicationName><prism:issn>03065251</prism:issn><prism:eIssn>13652125</prism:eIssn><prism:volume>79</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1040-1041</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bcp.12574</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016987</affiliation-url><afid>60016987</afid><affilname>Helsinki University Central Hospital</affilname><name-variant>Helsinki University Central Hospital</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36049596300</author-url><authid>36049596300</authid><authname>Neuvonen P.</authname><surname>Neuvonen</surname><given-name>Pertti J.</given-name><initials>P.J.</initials><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56131562200</author-url><authid>56131562200</authid><authname>Elonen E.</authname><surname>Elonen</surname><given-name>Erkki</given-name><initials>E.</initials><afid>60016987</afid></author><intid>1036045111</intid><source-id>20082</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926483843"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926483843?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926483843&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926483843&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1043466615001301"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926483843</prism:url><dc:identifier>SCOPUS_ID:84926483843</dc:identifier><eid>2-s2.0-84926483843</eid><dc:title>The effect of endurance training and downhill running on the expression of IL-1β, IL-6, and TNF-α and HSP72 in rat skeletal muscle</dc:title><dc:creator>Isanejad A.</dc:creator><prism:publicationName>Cytokine</prism:publicationName><prism:issn>10434666</prism:issn><prism:eIssn>10960023</prism:eIssn><prism:volume>73</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>302308</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>1016/j.cyto.2015.03.013</prism:doi><pii>S1043466615001301</pii><dc:description>© 2015 Elsevier Ltd. This study investigated changes in the myokines IL-1β, IL-6, and TNF-α, as well as HSP72, after endurance training and after a session of downhill running. Twenty-eight rats were allocated to four different groups: 1. Eight weeks of endurance training at 65-70% VO2max (Trained); 2. Endurance training and a single session of downhill running on a 16° slope (Trained plus downhill); 3. A single session of downhill running (Sedentary plus downhill); and 4. Sedentary (Control, no exercise). Soleus and extensor digitorum longus (EDL) muscles were harvested 48. h after training and/or a single session of downhill running and protein levels of IL-1β, IL-6, TNF-α, and HSP72 were measured and compared to the levels in the control animals. Creatine kinase (CK) was measured in plasma.Endurance training augmented intramuscular levels of HSP72 and IL-6 in both soleus and EDL muscles (p&lt;. 0.05). Endurance training elevated IL-1β and decreased TNF-α significantly only in EDL (P&lt;. 0.05). IL-6 increased in both sedentary and trained rats after downhill running (P&lt;. 0.05), while HSP72 increased only in the previously sedentary rats. CK was lower in trained than sedentary rats after downhill running.In conclusion, endurance training for 8. weeks elevated muscular HSP72 protein levels, which might have preconditioned the muscles for a single session of downhill running, as indicated by the CK and HSP72 responses. Interestingly, IL-6 was augmented by endurance training and further increased by downhill running. IL-1β, along with IL-6, was increased by endurance training, and these myokines thus appear to be differently regulated than TNF-α.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016972</affiliation-url><afid>60016972</afid><affilname>Shahed University</affilname><name-variant>Shahed University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016972</affiliation-url><afid>60016972</afid><affilname>Shahed University</affilname><name-variant>Shahed University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032053</affiliation-url><afid>60032053</afid><affilname>Tarbiat Modares University</affilname><name-variant>Tarbiat Modares University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005548</affiliation-url><afid>60005548</afid><affilname>Pasteur Institute of Iran</affilname><name-variant>Pasteur Institute of Iran</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032053</affiliation-url><afid>60032053</afid><affilname>Tarbiat Modares University</affilname><name-variant>Tarbiat Modares University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004030</affiliation-url><afid>60004030</afid><affilname>Norges idrettshogskole</affilname><name-variant>Norwegian School of Sport Sciences</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56118801200</author-url><authid>56118801200</authid><authname>Isanejad A.</authname><surname>Isanejad</surname><given-name>Amin</given-name><initials>A.</initials><afid>60016972</afid><afid>60016972</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56118801200</author-url><authid>56118801200</authid><authname>Isanejad A.</authname><surname>Isanejad</surname><given-name>Amin</given-name><initials>A.</initials><afid>60016972</afid><afid>60016972</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55427154400</author-url><authid>55427154400</authid><authname>Saraf Z.</authname><surname>Saraf</surname><given-name>Zahir Hassan</given-name><initials>Z.H.</initials><afid>60032053</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55650780700</author-url><authid>55650780700</authid><authname>Mahdavi M.</authname><surname>Mahdavi</surname><given-name>Mehdi</given-name><initials>M.</initials><afid>60005548</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507843889</author-url><authid>6507843889</authid><authname>Gharakhanlou R.</authname><surname>Gharakhanlou</surname><given-name>Reza</given-name><initials>R.</initials><afid>60032053</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55576992100</author-url><authid>55576992100</authid><authname>Shamsi M.</authname><surname>Shamsi</surname><given-name>Mahdieh Molanouri</given-name><initials>M.M.</initials><afid>60032053</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9434778300</author-url><authid>9434778300</authid><authname>Paulsen G.</authname><surname>Paulsen</surname><given-name>Gøran</given-name><initials>G.</initials><afid>60004030</afid></author><authkeywords>Eccentric exercise | HSP72 | Muscle damage | Myokines | Preconditioning</authkeywords><intid>35453829</intid><source-id>22083</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923060372"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923060372?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923060372&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923060372&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0191886915000938"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923060372</prism:url><dc:identifier>SCOPUS_ID:84923060372</dc:identifier><eid>2-s2.0-84923060372</eid><dc:title>Five-factor model and internalizing and externalizing syndromes: A 5-year prospective study</dc:title><dc:creator>Mezquita L.</dc:creator><prism:publicationName>Personality and Individual Differences</prism:publicationName><prism:issn>01918869</prism:issn><prism:volume>79</prism:volume><prism:pageRange>98-103</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.paid.2015.02.002</prism:doi><pii>S0191886915000938</pii><dc:description>© 2015 Elsevier Ltd. The main aim of the present research was to study the prospective relationships of the five-factor model of personality and the internalizing and externalizing suprafactors of psychopathology. A sample of 323 young adults completed the NEO-FFI at Time 1 and different scales of symptoms 5. years later. Neuroticism prospectively predicted the internalizing factor, while extraversion, low agreeableness and low conscientiousness predicted the externalizing factor. We found additional paths between introversion and social phobia symptoms, and between low agreeableness and psychopathy symptoms. These relationships remained significant, even when controlling for previous symptoms, except for extraversion. Gender had no moderation effect on the interrelationship between personality and psychopathology factors. The present study extends previous research about personality and psychopathology, and suggests different ways in which they can be related.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002676</affiliation-url><afid>60002676</afid><affilname>Universidad Jaume I</affilname><name-variant>Universitat Jaume I</name-variant><affiliation-city>Castellon de la Plana</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001602</affiliation-url><afid>60001602</afid><affilname>Instituto de Salud Carlos III</affilname><name-variant>Instituto de Salud Carlos III</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001576</affiliation-url><afid>60001576</afid><affilname>Universitat de Barcelona</affilname><name-variant>Universitat de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032717</affiliation-url><afid>60032717</afid><affilname>Universitat de Lleida</affilname><name-variant>Universitat de Lleida</name-variant><affiliation-city>Lleida</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35105527900</author-url><authid>35105527900</authid><authname>Mezquita L.</authname><surname>Mezquita</surname><given-name>Laura</given-name><initials>L.</initials><afid>60002676</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56242553800</author-url><authid>56242553800</authid><authname>Ibáñez M.</authname><surname>Ibáñez</surname><given-name>Manuel I.</given-name><initials>M.I.</initials><afid>60002676</afid><afid>60001602</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56242553800</author-url><authid>56242553800</authid><authname>Ibáñez M.</authname><surname>Ibáñez</surname><given-name>Manuel I.</given-name><initials>M.I.</initials><afid>60002676</afid><afid>60001602</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701747801</author-url><authid>6701747801</authid><authname>Villa H.</authname><surname>Villa</surname><given-name>Helena</given-name><initials>H.</initials><afid>60002676</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003809352</author-url><authid>7003809352</authid><authname>Fañanás L.</authname><surname>Fañanás</surname><given-name>Lourdes</given-name><initials>L.</initials><afid>60001602</afid><afid>60001576</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003809352</author-url><authid>7003809352</authid><authname>Fañanás L.</authname><surname>Fañanás</surname><given-name>Lourdes</given-name><initials>L.</initials><afid>60001602</afid><afid>60001576</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56405636900</author-url><authid>56405636900</authid><authname>Moya-Higueras J.</authname><surname>Moya-Higueras</surname><given-name>Jorge</given-name><initials>J.</initials><afid>60001602</afid><afid>60032717</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56405636900</author-url><authid>56405636900</authid><authname>Moya-Higueras J.</authname><surname>Moya-Higueras</surname><given-name>Jorge</given-name><initials>J.</initials><afid>60001602</afid><afid>60032717</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602975079</author-url><authid>6602975079</authid><authname>Ortet G.</authname><surname>Ortet</surname><given-name>Generós</given-name><initials>G.</initials><afid>60002676</afid><afid>60001602</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602975079</author-url><authid>6602975079</authid><authname>Ortet G.</authname><surname>Ortet</surname><given-name>Generós</given-name><initials>G.</initials><afid>60002676</afid><afid>60001602</afid></author><authkeywords>Externalizing | Five-factor model | Internalizing | Personality | Prospective</authkeywords><intid>1034903179</intid><source-id>12807</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923025776"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923025776?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923025776&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923025776&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000276"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923025776</prism:url><dc:identifier>SCOPUS_ID:84923025776</dc:identifier><eid>2-s2.0-84923025776</eid><dc:title>Priming healthy eating. You can't prime all the people all of the time</dc:title><dc:creator>Forwood S.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>93-102</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.01.018</prism:doi><pii>S0195666315000276</pii><dc:description>© 2015 The Authors. Objective: In the context of a food purchasing environment filled with advertising and promotions, and an increased desire from policy makers to guide individuals toward choosing healthier foods, this study tests whether priming methods that use healthy food adverts to increase preference for healthier food generalize to a representative population. MethodsIn two studies (Study 1 n = 143; Study 2 n = 764), participants were randomly allocated to a prime condition, where they viewed fruit and vegetable advertisements, or a control condition, with no advertisements. A subsequent forced choice task assessed preference between fruits and other sweet snacks. Additional measures included current hunger and thirst, dietary restraint, age, gender, education and self-reported weight and height. ResultsIn Study 1, hunger reduced preferences for fruits (OR (95% CI) = 0.38 (0.26-0.56), p &lt;. 0.0001), an effect countered by the prime (OR (95% CI) = 2.29 (1.33-3.96), p = 0.003). In Study 2, the effect of the prime did not generalize to a representative population. More educated participants, as used in Study 1, chose more fruit when hungry and primed (OR (95% CI) = 1.42 (1.13-1.79), p = 0.003), while less educated participants' fruit choice was unaffected by hunger or the prime. ConclusionThis study provides preliminary evidence that the effects of adverts on healthy eating choices depend on key individual traits (education level) and states (hunger), do not generalize to a broader population and have the potential to increase health inequalities arising from food choice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009587</affiliation-url><afid>60009587</afid><affilname>University of Cambridge, Institute of Public Health</affilname><name-variant>University Forvie Site</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015879</affiliation-url><afid>60015879</afid><affilname>Medical Research Council</affilname><name-variant>Medical Research Council</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8617731000</author-url><authid>8617731000</authid><authname>Forwood S.</authname><surname>Forwood</surname><given-name>Suzanna E.</given-name><initials>S.E.</initials><afid>60009587</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24437325200</author-url><authid>24437325200</authid><authname>Ahern A.</authname><surname>Ahern</surname><given-name>Amy L.</given-name><initials>A.L.</initials><afid>60015879</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25629622200</author-url><authid>25629622200</authid><authname>Hollands G.</authname><surname>Hollands</surname><given-name>Gareth J.</given-name><initials>G.J.</initials><afid>60009587</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56421418200</author-url><authid>56421418200</authid><authname>Ng Y.</authname><surname>Ng</surname><given-name>Yin Lam</given-name><initials>Y.L.</initials><afid>60009587</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006758192</author-url><authid>7006758192</authid><authname>Marteau T.</authname><surname>Marteau</surname><given-name>Theresa M.</given-name><initials>T.M.</initials><afid>60009587</afid></author><authkeywords>Advertisements | Food choice | Healthy eating | Priming</authkeywords><intid>1784908808</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929076979"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929076979?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929076979&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929076979&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929076979</prism:url><dc:identifier>SCOPUS_ID:84929076979</dc:identifier><eid>2-s2.0-84929076979</eid><dc:title>An integrative framework of comparing SaaS adoption for core and non-core business operations: An empirical study on Hong Kong industries</dc:title><dc:creator>Cho V.</dc:creator><prism:publicationName>Information Systems Frontiers</prism:publicationName><prism:issn>13873326</prism:issn><prism:volume>17</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>629-644</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10796-013-9450-9</prism:doi><dc:description>© 2013, Springer Science+Business Media New York. Software as a Service (SaaS), which offers the possibility to cover both core and non-core business operations of a company, has profoundly transformed traditional outsourcing approaches. As SaaS represents promising solutions for a variety of business processes, it is important to identify a theoretical framework to evaluate SaaS adoption for these two types of operations. We propose an integrative framework to evaluate SaaS adoption by including four perspectives–economic savings, strategic influences, management attitudes toward ownership and vendor’s service quality; and formulate hypotheses to predict the difference in SaaS adoption for core and non-core business operations. We validate our framework using data from 269 companies across different industries in Hong Kong. The results support the integrative framework. Perceived cost advantage has a positive influence on SaaS adoption for non-core business operations, whereas a gap in IT capabilities has a positive influence on SaaS adoption for core business operations. Furthermore, perceived service quality has a positive influence, and management attitude toward ownership and control has a negative influence on SaaS adoption for both types of operations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008928</affiliation-url><afid>60008928</afid><affilname>Hong Kong Polytechnic University</affilname><name-variant>The Hong Kong Polytechnic University</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086485</affiliation-url><afid>60086485</afid><affilname>Hong Kong Productivity Council</affilname><name-variant>Hong Kong Productivity Council</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603149827</author-url><authid>6603149827</authid><authname>Cho V.</authname><surname>Cho</surname><given-name>Vincent</given-name><initials>V.</initials><afid>60008928</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56637510500</author-url><authid>56637510500</authid><authname>Chan A.</authname><surname>Chan</surname><given-name>Aman</given-name><initials>A.</initials><afid>60086485</afid></author><authkeywords>Core business operations | Hong Kong industries | Non-core business operations | SaaS adoption</authkeywords><intid>1535900838</intid><source-id>15572</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927545822"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927545822?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927545822&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927545822&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003269715000482"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927545822</prism:url><dc:identifier>SCOPUS_ID:84927545822</dc:identifier><eid>2-s2.0-84927545822</eid><dc:title>Electrochemical assay for the determination of nitric oxide metabolites using copper(II) chlorophyllin modified screen printed electrodes</dc:title><dc:creator>Balamurugan M.</dc:creator><prism:publicationName>Analytical Biochemistry</prism:publicationName><prism:issn>00032697</prism:issn><prism:eIssn>10960309</prism:eIssn><prism:volume>478</prism:volume><prism:pageRange>121-127</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ab.2015.01.025</prism:doi><pii>S0003269715000482</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. This work presents a novel electrochemical assay for the collective measurement of nitric oxide (NO) and its metabolites nitrite (NO&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;) and nitrate (NO&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;) in volume miniaturized sample at low cost using copper(II) chlorophyllin (CuCP) modified sensor electrode. Zinc oxide (ZnO) incorporated screen printed carbon electrode (SPCE) was used as a host matrix for the immobilization of CuCP. The morphological changes of the ZnO and CuCP modified electrodes were investigated using scanning electron microscopy. The electrochemical characterization of CuCP-ZnO-SPCE exhibited the characteristic quasi-reversible redox peaks at the potential +0.06 V versus Ag/AgCl. This biosensor electrode showed a wide linear range of response over NO concentrations from 200 nM to 500 μM with a detection limit of 100 nM and sensitivity of 85.4 nA μM&lt;sup&gt;-1&lt;/sup&gt;. Furthermore, NO&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt; measurement showed linearity of 100 nM to 1 mM with a detection limit of 100 nM for NO&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt; and sensitivity of 96.4 nA μM&lt;sup&gt;-1&lt;/sup&gt;. Then, the concentration of NO&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt; was measured after its enzymatic conversion into NO&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;. Using this assay, the concentrations of NO, NO&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;, and NO&lt;inf&gt;3&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt; present in human plasma samples before and after beetroot supplement were estimated using suitable membrane coated CuCP-ZnO-SPCE and validated with the standard Griess method.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007431</affiliation-url><afid>60007431</afid><affilname>Virudhunagar Hindu Nadar's Senthikumara Nadar College</affilname><name-variant>VHNSN College</name-variant><affiliation-city>Virudhunagar</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014608</affiliation-url><afid>60014608</afid><affilname>Defence Institute of Physiology and Allied Sciences India</affilname><name-variant>Defence Institute of Physiology and Allied Sciences</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55311697700</author-url><authid>55311697700</authid><authname>Balamurugan M.</authname><surname>Balamurugan</surname><given-name>Murugesan</given-name><initials>M.</initials><afid>60007431</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55479602800</author-url><authid>55479602800</authid><authname>Madasamy T.</authname><surname>Madasamy</surname><given-name>Thangamuthu</given-name><initials>T.</initials><afid>60007431</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55481972100</author-url><authid>55481972100</authid><authname>Pandiaraj M.</authname><surname>Pandiaraj</surname><given-name>Manickam</given-name><initials>M.</initials><afid>60007431</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36493911300</author-url><authid>36493911300</authid><authname>Bhargava K.</authname><surname>Bhargava</surname><given-name>Kalpana</given-name><initials>K.</initials><afid>60014608</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:10039651700</author-url><authid>10039651700</authid><authname>Sethy N.</authname><surname>Sethy</surname><given-name>Niroj Kumar</given-name><initials>N.K.</initials><afid>60014608</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005623590</author-url><authid>7005623590</authid><authname>Karunakaran C.</authname><surname>Karunakaran</surname><given-name>Chandran</given-name><initials>C.</initials><afid>60007431</afid></author><authkeywords>Copper(II) chlorophyllin | Electrochemical assay | Nitrate | Nitric oxide | Nitrite | Screen printed carbon electrode</authkeywords><intid>535634895</intid><source-id>16789</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925302301"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925302301?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925302301&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925302301&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1043466615001003"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925302301</prism:url><dc:identifier>SCOPUS_ID:84925302301</dc:identifier><eid>2-s2.0-84925302301</eid><dc:title>Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects</dc:title><dc:creator>Hagen I.</dc:creator><prism:publicationName>Cytokine</prism:publicationName><prism:issn>10434666</prism:issn><prism:eIssn>10960023</prism:eIssn><prism:volume>73</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>265-269</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cyto.2015.02.022</prism:doi><pii>S1043466615001003</pii><dc:description>© 2015 Elsevier Ltd. Introduction: Obesity is associated with low-grade systemic inflammation which is thought to trigger the development of comorbidities such as type 2 diabetes. The soluble receptor for advanced glycation end products (sRAGE) belongs to the innate immune system and has been linked to obesity, recently. The aim of the present study was to examine whether serum sRAGE concentrations are related to the grade of weight loss and improvement of insulin resistance due to a very low calorie diet (VLCD). Methods: 22 severe obese subjects (Median Body Mass Index (BMI): 44.5kg/m2) were included in a dietary intervention study of 6month, consisting of a very low calorie formula diet phase (VLCD: 800kcal/d) for 12weeks and a following 12week weight maintenance phase. Fasting glucose, fasting insulin, adiponectin, leptin and sRAGE were determined from sera. Insulin sensitivity was estimated by Homeostasis Model Assessment (HOMA) index and leptin-to-adiponectin-ratio (LAR). Results: Mean body weight reduction by VLCD accounted to 21.7. kg with a significant improvement of insulin resistance. At baseline, sRAGE serum levels were significantly inversely related to BMI (. rS=. -0.642, p=. 0.001) and HOMA (. rS=. -0.419, p=. 0.041). Of interest, sRAGE serum levels at baseline were significantly lower in study subjects with greater reduction of BMI (. p=. 0.017). In addition, a significantly greater HOMA reduction was observed in subjects with lower sRAGE serum levels at baseline (. p=. 0.006). Finally, correlation analysis revealed, that changes of sRAGE serum levels were significantly correlated to changes of BMI (. rS=. -0.650, p=. 0.022) during intervention. Conclusion: Anti-inflammatory sRAGE might be a potential future biomarker to predict weight loss and improvement of insulin resistance by a VLCD whereby lower baseline sRAGE serum levels indicate a better outcome of the dietary intervention.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012345</affiliation-url><afid>60012345</afid><affilname>Christian-Albrechts-Universitat zu Kiel</affilname><name-variant>University of Kiel</name-variant><affiliation-city>Kiel</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012345</affiliation-url><afid>60012345</afid><affilname>Christian-Albrechts-Universitat zu Kiel</affilname><name-variant>University of Kiel</name-variant><affiliation-city>Kiel</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56541193500</author-url><authid>56541193500</authid><authname>Hagen I.</authname><surname>Hagen</surname><given-name>Imke</given-name><initials>I.</initials><afid>60012345</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:29867483500</author-url><authid>29867483500</authid><authname>Schulte D.</authname><surname>Schulte</surname><given-name>Dominik M.</given-name><initials>D.M.</initials><afid>60012345</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55039136900</author-url><authid>55039136900</authid><authname>Müller N.</authname><surname>Müller</surname><given-name>Nike</given-name><initials>N.</initials><afid>60012345</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56565222300</author-url><authid>56565222300</authid><authname>Martinsen J.</authname><surname>Martinsen</surname><given-name>Jessica</given-name><initials>J.</initials><afid>60012345</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56091073400</author-url><authid>56091073400</authid><authname>Türk K.</authname><surname>Türk</surname><given-name>Kathrin</given-name><initials>K.</initials><afid>60012345</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003362776</author-url><authid>7003362776</authid><authname>Hedderich J.</authname><surname>Hedderich</surname><given-name>Jürgen</given-name><initials>J.</initials><afid>60012345</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56540733800</author-url><authid>56540733800</authid><authname>Schreiber S.</authname><surname>Schreiber</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60012345</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56550250600</author-url><authid>56550250600</authid><authname>Laudes M.</authname><surname>Laudes</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60012345</afid></author><authkeywords>Biomarker | Dietary intervention | Soluble receptor for advanced glycation end products | Very low calorie diet</authkeywords><intid>1035275862</intid><source-id>22083</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925795833"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925795833?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925795833&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925795833&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304388615000261"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925795833</prism:url><dc:identifier>SCOPUS_ID:84925795833</dc:identifier><eid>2-s2.0-84925795833</eid><dc:title>A preliminary study on time series forecast of fair-weather atmospheric electric field with WT-LSSVM method</dc:title><dc:creator>Zhang Y.</dc:creator><prism:publicationName>Journal of Electrostatics</prism:publicationName><prism:issn>03043886</prism:issn><prism:volume>75</prism:volume><prism:pageRange>85-89</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.elstat.2015.03.005</prism:doi><pii>S0304388615000261</pii><dc:description>© 2015 Elsevier B.V. Accurate forecasting of fair-weather atmospheric electric field is of great importance to denote the climate change, and it also plays a vital role in lightning forecasting. In this paper, the WT (Wavelet transform)-LSSVM (Least squares support vector machine) method is proposed to develop a model to forecast time series of fair-weather atmospheric electric field. The application experiments with data from Verhnee Dubrovo, Dusheti, and Voeikovo stations show that the predicted data and observed value have the same tendency. The correlation coefficients between them are 0.8149, 0.6395 and 0.7308, while the MSE are 16.9869V/m, 28.8876V/m and 32.2163V/m, respectively. Furthermore, comparing to LSSVM and ANN, WT-LSSVM is a superior method to predict the monthly mean values of fair-weather atmospheric electric field.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106310596</affiliation-url><afid>106310596</afid><affilname>Lightning Protection Center of Zhejiang Province</affilname><name-variant>Institute of Zhejiang Province</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60064143</affiliation-url><afid>60064143</afid><affilname>Nanjing University of Information Science and Technology</affilname><name-variant>Nanjing University of Information Science and Technology</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60064143</affiliation-url><afid>60064143</afid><affilname>Nanjing University of Information Science and Technology</affilname><name-variant>Nanjing University of Information Science and Technology</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55739998100</author-url><authid>55739998100</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>106310596</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56573063600</author-url><authid>56573063600</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hao</given-name><initials>H.</initials><afid>106310596</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56573043800</author-url><authid>56573043800</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhenhui</given-name><initials>Z.</initials><afid>60064143</afid><afid>60064143</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56573043800</author-url><authid>56573043800</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhenhui</given-name><initials>Z.</initials><afid>60064143</afid><afid>60064143</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56573081400</author-url><authid>56573081400</authid><authname>Zhang W.</authname><surname>Zhang</surname><given-name>Weibin</given-name><initials>W.</initials><afid>106310596</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56573132100</author-url><authid>56573132100</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jian</given-name><initials>J.</initials><afid>106310596</afid></author><authkeywords>Fair-weather atmospheric electric field | Forecast | WT-LSSVM</authkeywords><intid>2035341466</intid><source-id>18041</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926626305"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926626305?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926626305&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926626305&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926626305</prism:url><dc:identifier>SCOPUS_ID:84926626305</dc:identifier><eid>2-s2.0-84926626305</eid><dc:title>Adiponectin prevents reduction of lipid-induced mitochondrial biogenesis via AMPK/ACC2 pathway in chicken adipocyte</dc:title><dc:creator>Gan L.</dc:creator><prism:publicationName>Journal of Cellular Biochemistry</prism:publicationName><prism:issn>07302312</prism:issn><prism:eIssn>10974644</prism:eIssn><prism:volume>116</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1090-1100</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/jcb.25064</prism:doi><dc:description>© 2014 Wiley Periodicals, Inc. Adiponectin (APN) stimulates mitochondrial biogenesis and reduces lipid content in human and animal adipocytes. However, the mechanism of adiponectin in regulating mitochondrial biogenesis in chicken adipocytes has never been reported. The objective of this study is to examine the mechanism that adiponectin plays in lipid-induced mitochondrial biogenesis and mitochondrial function in chicken adipocytes. We found that the overexpression of adiponectin reduced the membrane DAG content and elevated the membrane translocation of PKCθ. In contrast to control groups, the overexpression of adiponectin increased mitochondrial density and mitochondrial DNA contents and peroxisome proliferator-activated receptor αcoactivator 1α (PGC1-α) expression. Mitochondrial membrane potential and cytochrome C (Cyt C) content were detected by JC-1 fluorescent staining and immunofluorescence which indicated that overexpression of adiponectin enhanced mitochondrial ATP synthesis. Moreover, AMPK/ACC2 signaling pathway was activated along with the elevation of PGC1-α and TFAM by the overexpression of adiponectin, meanwhile the lipid transcription marker genes were down-regulated. This effect was alleviated by reducing adiponectin and a specific inhibitor of AMPK pathway. We concluded that adiponectin could prevent reduction of lipid-induced mitochondrial biogenesis via AMPK/ACC2 pathway in chicken adipocytes. J. Cell. Biochem. 116: 1090-1100, 2015.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031041</affiliation-url><afid>60031041</afid><affilname>Northwest A&amp;F University</affilname><name-variant>Northwest A and F University</name-variant><affiliation-city>Yangling</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36571686800</author-url><authid>36571686800</authid><authname>Gan L.</authname><surname>Gan</surname><given-name>Lu</given-name><initials>L.</initials><afid>60031041</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55325021100</author-url><authid>55325021100</authid><authname>Yan J.</authname><surname>Yan</surname><given-name>Jun</given-name><initials>J.</initials><afid>60031041</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55965513500</author-url><authid>55965513500</authid><authname>Liu Z.</authname><surname>Liu</surname><given-name>Zhenjiang</given-name><initials>Z.</initials><afid>60031041</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55499703900</author-url><authid>55499703900</authid><authname>Feng M.</authname><surname>Feng</surname><given-name>Min</given-name><initials>M.</initials><afid>60031041</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35308428500</author-url><authid>35308428500</authid><authname>Sun C.</authname><surname>Sun</surname><given-name>Chao</given-name><initials>C.</initials><afid>60031041</afid></author><authkeywords>ADIPOCYTOKINE | AMPK | FAT CELLS | MITOCHONDRIA | POULTRY</authkeywords><intid>2035480451</intid><source-id>17598</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927947393"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927947393?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927947393&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927947393&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927947393</prism:url><dc:identifier>SCOPUS_ID:84927947393</dc:identifier><eid>2-s2.0-84927947393</eid><dc:title>Income-based life-course models of caries in 30-year-old Australian adults</dc:title><dc:creator>Brennan D.</dc:creator><prism:publicationName>Community Dentistry and Oral Epidemiology</prism:publicationName><prism:issn>03015661</prism:issn><prism:eIssn>16000528</prism:eIssn><prism:volume>43</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>262-271</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/cdoe.12150</prism:doi><dc:description>© 2015 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd. Objectives To assess income-based life-course models between the age of 13 and 30 years and caries in young adults. Methods In 1988-89, n = 7673 South Australian school children aged 13 years were sampled with n = 4604 children (60.0%) and n = 4476 parents (58.3%) returning questionnaires. In 2005-06, n = 632 baseline study participants aged 30 years responded (43.0% of those traced and living in Adelaide). Life-course models representing critical period, cumulative risk and social mobility were constructed using income tertiles at ages 13 and 30 years. Critical period was evaluated by comparing the low tertile with the middle and higher tertiles at age 13. Cumulative risk was evaluated by coding the low tertile as 2, the middle tertile as 1 and highest tertile as 0, and summing to produce a cumulative risk score categorized into lower (score 0-1), moderate (score of 2) and higher risk (scores 3-4). Social mobility was classified using tertiles into stable disadvantaged, downwardly mobile, stable middle income, upwardly mobile and stable advantaged. Results Models adjusting for sex, visiting and toothbrushing at age 30 showed no association between caries at age 30 and low income at age 13 years (critical period model). Compared to the low cumulative risk group based on income, decayed teeth (RR = 1.6) and missing teeth (RR = 7.2) were higher (P &lt; 0.05) in the higher risk group, and missing teeth (RR = 6.0) were higher in the moderate risk group (cumulative risk model). There were more (P &lt; 0.05) decayed teeth in the disadvantaged (RR = 3.1) and stable middle income groups (RR = 2.2), more missing teeth for those classified as disadvantaged (RR = 6.4), stable middle (RR = 6.3) and downwardly mobile (RR = 2.8), and higher DMFT for the disadvantaged group (RR = 1.5) compared to the upwardly mobile group (social mobility model). Conclusions Socioeconomic advantage and upward mobility were associated with fewer decayed and missing teeth at age 30 years. Life-course models of cumulative risk and social mobility influenced oral health outcomes across childhood to adulthood.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009512</affiliation-url><afid>60009512</afid><affilname>University of Adelaide</affilname><name-variant>University of Adelaide</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009512</affiliation-url><afid>60009512</afid><affilname>University of Adelaide</affilname><name-variant>University of Adelaide</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7103174490</author-url><authid>7103174490</authid><authname>Brennan D.</authname><surname>Brennan</surname><given-name>David Simon</given-name><initials>D.S.</initials><afid>60009512</afid><afid>60009512</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7103174490</author-url><authid>7103174490</authid><authname>Brennan D.</authname><surname>Brennan</surname><given-name>David Simon</given-name><initials>D.S.</initials><afid>60009512</afid><afid>60009512</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56492287000</author-url><authid>56492287000</authid><authname>Spencer A.</authname><surname>Spencer</surname><given-name>A. John</given-name><initials>A.J.</initials><afid>60009512</afid></author><authkeywords>caries | life course | mobility | young adults</authkeywords><intid>535701980</intid><source-id>24413</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925742178"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925742178?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925742178&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925742178&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213576615000317"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925742178</prism:url><dc:identifier>SCOPUS_ID:84925742178</dc:identifier><eid>2-s2.0-84925742178</eid><dc:title>Newborn male presented with congenital diaphragmatic hernia and choledochal cyst: A case report</dc:title><dc:creator>Krebs D.</dc:creator><prism:publicationName>Journal of Pediatric Surgery Case Reports</prism:publicationName><prism:eIssn>22135766</prism:eIssn><prism:volume>3</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>179-181</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.epsc.2015.03.001</prism:doi><pii>S2213576615000317</pii><dc:description>© 2015 The Authors. Infants with congenital diaphragmatic hernia (CDH) have an increased incidence of associated malformations, ranging from 10% to 50% higher than the general population [1-5]. Choedochal cysts, congenital cystic dilations of the biliary tree, are anomalies that have not yet been described in association with CDH. We describe a patient with a left congenital diaphragmatic hernia who was later diagnosed with a choledochal cyst.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004109</affiliation-url><afid>60004109</afid><affilname>University of Mississippi Medical Center</affilname><name-variant>Univ. of Mississippi Medical Center</name-variant><affiliation-city>Jackson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004109</affiliation-url><afid>60004109</afid><affilname>University of Mississippi Medical Center</affilname><name-variant>Univ. of Mississippi Medical Center</name-variant><affiliation-city>Jackson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56573579600</author-url><authid>56573579600</authid><authname>Krebs D.</authname><surname>Krebs</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60004109</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56573461800</author-url><authid>56573461800</authid><authname>Herman R.</authname><surname>Herman</surname><given-name>Richard S.</given-name><initials>R.S.</initials><afid>60004109</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701845091</author-url><authid>6701845091</authid><authname>Blewett C.</authname><surname>Blewett</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60004109</afid></author><authkeywords>Choledochal cyst | Congenital anomalies | Congenital diaphragmatic hernia</authkeywords><intid>1035342885</intid><source-id>21100255429</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926453830"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926453830?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926453830&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926453830&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501500221X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926453830</prism:url><dc:identifier>SCOPUS_ID:84926453830</dc:identifier><eid>2-s2.0-84926453830</eid><dc:title>Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic tangier disease with compound heterozygous mutations in ABCA1 gene</dc:title><dc:creator>Tada H.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>324-329</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.003</prism:doi><pii>S002191501500221X</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: Molecular diagnosis for subjects with extremely low HDL-C through candidate-gene approaches requires huge effort. Whole exome-sequencing (WES) has already shown approximately ~30% success in the diagnosis of Mendelian disorders. Moreover, novel in silico prediction software for the pathogenicity of novel missense variants named Combined Annotation Dependent Depletion (CADD) has recently been developed, enabling the objective integration of many diverse annotations into a single measure (C-score) for each variant. Here, we investigated whether WES combined with integrated variant annotation prediction could facilitate the molecular diagnosis of this rare condition. Methods: WES was performed on 8 individuals including 2 individuals exhibiting extremely low HDL-C (2mg/dl and 6mg/dl), 2 unaffected family members, and 4 unrelated individuals as controls. We filtered out the following variants: 1) Benign variants predicted by SnpEff; 2) Minor allele frequency (MAF)&lt;1%; 3) Segregation unmatched for the recessive form of inheritance; 4) C-score&lt;10. Results: Among 305,202 variants found in those individuals, we found 21,708 nonsense, missense, or splice site variants, of which 5192 were rare (MAF≤1% or not reported). Filtering assuming a recessive pattern of inheritance, combined with the use of the C-score, successfully narrowed down the candidates to compound heterozygous mutations in the ABCA1 gene (c.6230C&lt;A or p.P2077H/c.6137G&lt;A or p.S2046N, and c.2842G&lt;A or p.G948R/c.1130C&lt;T or p.P377L). Conclusions: WES combined with integrated variant annotation prediction successfully identified asymptomatic Tangier disease with novel ABCA1 mutations. This comprehensive approach is useful to determine causative variants, especially in recessive inherited diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032572</affiliation-url><afid>60032572</afid><affilname>Kanazawa University School of Medicine</affilname><name-variant>Kanazawa University School of Medicine</name-variant><affiliation-city>Kanazawa</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032572</affiliation-url><afid>60032572</afid><affilname>Kanazawa University School of Medicine</affilname><name-variant>Kanazawa University School of Medicine</name-variant><affiliation-city>Kanazawa</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032572</affiliation-url><afid>60032572</afid><affilname>Kanazawa University School of Medicine</affilname><name-variant>Kanazawa University School of Medicine</name-variant><affiliation-city>Kanazawa</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032572</affiliation-url><afid>60032572</afid><affilname>Kanazawa University School of Medicine</affilname><name-variant>Kanazawa University School of Medicine</name-variant><affiliation-city>Kanazawa</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9333723300</author-url><authid>9333723300</authid><authname>Tada H.</authname><surname>Tada</surname><given-name>Hayato</given-name><initials>H.</initials><afid>60032572</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23469781200</author-url><authid>23469781200</authid><authname>Kawashiri M.</authname><surname>Kawashiri</surname><given-name>Masa aki</given-name><initials>M.a.</initials><afid>60032572</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005293541</author-url><authid>7005293541</authid><authname>Nohara A.</authname><surname>Nohara</surname><given-name>Atsushi</given-name><initials>A.</initials><afid>60032572</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54382303800</author-url><authid>54382303800</authid><authname>Saito R.</authname><surname>Saito</surname><given-name>Reina</given-name><initials>R.</initials><afid>60032572</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56108604100</author-url><authid>56108604100</authid><authname>Tanaka Y.</authname><surname>Tanaka</surname><given-name>Yoshihiro</given-name><initials>Y.</initials><afid>60032572</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56425231800</author-url><authid>56425231800</authid><authname>Nomura A.</authname><surname>Nomura</surname><given-name>Akihiro</given-name><initials>A.</initials><afid>60032572</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56425162600</author-url><authid>56425162600</authid><authname>Konno T.</authname><surname>Konno</surname><given-name>Tetsuo</given-name><initials>T.</initials><afid>60032572</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56489688400</author-url><authid>56489688400</authid><authname>Sakata K.</authname><surname>Sakata</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60032572</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56583858800</author-url><authid>56583858800</authid><authname>Fujino N.</authname><surname>Fujino</surname><given-name>Noboru</given-name><initials>N.</initials><afid>60032572</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56583697500</author-url><authid>56583697500</authid><authname>Takamura T.</authname><surname>Takamura</surname><given-name>Toshinari</given-name><initials>T.</initials><afid>60032572</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56568809300</author-url><authid>56568809300</authid><authname>Inazu A.</authname><surname>Inazu</surname><given-name>Akihiro</given-name><initials>A.</initials><afid>60032572</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35376004200</author-url><authid>35376004200</authid><authname>Mabuchi H.</authname><surname>Mabuchi</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60032572</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7202970814</author-url><authid>7202970814</authid><authname>Yamagishi M.</authname><surname>Yamagishi</surname><given-name>Masakazu</given-name><initials>M.</initials><afid>60032572</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56424508700</author-url><authid>56424508700</authid><authname>Hayashi K.</authname><surname>Hayashi</surname><given-name>Kenshi</given-name><initials>K.</initials><afid>60032572</afid></author><authkeywords>ABCA1 | Exome | Genetics | HDL | Tangier disease</authkeywords><intid>35454686</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922426787"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922426787?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922426787&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922426787&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1095643315000094"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922426787</prism:url><dc:identifier>SCOPUS_ID:84922426787</dc:identifier><eid>2-s2.0-84922426787</eid><dc:title>Adaptation of oxidative phosphorylation to photoperiod-induced seasonal metabolic states in migratory songbirds</dc:title><dc:creator>Trivedi A.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology</prism:publicationName><prism:issn>10956433</prism:issn><prism:eIssn>15314332</prism:eIssn><prism:volume>184</prism:volume><prism:pageRange>34-40</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpa.2015.01.011</prism:doi><pii>S1095643315000094</pii><dc:description>© 2015 Elsevier Inc. Eukaryotic cells produce chemical energy in the form of ATP by oxidative phosphorylation of metabolic fuels via a series of enzyme mediated biochemical reactions. We propose that the rates of these reactions are altered, as per energy needs of the seasonal metabolic states in avian migrants. To investigate this, blackheaded buntings were photoperiodically induced with non-migratory, premigratory, migratory and post-migratory phenotypes. High plasma levels of free fatty acids, citrate (an intermediate that begins the TCA cycle) and malate dehydrogenase (mdh, an enzyme involved at the end of the TCA cycle) confirmed increased availability of metabolic reserves and substrates to the TCA cycle during the premigratory and migratory states, respectively. Further, daily expression pattern of genes coding for enzymes involved in the oxidative decarboxylation of pyruvate to acetyl-CoA (pdc and pdk) and oxidative phosphorylation in the TCA cycle (cs, odgh, sdhd and mdh) was monitored in the hypothalamus and liver. Reciprocal relationship between pdc and pdk expressions conformed with the altered requirements of acetyl-CoA for the TCA cycle in different metabolic states. Except for pdk, all genes had a daily expression pattern, with high mRNA expression during the day in the premigratory/migratory phenotypes, and at night (cs, odhg, sdhd and mdh) in the nonmigratory phenotype. Differences in mRNA expression patterns of pdc, sdhd and mdh, but not of pdk, cs and odgh, between the hypothalamus and liver indicated a tissue dependent metabolism in buntings. These results suggest the adaptation of oxidative phosphorylation pathway(s) at gene levels to the seasonal alternations in metabolism in migratory songbirds.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029284</affiliation-url><afid>60029284</afid><affilname>University of Delhi</affilname><name-variant>University of Delhi</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004095</affiliation-url><afid>60004095</afid><affilname>University of Lucknow</affilname><name-variant>Lucknow University</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9746525900</author-url><authid>9746525900</authid><authname>Trivedi A.</authname><surname>Trivedi</surname><given-name>Amit Kumar</given-name><initials>A.K.</initials><afid>60029284</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402973278</author-url><authid>7402973278</authid><authname>Malik S.</authname><surname>Malik</surname><given-name>Shalie</given-name><initials>S.</initials><afid>60004095</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005597725</author-url><authid>7005597725</authid><authname>Rani S.</authname><surname>Rani</surname><given-name>Sangeeta</given-name><initials>S.</initials><afid>60004095</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404633980</author-url><authid>7404633980</authid><authname>Kumar V.</authname><surname>Kumar</surname><given-name>Vinod</given-name><initials>V.</initials><afid>60029284</afid></author><authkeywords>Bunting | Energy generation | Migration | Oxidative phosphorylation | TCA cycle</authkeywords><intid>2034805110</intid><source-id>3500148021</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929151683"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929151683?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929151683&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929151683&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929151683</prism:url><dc:identifier>SCOPUS_ID:84929151683</dc:identifier><eid>2-s2.0-84929151683</eid><dc:title>Evaluation of serum antioxidants in age-related hearing loss</dc:title><dc:creator>Lasisi T.</dc:creator><prism:publicationName>Aging Clinical and Experimental Research</prism:publicationName><prism:issn>15940667</prism:issn><prism:eIssn>17208319</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>265-269</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s40520-014-0282-3</prism:doi><dc:description>© 2014, Springer International Publishing Switzerland. Background: Age-related hearing loss (ARHL) has been linked to the shift in the pro-oxidant/antioxidant ratio. Our objectives were to assess serum levels of retinol and zinc among the elderly individuals and to correlate the levels with hearing threshold. Methods: Prospective study of apparently healthy individuals aged ≥60 years of age. Participants had complete clinical history, physical examination and pure tone average conducted. Blood samples were collected for determination of serum levels of retinol and zinc. Mann–Whitney U test was used to compare retinol and zinc values. Pearson’s correlation test was used to determine the relationship between hearing threshold and serum levels of retinol and zinc. Results: Among 126 elderly participants with mean age 67 ± 2.7 years; the mean pure tone average for air conduction was 29.3 ± 1.6 dBHL while the mean bone conduction was 36.5 ± 1.8 dBHL. The median values of serum retinol and zinc levels in the elderly participants who had hearing loss in the speech frequencies were 52 and 83.3 μg/L, respectively, while among participants with normal hearing threshold, values were 50 and 89.9 μg/L, respectively (p = 0.59 and 0.99, respectively). For the high frequencies, the median value of serum retinol and zinc levels among the elderly participants with normal hearing threshold was 70.3 and 99.9 μg/L, while among those with hearing loss, it was 46.9 and 83.2 μg/L, respectively (p = 0.000 and 0.005, respectively). Conclusion: Serum retinol and zinc levels were significantly lower among elderly with hearing loss involving the high frequencies. This is added evidence to extant literature on the possible role of antioxidants in the development of ARHL and suggests further study on the effect of antioxidants supplementation in the control of ARHL which is presently controversial and inconclusive.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006270</affiliation-url><afid>60006270</afid><affilname>University of Ibadan</affilname><name-variant>University of Ibadan</name-variant><affiliation-city>Ibadan</affiliation-city><affiliation-country>Nigeria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006270</affiliation-url><afid>60006270</afid><affilname>University of Ibadan</affilname><name-variant>University of Ibadan</name-variant><affiliation-city>Ibadan</affiliation-city><affiliation-country>Nigeria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55624834700</author-url><authid>55624834700</authid><authname>Lasisi T.</authname><surname>Lasisi</surname><given-name>Taye Jemilat</given-name><initials>T.J.</initials><afid>60006270</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:18037511800</author-url><authid>18037511800</authid><authname>Lasisi A.</authname><surname>Lasisi</surname><given-name>Akeem Olawale</given-name><initials>A.O.</initials><afid>60006270</afid></author><authkeywords>Age related hearing loss | Antioxidants | Elderly | Hearing threshold | Retinol | Zinc</authkeywords><intid>535918345</intid><source-id>28496</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923857629"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923857629?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923857629&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923857629&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0889157515000538"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923857629</prism:url><dc:identifier>SCOPUS_ID:84923857629</dc:identifier><eid>2-s2.0-84923857629</eid><dc:title>Human exposure in Italy to lead, cadmium and mercury through fish and seafood product consumption from Eastern Central Atlantic Fishing Area</dc:title><dc:creator>Zaza S.</dc:creator><prism:publicationName>Journal of Food Composition and Analysis</prism:publicationName><prism:issn>08891575</prism:issn><prism:volume>40</prism:volume><prism:pageRange>148-153</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jfca.2015.01.007</prism:doi><pii>S0889157515000538</pii><dc:description>© 2015 Elsevier Inc. The presence of cadmium (Cd), lead (Pb) and mercury (Hg) was investigated in fish and seafood products collected from the FAO Major Fishing Area 34, Eastern Central Atlantic. Samples were purchased from different retail outlets in Italy. Samples were selected so as to assess human exposure through diet. Metals were detected by Q-ICP-MS and Hg-AAS. All the metal concentrations detected were largely below the maximum levels (MLs) established by the European Union. The exposure assessment was undertaken by matching the concentration of Cd, Pb and total Hg in fish and other seafood products selected purposed according to Italian consumption data. The estimated weekly intakes (EWIs) for the evaluated elements related to the consumption of fish and other seafood products by the median of the Italian total population accounted for 14%, 2% and 14% of the standard tolerable weekly intake (TWI) for Cd and Hg as well as the provisional tolerable weekly intake (PTWI) for Pb, respectively.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Istituto Superiore di Sanità</affilname><name-variant>Ondico Organismo Notificato Dispositivi Medici e Cosmetici</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Food and Agriculture Organization (FAO)</affilname><name-variant>Veterinary Public Health</name-variant><name-variant>Animal Health Service</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Sapienza University of Rome</affilname><name-variant>Department of Physiology and Pharmacology</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Istituto Superiore di Sanità</affilname><name-variant>National Reference Laboratory for Heavy Metals in Food</name-variant><name-variant>Department of Food Safety and Veterinary Public Health</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36151522900</author-url><authid>36151522900</authid><authname>Zaza S.</authname><surname>Zaza</surname><given-name>Silvia</given-name><initials>S.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23110408300</author-url><authid>23110408300</authid><authname>de Balogh K.</authname><surname>de Balogh</surname><given-name>Katinka</given-name><initials>K.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003770948</author-url><authid>7003770948</authid><authname>Palmery M.</authname><surname>Palmery</surname><given-name>Maura</given-name><initials>M.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55440650700</author-url><authid>55440650700</authid><authname>Pastorelli A.</authname><surname>Pastorelli</surname><given-name>Augusto Alberto</given-name><initials>A.A.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602976552</author-url><authid>6602976552</authid><authname>Stacchini P.</authname><surname>Stacchini</surname><given-name>Paolo</given-name><initials>P.</initials><afid/></author><authkeywords>Fish | Food analysis | Food composition | Food safety | Heavy metals | Provisional tolerable weekly intake | Seafood products | Tolerable weekly intake</authkeywords><intid>2035071616</intid><source-id>20582</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928653822"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928653822?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928653822&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928653822&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928653822</prism:url><dc:identifier>SCOPUS_ID:84928653822</dc:identifier><eid>2-s2.0-84928653822</eid><dc:title>Measuring Implicit and Explicit Acceptability of Reinforcement Versus Punishment Interventions with Teachers Working in ABA Versus Mainstream Schools</dc:title><dc:creator>Kelly M.</dc:creator><prism:publicationName>Psychological Record</prism:publicationName><prism:issn>00332933</prism:issn><prism:eIssn>21633452</prism:eIssn><prism:volume>65</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>251-265</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s40732-014-0101-4</prism:doi><dc:description>© 2014, Association for Behavior Analysis International. This research aimed to develop the implicit relational assessment procedure (IRAP) as a measure of treatment acceptability and to assess teachers’ acceptability of reinforcement and punishment interventions in the presence of “good” and “bad” behaviors. Participants included 15 teachers trained in ABA (ABATs) who worked with children with developmental disabilities, and 15 teachers trained in mainstream primary education (MTs) who worked with typically developing children. On the IRAP, the ABAT group showed proreinforcement biases for all behaviors, while MTs showed a proreinforcement bias for good behavior but a propunishment bias for bad behavior. On explicit measures of acceptability, although both groups showed proreinforcement and antipunishment biases, the ABATs rated reinforcement as significantly more acceptable than the MTs; the ratings of punishment did not differ across the two groups. The research provides support for the IRAP as a measure of treatment acceptability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026281</affiliation-url><afid>60026281</afid><affilname>Maynooth University</affilname><name-variant>National University of Ireland</name-variant><affiliation-city>Maynooth</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36866510700</author-url><authid>36866510700</authid><authname>Kelly M.</authname><surname>Kelly</surname><given-name>Michelle E.</given-name><initials>M.E.</initials><afid>60026281</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004356899</author-url><authid>7004356899</authid><authname>Barnes-Holmes D.</authname><surname>Barnes-Holmes</surname><given-name>Dermot</given-name><initials>D.</initials><afid>60026281</afid></author><authkeywords>Implicit attitudes | Punishment | Reinforcement | Stimulus modalities | Treatment acceptability</authkeywords><intid>1785824894</intid><source-id>13464</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928143241"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928143241?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928143241&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928143241&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001161"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928143241</prism:url><dc:identifier>SCOPUS_ID:84928143241</dc:identifier><eid>2-s2.0-84928143241</eid><dc:title>Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt;/PGF&lt;inf&gt;2α&lt;/inf&gt; ratio distinguishes chemical from enzymatic lipid peroxidation</dc:title><dc:creator>Van'T Erve T.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>245-251</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.03.004</prism:doi><pii>S0891584915001161</pii><dc:description>The biomarker 8-iso-prostaglandin F&lt;inf&gt;2α&lt;/inf&gt; (8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt;) is regarded as the gold standard for detection of excessive chemical lipid peroxidation in humans. However, biosynthesis of 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; via enzymatic lipid peroxidation by prostaglandin-endoperoxide synthases (PGHSs), which are significantly induced in inflammation, could lead to incorrect biomarker interpretation. To resolve the ambiguity with this biomarker, the ratio of 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; to prostaglandin F&lt;inf&gt;2α&lt;/inf&gt; (PGF&lt;inf&gt;2α&lt;/inf&gt;) is established as a quantitative measure to distinguish enzymatic from chemical lipid peroxidation in vitro, in animal models, and in humans. Using this method, we find that chemical lipid peroxidation contributes only 3% to the total 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; in the plasma of rats. In contrast, the 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; levels in plasma of human males are generated &gt;99% by chemical lipid peroxidation. This establishes the potential for an alternate pathway of biomarker synthesis, and draws into question the source of increases in 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; seen in many human diseases. In conclusion, increases in 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; do not necessarily reflect increases in oxidative stress; therefore, past studies using 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt; as a marker of oxidative stress may have been misinterpreted. The 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt;/PGF&lt;inf&gt;2α&lt;/inf&gt; ratio can be used to distinguish biomarker synthesis pathways and thus confirm the potential change in oxidative stress in the myriad of disease and chemical exposures known to induce 8-iso-PGF&lt;inf&gt;2α&lt;/inf&gt;.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005280</affiliation-url><afid>60005280</afid><affilname>The Research Triangle Park</affilname><name-variant>RTP</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028652</affiliation-url><afid>60028652</afid><affilname>National Institute of Environmental Health Sciences</affilname><name-variant>Natl. Inst. of Environ. Hlth. Sci.</name-variant><affiliation-city>Research Triangle Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028652</affiliation-url><afid>60028652</afid><affilname>National Institute of Environmental Health Sciences</affilname><name-variant>Natl. Inst. of Environ. Hlth. Sci.</name-variant><affiliation-city>Research Triangle Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37032210700</author-url><authid>37032210700</authid><authname>Van'T Erve T.</authname><surname>Van'T Erve</surname><given-name>Thomas J.</given-name><initials>T.J.</initials><afid>60005280</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9044394600</author-url><authid>9044394600</authid><authname>Lih F.</authname><surname>Lih</surname><given-name>Fred B.</given-name><initials>F.B.</initials><afid>60028652</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006405147</author-url><authid>7006405147</authid><authname>Kadiiska M.</authname><surname>Kadiiska</surname><given-name>Maria B.</given-name><initials>M.B.</initials><afid>60005280</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004195850</author-url><authid>7004195850</authid><authname>Deterding L.</authname><surname>Deterding</surname><given-name>Leesa J.</given-name><initials>L.J.</initials><afid>60028652</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102076436</author-url><authid>7102076436</authid><authname>Eling T.</authname><surname>Eling</surname><given-name>Thomas E.</given-name><initials>T.E.</initials><afid>60028652</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35372107900</author-url><authid>35372107900</authid><authname>Mason R.</authname><surname>Mason</surname><given-name>Ronald P.</given-name><initials>R.P.</initials><afid>60005280</afid></author><authkeywords>Biomarkers | F&lt;inf&gt;2&lt;/inf&gt;-isoprostanes | Inflammation | Lipid peroxidation | Oxidative stress</authkeywords><intid>2035728341</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928106071"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928106071?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928106071&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928106071&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928106071</prism:url><dc:identifier>SCOPUS_ID:84928106071</dc:identifier><eid>2-s2.0-84928106071</eid><dc:title>Drug-drug plasma protein binding interactions of ivacaftor</dc:title><dc:creator>Schneider E.</dc:creator><prism:publicationName>Journal of Molecular Recognition</prism:publicationName><prism:issn>09523499</prism:issn><prism:eIssn>10991352</prism:eIssn><prism:volume>28</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>339-348</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/jmr.2447</prism:doi><dc:description>Copyright © 2015 John Wiley &amp; Sons, Ltd. Ivacaftor is a novel cystic fibrosis (CF) transmembrane conductance regulator (CFTR) potentiator that improves the pulmonary function for patients with CF bearing a G551D CFTR-protein mutation. Because ivacaftor is highly bound (&gt;97%) to plasma proteins, there is the strong possibility that co-administered CF drugs may compete for the same plasma protein binding sites and impact the free drug concentration. This, in turn, could lead to drastic changes in the in vivo efficacy of ivacaftor and therapeutic outcomes. This biochemical study compares the binding affinity of ivacaftor and co-administered CF drugs for human serum albumin (HSA) and α&lt;inf&gt;1&lt;/inf&gt;-acid glycoprotein (AGP) using surface plasmon resonance and fluorimetric binding assays that measure the displacement of site-selective probes. Because of their ability to strongly compete for the ivacaftor binding sites on HSA and AGP, drug-drug interactions between ivacaftor are to be expected with ducosate, montelukast, ibuprofen, dicloxacillin, omeprazole, and loratadine. The significance of these plasma protein drug-drug interactions is also interpreted in terms of molecular docking simulations. This in vitro study provides valuable insights into the plasma protein drug-drug interactions of ivacaftor with co-administered CF drugs. The data may prove useful in future clinical trials for a staggered treatment that aims to maximize the effective free drug concentration and clinical efficacy of ivacaftor.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115172866</affiliation-url><afid>115172866</afid><affilname>Leopold-Franzen-Universität Innsbruck</affilname><name-variant>Leopold-Franzen-Universität Innsbruck</name-variant><affiliation-city/><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031004</affiliation-url><afid>60031004</afid><affilname>University of Queensland</affilname><name-variant>The University of Queensland</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114758784</affiliation-url><afid>114758784</afid><affilname>Ag Research Limited</affilname><name-variant>Ag Research Limited</name-variant><affiliation-city/><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010571</affiliation-url><afid>60010571</afid><affilname>University of Newcastle, Australia</affilname><name-variant>University of Newcastle</name-variant><affiliation-city>Callaghan</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56599740300</author-url><authid>56599740300</authid><authname>Schneider E.</authname><surname>Schneider</surname><given-name>Elena K.</given-name><initials>E.K.</initials><afid>60019578</afid><afid>115172866</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56599740300</author-url><authid>56599740300</authid><authname>Schneider E.</authname><surname>Schneider</surname><given-name>Elena K.</given-name><initials>E.K.</initials><afid>60019578</afid><afid>115172866</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56244337700</author-url><authid>56244337700</authid><authname>Huang J.</authname><surname>Huang</surname><given-name>Johnny X.</given-name><initials>J.X.</initials><afid>60031004</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56544755400</author-url><authid>56544755400</authid><authname>Carbone V.</authname><surname>Carbone</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>114758784</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55444331500</author-url><authid>55444331500</authid><authname>Baker M.</authname><surname>Baker</surname><given-name>Mark</given-name><initials>M.</initials><afid>60010571</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55224655300</author-url><authid>55224655300</authid><authname>Azad M.</authname><surname>Azad</surname><given-name>Mohammad A K</given-name><initials>M.A.K.</initials><afid>60019578</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7404411451</author-url><authid>7404411451</authid><authname>Cooper M.</authname><surname>Cooper</surname><given-name>Matthew A.</given-name><initials>M.A.</initials><afid>60031004</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:53881345800</author-url><authid>53881345800</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jian</given-name><initials>J.</initials><afid>60019578</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6508388622</author-url><authid>6508388622</authid><authname>Velkov T.</authname><surname>Velkov</surname><given-name>Tony</given-name><initials>T.</initials><afid>60019578</afid></author><authkeywords>binding affinity | cystic fibrosis | human serum albumin | human α-1-acid glycoprotein | ivacaftor</authkeywords><intid>2035727796</intid><source-id>25895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928017438"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928017438?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928017438&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928017438&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S030090841500108X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928017438</prism:url><dc:identifier>SCOPUS_ID:84928017438</dc:identifier><eid>2-s2.0-84928017438</eid><dc:title>An overview of pentatricopeptide repeat proteins and their applications</dc:title><dc:creator>Manna S.</dc:creator><prism:publicationName>Biochimie</prism:publicationName><prism:issn>03009084</prism:issn><prism:eIssn>61831638</prism:eIssn><prism:volume>113</prism:volume><prism:pageRange>93-99</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biochi.2015.04.004</prism:doi><pii>S030090841500108X</pii><dc:description>© 2015 The Author. Published by Elsevier B.V. Pentatricopeptide repeat (PPR) proteins are a large family of modular RNA-binding proteins which mediate several aspects of gene expression primarily in organelles but also in the nucleus. These proteins facilitate processing, splicing, editing, stability and translation of RNAs. While major advances in PPR research have been achieved with plant PPR proteins, the significance of non-plant PPR proteins is becoming of increasing importance. PPR proteins are classified into different subclasses based on their domain architecture, which is often a reflection of their function. This review provides an overview of the significant findings regarding the functions, evolution and applications of PPR proteins. Horizontal gene transfer appears to have played a major role in the sporadic phylogenetic distribution of different PPR subclasses in both eukaryotes and prokaryotes. Additionally, the use of synthetic biology and protein engineering to create designer PPR proteins to control gene expression in vivo is discussed. This review also highlights some of the aspects of PPR research that require more attention particularly in non-plant organisms. This includes the lack of research into the recently discovered PPR-TGM subclass, which is not only the first PPR subclass absent from plants but present in economically and clinically-relevant pathogens. Investigation into the structure and function of PPR-TGM proteins in these pathogens presents a novel opportunity for the exploitation of PPR proteins as drug targets to prevent disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006925</affiliation-url><afid>60006925</afid><affilname>La Trobe University</affilname><name-variant>La Trobe University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55612606300</author-url><authid>55612606300</authid><authname>Manna S.</authname><surname>Manna</surname><given-name>Sam</given-name><initials>S.</initials><afid>60006925</afid></author><authkeywords>Chloroplast | Horizontal gene transfer | Mitochondria | Pentatricopeptide repeat protein | tRNA guanine methyltransferase</authkeywords><intid>1785717262</intid><source-id>16874</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929521195"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929521195?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929521195&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929521195&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929521195</prism:url><dc:identifier>SCOPUS_ID:84929521195</dc:identifier><eid>2-s2.0-84929521195</eid><dc:title>Reduced fractional modeling of 3D video streams: the FERMA approach</dc:title><dc:creator>Nigmatullin R.</dc:creator><prism:publicationName>Nonlinear Dynamics</prism:publicationName><prism:issn>0924090X</prism:issn><prism:volume>80</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>1869-1882</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11071-014-1792-4</prism:doi><dc:description>© 2014, Springer Science+Business Media Dordrecht. Multimedia streaming of three-dimensional (3D) stereoscopic videos over last-generation networks subject to bandwidth limitations is an open problem. The development and spread of communication networks and devices that accept 3D videos is not supported by proper scheduling strategies. Namely the high variability of streams should be considered to reduce effects of network delays, packet losses, shortage of bandwidth resources, and shared use by multiple clients. Then, it is important to improve the characterization of 3D videos for more effective streaming. To this aim, this paper proposes a fractional exponential reduction moments approach based on the statistics of the so-called fractional moments. Each random sequence of frames in 3D videos can be analyzed and reduced to a finite set of parameters, that allow fitting to the sequence by exponential functions and then a characterization and classification of the video by a sort of fingerprint. The method does not depend on the format and the encoding technique of the video. Finally, the approach will allow comparing real streams and numerical data output from fractional dynamical models by means of the reduced parameters. Statistical proximity between time series and a fractional model or between different models simplifies formalization and classification of fractional models.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114784101</affiliation-url><afid>114784101</afid><affilname>Kazan National Research Technical University</affilname><name-variant>Kazan National Research Technical University</name-variant><affiliation-city/><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027299</affiliation-url><afid>60027299</afid><affilname>Politecnico di Bari</affilname><name-variant>Politecnico di Bari</name-variant><affiliation-city>Bari</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006385494</author-url><authid>7006385494</authid><authname>Nigmatullin R.</authname><surname>Nigmatullin</surname><given-name>Raoul R.</given-name><initials>R.R.</initials><afid>114784101</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55911527600</author-url><authid>55911527600</authid><authname>Ceglie C.</authname><surname>Ceglie</surname><given-name>Cristiano</given-name><initials>C.</initials><afid>60027299</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004331451</author-url><authid>7004331451</authid><authname>Maione G.</authname><surname>Maione</surname><given-name>Guido</given-name><initials>G.</initials><afid>60027299</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55911429000</author-url><authid>55911429000</authid><authname>Striccoli D.</authname><surname>Striccoli</surname><given-name>Domenico</given-name><initials>D.</initials><afid>60027299</afid></author><authkeywords>3D video stream | Fractional exponential reduction moments approach (FERMA) | Fractional order modeling | Statistics of fractional moments</authkeywords><intid>1535968404</intid><source-id>21576</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926226047"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926226047?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926226047&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926226047&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014305715001469"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926226047</prism:url><dc:identifier>SCOPUS_ID:84926226047</dc:identifier><eid>2-s2.0-84926226047</eid><dc:title>Chemical foaming extrusion of poly(lactic acid) with chain-extenders: Physical and morphological characterizations</dc:title><dc:creator>Julien J.</dc:creator><prism:publicationName>European Polymer Journal</prism:publicationName><prism:issn>00143057</prism:issn><prism:volume>67</prism:volume><prism:pageRange>40-49</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eurpolymj.2015.03.011</prism:doi><pii>S0014305715001469</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. The effects of an epoxide-based chain-extender (CE) on the properties of poly(lactic acid) (PLA) foams obtained by chemical foaming extrusion using 4 wt.% of chemical foaming agent (CFA) were studied. PLA/CE blends with different weight ratios of CE were initially processed using a co-rotating twin-screw extruder. PLA/CE foams were then produced using a single-screw extruder. Various PLA/CE foams characterizations, including solution viscosity, thermal properties (DSC, TGA), cellular structure (void fraction, cell size, open cell content), mechanical and dynamic rheological behaviors, were investigated. Results show that the addition of CE enhances the viscosimetric average molecular weight and rheological properties (viscosity and storage modulus) of PLA, but it has no significant effects on the thermal properties of PLA, except the occurring of a cold crystallization. The CE incorporation also led to a decrease in the void fraction of cellular PLA, in the cell size and in the open cell content and to an increase in the cell density. Furthermore, the tensile mechanical properties such as yield stress and elongation at break of cellular materials increased with the addition of CE.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104665</affiliation-url><afid>60104665</afid><affilname>Universite Lille Nord de France</affilname><name-variant>Université Lille Nord de</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003375</affiliation-url><afid>60003375</afid><affilname>Ecole des Mines Douai</affilname><name-variant>Ecole des Mines de Douai</name-variant><affiliation-city>Douai</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012033</affiliation-url><afid>60012033</afid><affilname>Ecole des Mines d'Ales</affilname><name-variant>Ecole des Mines d'Ales</name-variant><affiliation-city>Ales</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55425864900</author-url><authid>55425864900</authid><authname>Julien J.</authname><surname>Julien</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60104665</afid><afid>60003375</afid><afid>60012033</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55425864900</author-url><authid>55425864900</authid><authname>Julien J.</authname><surname>Julien</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60104665</afid><afid>60003375</afid><afid>60012033</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55425864900</author-url><authid>55425864900</authid><authname>Julien J.</authname><surname>Julien</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60104665</afid><afid>60003375</afid><afid>60012033</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603226298</author-url><authid>6603226298</authid><authname>Quantin J.</authname><surname>Quantin</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60012033</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603872759</author-url><authid>6603872759</authid><authname>Bénézet J.</authname><surname>Bénézet</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60012033</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006802990</author-url><authid>7006802990</authid><authname>Bergeret A.</authname><surname>Bergeret</surname><given-name>A.</given-name><initials>A.</initials><afid>60012033</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8661675600</author-url><authid>8661675600</authid><authname>Lacrampe M.</authname><surname>Lacrampe</surname><given-name>M. F.</given-name><initials>M.F.</initials><afid>60104665</afid><afid>60003375</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8661675600</author-url><authid>8661675600</authid><authname>Lacrampe M.</authname><surname>Lacrampe</surname><given-name>M. F.</given-name><initials>M.F.</initials><afid>60104665</afid><afid>60003375</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603881319</author-url><authid>6603881319</authid><authname>Krawczak P.</authname><surname>Krawczak</surname><given-name>P.</given-name><initials>P.</initials><afid>60104665</afid><afid>60003375</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603881319</author-url><authid>6603881319</authid><authname>Krawczak P.</authname><surname>Krawczak</surname><given-name>P.</given-name><initials>P.</initials><afid>60104665</afid><afid>60003375</afid></author><authkeywords>Cell morphology | Chemical foaming agent | Epoxide based chain-extender | Extrusion foaming | Poly(lactic acid)</authkeywords><intid>35405650</intid><source-id>25854</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927534143"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927534143?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927534143&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927534143&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000440"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927534143</prism:url><dc:identifier>SCOPUS_ID:84927534143</dc:identifier><eid>2-s2.0-84927534143</eid><dc:title>Phosphatidylcholine composition of pulmonary surfactant from terrestrial and marine diving mammals</dc:title><dc:creator>Gutierrez D.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>211</prism:volume><prism:pageRange>29-36</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.02.004</prism:doi><pii>S1569904815000440</pii><dc:description>© 2015 Elsevier B.V. Marine mammals are repeatedly exposed to elevated extra-thoracic pressure and alveolar collapse during diving and readily experience alveolar expansion upon inhalation - a unique capability as compared to terrestrial mammals. How marine mammal lungs overcome the challenges of frequent alveolar collapse and recruitment remains unknown. Recent studies indicate that pinniped lung surfactant has more anti-adhesive components compared to terrestrial mammals, which would aid in alveolar opening. However, pulmonary surfactant composition has not yet been investigated in odontocetes, whose physiology and diving behavior differ from pinnipeds. The aim of this study was to investigate the phosphatidylcholine (PC) composition of lung surfactants from various marine mammals and compare these to a terrestrial mammal. We found an increase in anti-adhesive PC species in harp seal (Pagophilus groenlandicus) and California sea lion (Zalophus californianus) compared to dog (Canus lupus familiaris), as well as an increase in the fluidizing PCs 16:0/14:0 and 16:0/16:1 in pinnipeds compared to odontocetes. The harbor porpoise (a representative of the odontocetes) did not have higher levels of fluidizing PCs compared to dog. Our preliminary results support previous findings that pinnipeds may have adapted unique surfactant compositions that allow them to dive at high pressures for extended periods without adverse effects. Future studies will need to investigate the differences in other surfactant components to fully assess the surfactant composition in odontocetes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002208</affiliation-url><afid>60002208</afid><affilname>Texas A and M University - Corpus Christi</affilname><name-variant>Texas A and M University-Corpus Christi</name-variant><affiliation-city>Corpus Christi</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002208</affiliation-url><afid>60002208</afid><affilname>Texas A and M University - Corpus Christi</affilname><name-variant>Texas A and M University-Corpus Christi</name-variant><affiliation-city>Corpus Christi</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60079206</affiliation-url><afid>60079206</afid><affilname>Ministry of Agriculture and Lands</affilname><name-variant>British Columbia Ministry of Agriculture and Lands</name-variant><affiliation-city>Victoria</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100324904</affiliation-url><afid>100324904</afid><affilname>Vancouver Aquarium</affilname><name-variant>Vancouver Public Aquarium</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36610124200</author-url><authid>36610124200</authid><authname>Gutierrez D.</authname><surname>Gutierrez</surname><given-name>Danielle B.</given-name><initials>D.B.</initials><afid>60002208</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602672144</author-url><authid>6602672144</authid><authname>Fahlman A.</authname><surname>Fahlman</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60002208</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401638317</author-url><authid>7401638317</authid><authname>Gardner M.</authname><surname>Gardner</surname><given-name>Manuela</given-name><initials>M.</initials><afid>60002208</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56589849400</author-url><authid>56589849400</authid><authname>Kleinhenz D.</authname><surname>Kleinhenz</surname><given-name>Danielle</given-name><initials>D.</initials><afid>60002208</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25825481700</author-url><authid>25825481700</authid><authname>Piscitelli M.</authname><surname>Piscitelli</surname><given-name>Marina</given-name><initials>M.</initials><afid>60010365</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603598100</author-url><authid>6603598100</authid><authname>Raverty S.</authname><surname>Raverty</surname><given-name>Stephen</given-name><initials>S.</initials><afid>60079206</afid><afid>60010365</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603598100</author-url><authid>6603598100</authid><authname>Raverty S.</authname><surname>Raverty</surname><given-name>Stephen</given-name><initials>S.</initials><afid>60079206</afid><afid>60010365</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603022596</author-url><authid>6603022596</authid><authname>Haulena M.</authname><surname>Haulena</surname><given-name>Martin</given-name><initials>M.</initials><afid>100324904</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55891818800</author-url><authid>55891818800</authid><authname>Zimba P.</authname><surname>Zimba</surname><given-name>Paul V.</given-name><initials>P.V.</initials><afid>60002208</afid></author><intid>2035628366</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926199008"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926199008?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926199008&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926199008&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000416"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926199008</prism:url><dc:identifier>SCOPUS_ID:84926199008</dc:identifier><eid>2-s2.0-84926199008</eid><dc:title>NADP&lt;sup&gt;+&lt;/sup&gt;-dependent dehydrogenase activity of carbonyl reductase on glutathionylhydroxynonanal as a new pathway for hydroxynonenal detoxification</dc:title><dc:creator>Moschini R.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>66-76</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.001</prism:doi><pii>S0891584915000416</pii><dc:description>© 2015 Published by Elsevier Inc. An NADP&lt;sup&gt;+&lt;/sup&gt;-dependent dehydrogenase activity on 3-glutathionyl-4-hydroxynonanal (GSHNE) was purified to electrophoretic homogeneity from a line of human astrocytoma cells (ADF). Proteomic analysis identified this enzymatic activity as associated with carbonyl reductase 1 (EC 1.1.1.184). The enzyme is highly efficient at catalyzing the oxidation of GSHNE (K&lt;inf&gt;M&lt;/inf&gt; 33 μM, k&lt;inf&gt;cat&lt;/inf&gt; 405 min&lt;sup&gt;-1&lt;/sup&gt;), as it is practically inactive toward trans-4-hydroxy-2-nonenal (HNE) and other HNE-adducted thiol-containing amino acid derivatives. Combined mass spectrometry and nuclear magnetic resonance spectroscopy analysis of the reaction products revealed that carbonyl reductase oxidizes the hydroxyl group of GSHNE in its hemiacetal form, with the formation of the corresponding 3-glutathionylnonanoic-δ-lactone. The relevance of this new reaction catalyzed by carbonyl reductase 1 is discussed in terms of HNE detoxification and the recovery of reducing power.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028868</affiliation-url><afid>60028868</afid><affilname>Universita di Pisa</affilname><name-variant>University of Pisa</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115119340</affiliation-url><afid>115119340</afid><affilname>ISPAAM-CNR</affilname><name-variant>ISPAAM-CNR</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105814425</affiliation-url><afid>105814425</afid><affilname>Pontedera Hospital</affilname><name-variant>Pontedera Hospital</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030674</affiliation-url><afid>60030674</afid><affilname>Scuola Normale Superiore di Pisa</affilname><name-variant>Scuola Normale Superiore</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602749913</author-url><authid>6602749913</authid><authname>Moschini R.</authname><surname>Moschini</surname><given-name>Roberta</given-name><initials>R.</initials><afid>60028868</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55503547100</author-url><authid>55503547100</authid><authname>Peroni E.</authname><surname>Peroni</surname><given-name>Eleonora</given-name><initials>E.</initials><afid>60028868</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56458423900</author-url><authid>56458423900</authid><authname>Rotondo R.</authname><surname>Rotondo</surname><given-name>Rossella</given-name><initials>R.</initials><afid>60028868</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9041903100</author-url><authid>9041903100</authid><authname>Renzone G.</authname><surname>Renzone</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>115119340</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603858955</author-url><authid>6603858955</authid><authname>Melck D.</authname><surname>Melck</surname><given-name>Dominique</given-name><initials>D.</initials><afid>60021199</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35500805800</author-url><authid>35500805800</authid><authname>Cappiello M.</authname><surname>Cappiello</surname><given-name>Mario</given-name><initials>M.</initials><afid>60028868</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56580347500</author-url><authid>56580347500</authid><authname>Srebot M.</authname><surname>Srebot</surname><given-name>Massimo</given-name><initials>M.</initials><afid>105814425</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56227753300</author-url><authid>56227753300</authid><authname>Napolitano E.</authname><surname>Napolitano</surname><given-name>Elio</given-name><initials>E.</initials><afid>60030674</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56579798500</author-url><authid>56579798500</authid><authname>Motta A.</authname><surname>Motta</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60021199</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7007083035</author-url><authid>7007083035</authid><authname>Scaloni A.</authname><surname>Scaloni</surname><given-name>Andrea</given-name><initials>A.</initials><afid>115119340</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005965477</author-url><authid>7005965477</authid><authname>Mura U.</authname><surname>Mura</surname><given-name>Umberto</given-name><initials>U.</initials><afid>60028868</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003735252</author-url><authid>7003735252</authid><authname>Del-Corso A.</authname><surname>Del-Corso</surname><given-name>Antonella</given-name><initials>A.</initials><afid>60028868</afid></author><authkeywords>3-Glutathionyl-4-hydroxynonanal | 4-Hydroxy-2-nonenal | Carbonyl reductase | Free radicals | Hydroxynonenal detoxification</authkeywords><intid>35406161</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928720297"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928720297?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928720297&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928720297&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647415000227"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928720297</prism:url><dc:identifier>SCOPUS_ID:84928720297</dc:identifier><eid>2-s2.0-84928720297</eid><dc:title>Multifactorial determinants of cognition - Thyroid function is not the only one</dc:title><dc:creator>Moncayo R.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>289-298</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2015.04.002</prism:doi><pii>S2214647415000227</pii><dc:description>© 2015. Background: Since the 1960s hypothyroidism together with iodine deficiency have been considered to be a principal determinant of cognition development. Following iodine supplementation programs and improved treatment options for hypothyroidism this relation might not be valid in 2015. On the other hand neurosciences have added different inputs also related to cognition. Scope of review: We will examine the characteristics of the original and current publications on thyroid function and cognition and also add some general determinants of intelligence and cognition. One central issue for us is the relation of stress to cognition knowing that both physical and psychological stress, are frequent elements in subjects with thyroid dysfunction. We have considered a special type of stress called pre-natal stress which can influence cognitive functions. Fear and anxiety can be intermingled requiring mechanisms of fear extinction. Major conclusions: Recent studies have failed to show an influence of thyroid medication during pregnancy on intellectual development. Neuroscience offers a better explanation of cognition than hypothyroidism and iodine deficiency. Additional factors relevant to cognition are nutrition, infection, prenatal stress, and early life stress. In turn stress is related to low magnesium levels. Magnesium supplementation can correct both latent hypothyroidism and acquired mild cognitive deficits. General significance: Cognition is a complex process that depends on many determinants and not only on thyroid function. Magnesium deficiency appears to be a basic mechanism for changes in thyroid function as well as of cognition.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56227982200</author-url><authid>56227982200</authid><authname>Moncayo R.</authname><surname>Moncayo</surname><given-name>Roy</given-name><initials>R.</initials><afid>60008222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56515038000</author-url><authid>56515038000</authid><authname>Ortner K.</authname><surname>Ortner</surname><given-name>Karina</given-name><initials>K.</initials><afid>60008222</afid></author><authkeywords>Cognition | Hippocampus | Magnesium | NMDA receptors | Prenatal maternal stress | Thyroid function</authkeywords><intid>1535838215</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926617762"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926617762?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926617762&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926617762&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0969996115001047"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926617762</prism:url><dc:identifier>SCOPUS_ID:84926617762</dc:identifier><eid>2-s2.0-84926617762</eid><dc:title>Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis</dc:title><dc:creator>Isaev D.</dc:creator><prism:publicationName>Neurobiology of Disease</prism:publicationName><prism:issn>09699961</prism:issn><prism:eIssn>1095953X</prism:eIssn><prism:volume>78</prism:volume><prism:pageRange>68-76</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.nbd.2015.03.026</prism:doi><pii>S0969996115001047</pii><dc:description>© 2015 Elsevier Inc. Clinical observations and studies on different animal models of acquired epilepsy consistently demonstrate that blood-brain barrier (BBB) leakage can be an important risk factor for developing recurrent seizures. However, the involved signaling pathways remain largely unclear. Given the important role of thrombin and its major receptor in the brain, protease-activated receptor 1 (PAR1), in the pathophysiology of neurological injury, we hypothesized that PAR1 may contribute to status epilepticus (SE)-induced epileptogenesis and that its inhibition shortly after SE will have neuroprotective and antiepileptogenic effects. Adult rats subjected to lithium-pilocarpine SE were administrated with SCH79797 (a PAR1 selective antagonist) after SE termination. Thrombin and PAR1 levels and neuronal cell survival were evaluated 48. h following SE. The effect of PAR1 inhibition on animal survival, interictal spikes (IIS) and electrographic seizures during the first two weeks after SE and behavioral seizures during the chronic period was evaluated. SE resulted in a high mortality rate and incidence of IIS and seizures in the surviving animals. There was a marked increase in thrombin, decrease in PAR1 immunoreactivity and hippocampal cell loss in the SE-treated rats. Inhibition of PAR1 following SE resulted in a decrease in mortality and morbidity, increase in neuronal cell survival in the hippocampus and suppression of IIS, electrographic and behavioral seizures following SE. These data suggest that the PAR1 signaling pathway contributes to epileptogenesis following SE. Because breakdown of the BBB occurs frequently in brain injuries, PAR1 inhibition may have beneficial effects in a variety of acquired injuries leading to epilepsy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068502</affiliation-url><afid>60068502</afid><affilname>Bogomoletz Institute of Physiology</affilname><name-variant>Academy of Sciences of the Ukrainian SSR</name-variant><affiliation-city>Kiev</affiliation-city><affiliation-country>Ukraine</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068502</affiliation-url><afid>60068502</afid><affilname>Bogomoletz Institute of Physiology</affilname><name-variant>Academy of Sciences of the Ukrainian SSR</name-variant><affiliation-city>Kiev</affiliation-city><affiliation-country>Ukraine</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031576</affiliation-url><afid>60031576</afid><affilname>University of Vermont College of Medicine</affilname><name-variant>Univ. of Vermont College of Medicine</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8835977100</author-url><authid>8835977100</authid><authname>Isaev D.</authname><surname>Isaev</surname><given-name>D.</given-name><initials>D.</initials><afid>60068502</afid><afid>60031576</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8835977100</author-url><authid>8835977100</authid><authname>Isaev D.</authname><surname>Isaev</surname><given-name>D.</given-name><initials>D.</initials><afid>60068502</afid><afid>60031576</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506882033</author-url><authid>6506882033</authid><authname>Lushnikova I.</authname><surname>Lushnikova</surname><given-name>I.</given-name><initials>I.</initials><afid>60068502</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55964147700</author-url><authid>55964147700</authid><authname>Lunko O.</authname><surname>Lunko</surname><given-name>O.</given-name><initials>O.</initials><afid>60068502</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56586174000</author-url><authid>56586174000</authid><authname>Zapukhliak O.</authname><surname>Zapukhliak</surname><given-name>O.</given-name><initials>O.</initials><afid>60068502</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6506169475</author-url><authid>6506169475</authid><authname>Maximyuk O.</authname><surname>Maximyuk</surname><given-name>O.</given-name><initials>O.</initials><afid>60068502</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56485263800</author-url><authid>56485263800</authid><authname>Romanov A.</authname><surname>Romanov</surname><given-name>A.</given-name><initials>A.</initials><afid>60068502</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004529090</author-url><authid>7004529090</authid><authname>Skibo G.</authname><surname>Skibo</surname><given-name>G. G.</given-name><initials>G.G.</initials><afid>60068502</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56567307400</author-url><authid>56567307400</authid><authname>Tian C.</authname><surname>Tian</surname><given-name>C.</given-name><initials>C.</initials><afid>60031576</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55628579790</author-url><authid>55628579790</authid><authname>Holmes G.</authname><surname>Holmes</surname><given-name>G. L.</given-name><initials>G.L.</initials><afid>60031576</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005900367</author-url><authid>7005900367</authid><authname>Isaeva E.</authname><surname>Isaeva</surname><given-name>E.</given-name><initials>E.</initials><afid>60068502</afid><afid>60031576</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005900367</author-url><authid>7005900367</authid><authname>Isaeva E.</authname><surname>Isaeva</surname><given-name>E.</given-name><initials>E.</initials><afid>60068502</afid><afid>60031576</afid></author><authkeywords>Epileptogenesis | Hippocampus | Pilocarpine | Protease-activated receptor | Status epilepticus | Thrombin</authkeywords><intid>1785485784</intid><source-id>17466</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929119536"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929119536?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929119536&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929119536&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0584854715000865"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929119536</prism:url><dc:identifier>SCOPUS_ID:84929119536</dc:identifier><eid>2-s2.0-84929119536</eid><dc:title>A multi-analytical approach to gold in Ancient Egypt: Studies on provenance and corrosion</dc:title><dc:creator>Tissot I.</dc:creator><prism:publicationName>Spectrochimica Acta - Part B Atomic Spectroscopy</prism:publicationName><prism:issn>05848547</prism:issn><prism:volume>108</prism:volume><prism:pageRange>75-82</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.sab.2015.03.012</prism:doi><pii>S0584854715000865</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Recent results from a three-year multi-disciplinary project on Ancient Egyptian gold jewellery revealed that items of jewellery from the Middle Kingdom to the New Kingdom were manufactured using a variety of alluvial gold alloys. These alloys cover a wide range of colours and the majority contain Platinum Group Elements inclusions. However, in all the gold foils analysed, these inclusions were found to be absent. In this work a selection of gilded wood and leather items and gold foil fragments, all from the excavations by John Garstang at Abydos (primarily from Middle Kingdom graves), were examined using Scanning Electron Microscopy-Energy Disperse Spectroscopy (SEM-EDS), X-Ray Fluorescence (μXRF), Particle Induced X-Ray Emission (μPIXE) and Double Dispersive X-Ray Fluorescence (D&lt;sup&gt;2&lt;/sup&gt;XRF). The work allowed us to characterise the composition of the base-alloys and also to reveal the presence of Pt at trace levels, confirming the use of alluvial gold deposits. Corrosion products were also investigated in the foils where surface tarnish was visually observed. Results showed that the differences in the colour of corrosion observed for the foils are related not only to the thickness of the corrosion layer but also to a multi-layer structure containing the various corrosion products.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115229028</affiliation-url><afid>115229028</afid><affilname>LIBPhys - UNL</affilname><name-variant>LIBPhys - UNL</name-variant><affiliation-city/><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002769</affiliation-url><afid>60002769</afid><affilname>Faculdade de Ciencias da Universidade de Lisboa</affilname><name-variant>Universidade de Lisboa</name-variant><affiliation-city>Lisbon</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107512683</affiliation-url><afid>107512683</afid><affilname>National Museums Scotland</affilname><name-variant>National Museums Scotland</name-variant><affiliation-city>Edinburgh</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001746</affiliation-url><afid>60001746</afid><affilname>Universidade de Lisboa</affilname><name-variant>University of Lisbon</name-variant><affiliation-city>Lisbon</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020661</affiliation-url><afid>60020661</afid><affilname>University of Liverpool</affilname><name-variant>University of Liverpool</name-variant><affiliation-city>Liverpool</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072294</affiliation-url><afid>60072294</afid><affilname>Federal Institute for Materials Research and Testing Berlin</affilname><name-variant>BAM Federal Institute for Materials Research and Testing</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>I.P.</affilname><name-variant>LNEG</name-variant><affiliation-city>Lisbon</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018733</affiliation-url><afid>60018733</afid><affilname>Universite Paris Sorbonne - Paris IV</affilname><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55575226000</author-url><authid>55575226000</authid><authname>Tissot I.</authname><surname>Tissot</surname><given-name>I.</given-name><initials>I.</initials><afid>115229028</afid><afid>60002769</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55575226000</author-url><authid>55575226000</authid><authname>Tissot I.</authname><surname>Tissot</surname><given-name>I.</given-name><initials>I.</initials><afid>115229028</afid><afid>60002769</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35796393000</author-url><authid>35796393000</authid><authname>Troalen L.</authname><surname>Troalen</surname><given-name>L. G.</given-name><initials>L.G.</initials><afid>107512683</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35230522300</author-url><authid>35230522300</authid><authname>Manso M.</authname><surname>Manso</surname><given-name>M.</given-name><initials>M.</initials><afid>115229028</afid><afid>60001746</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35230522300</author-url><authid>35230522300</authid><authname>Manso M.</authname><surname>Manso</surname><given-name>M.</given-name><initials>M.</initials><afid>115229028</afid><afid>60001746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602399138</author-url><authid>6602399138</authid><authname>Ponting M.</authname><surname>Ponting</surname><given-name>M.</given-name><initials>M.</initials><afid>60020661</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003659451</author-url><authid>7003659451</authid><authname>Radtke M.</authname><surname>Radtke</surname><given-name>M.</given-name><initials>M.</initials><afid>60072294</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507938878</author-url><authid>6507938878</authid><authname>Reinholz U.</authname><surname>Reinholz</surname><given-name>U.</given-name><initials>U.</initials><afid>60072294</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603680496</author-url><authid>6603680496</authid><authname>Barreiros M.</authname><surname>Barreiros</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid/></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56637908200</author-url><authid>56637908200</authid><authname>Shaw I.</authname><surname>Shaw</surname><given-name>I.</given-name><initials>I.</initials><afid>60020661</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7201414086</author-url><authid>7201414086</authid><authname>Carvalho M.</authname><surname>Carvalho</surname><given-name>M. L.</given-name><initials>M.L.</initials><afid>115229028</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55256407700</author-url><authid>55256407700</authid><authname>Guerra M.</authname><surname>Guerra</surname><given-name>M. F.</given-name><initials>M.F.</initials><afid>60018733</afid></author><authkeywords>Corrosion | Egypt | Gold | PGE | Provenance</authkeywords><intid>1535900279</intid><source-id>24532</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926323957"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926323957?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926323957&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926323957&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926323957</prism:url><dc:identifier>SCOPUS_ID:84926323957</dc:identifier><eid>2-s2.0-84926323957</eid><dc:title>Perilla frutescens modulates CYP1A1/2 and HO-1 and activates Nrf2 in oxidative stress-induced hepatotoxicity</dc:title><dc:creator>Kang J.</dc:creator><prism:publicationName>Journal of the Korean Society for Applied Biological Chemistry</prism:publicationName><prism:issn>17382203</prism:issn><prism:eIssn>2234344X</prism:eIssn><prism:volume>58</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>305-315</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s13765-015-0044-8</prism:doi><dc:description>© 2015, The Korean Society for Applied Biological Chemistry. We speculated that lipid peroxidation induced by tert-butyl hydroperoxide (t-BHP) in liver is closely linked with the metabolism mediated by CYPs. In this study, we have examined the effect of Perilla leaf extract (PLE) on CYPs using 7-ethoxyresorufin-O-deethylase (EROD, indicator of CYP1A1), 7-methoxyresorufin-O-demethylase (MROD, indicator of CYP1A2), erythromycin N-demethylase (ERDM, indicator of CYP3A), and p-nitrophenol hydroxylase (PNPH, indicator of CYP2E1) in rat liver. Rats orally pretreated with PLE (250, 500, and 1,000 mg/kg b.w.) for 5 days were administered with a single i.p. dose of t-BHP (0.5 mmol/kg). Kinetic analysis of CYP1A1/2 activities in t-BHP-treated liver demonstrated that PLE inhibits the enzyme activities by competitive and noncompetitive inhibitions. The pretreatment with PLE decreased the expression of CYP1A1/2 mRNA and protein compared with t-BHP treatment alone. A Phase II enzyme, heme oxygenase-1 (HO-1), is involved in hepatoprotection against oxidative damage, and we confirmed that PLE increases the levels of HO-1 mRNA and protein, as well as its activity in t-BHP-induced liver damage. PLE administration resulted in enhanced nuclear translocation and ARE binding of NF-E2-related factor 2. These findings suggest that PLE protects against t-BHP-induced hepatotoxicity through modulated activity and expression of selective CYPs, and ARE-driven induction of HO-1 expression and its activity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005273</affiliation-url><afid>60005273</afid><affilname>Korea University</affilname><name-variant>Korea University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068707</affiliation-url><afid>60068707</afid><affilname>Korea Food Research Institute</affilname><name-variant>Korea Food Research Institute</name-variant><affiliation-city>Seongnam</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56459291000</author-url><authid>56459291000</authid><authname>Kang J.</authname><surname>Kang</surname><given-name>Jeong Han</given-name><initials>J.H.</initials><afid>60005273</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35486217800</author-url><authid>35486217800</authid><authname>Yang S.</authname><surname>Yang</surname><given-name>Sung Yong</given-name><initials>S.Y.</initials><afid>60005273</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56581118600</author-url><authid>56581118600</authid><authname>Ha J.</authname><surname>Ha</surname><given-name>Jaeho</given-name><initials>J.</initials><afid>60068707</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56582706500</author-url><authid>56582706500</authid><authname>Lee K.</authname><surname>Lee</surname><given-name>Kwang Won</given-name><initials>K.W.</initials><afid>60005273</afid></author><authkeywords>Cytochrome P450s | Hepatoprotection | HO-1 | Nrf2 | Oxidative stress | Perilla frutescens</authkeywords><intid>35431608</intid><source-id>19900191616</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930082022"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930082022?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930082022&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930082022&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930082022</prism:url><dc:identifier>SCOPUS_ID:84930082022</dc:identifier><eid>2-s2.0-84930082022</eid><dc:title>The challenging ultrasound diagnosis of perforated appendicitis in children: constellations of sonographic findings improve specificity</dc:title><dc:creator>Tulin-Silver S.</dc:creator><prism:publicationName>Pediatric Radiology</prism:publicationName><prism:issn>03010449</prism:issn><prism:eIssn>14321998</prism:eIssn><prism:volume>45</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>820-830</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00247-014-3232-5</prism:doi><dc:description>© 2014, Springer-Verlag Berlin Heidelberg. Background: Rapid and accurate diagnosis of appendicitis, particularly with respect to the presence or absence of perforation, is essential in guiding appropriate management. Although many studies have explored sonographic findings associated with acute appendicitis, few investigations discuss specific signs that can reliably differentiate perforated appendicitis from acute appendicitis prior to abscess formation. Objective: The purpose of our study was to identify sonographic findings that improve the specificity of US in the diagnosis of perforated appendicitis. Our assessment of hepatic periportal echogenicity, detailed analysis of intraperitoneal fluid, and formulation of select constellations of sonographic findings expands upon the literature addressing this important diagnostic challenge. Materials and methods: We retrospectively reviewed 116 abdominal US examinations for evaluation of abdominal pain in children ages 2 to 18 years from January 2008 to September 2011 at a university hospital pediatric radiology department. The study group consisted of surgical and pathology proven acute appendicitis (n = 51) and perforated appendicitis (n = 22) US exams. US exams without a sonographic diagnosis of appendicitis (n = 43) confirmed by follow-up verbal communication were included in the study population as the control group. After de-identification, the US exams were independently reviewed on a PACS workstation by four pediatric radiologists blinded to diagnosis and all clinical information. We recorded the presence of normal or abnormal appendix, appendicolith, appendiceal wall vascularity, thick-walled bowel, dilated bowel, right lower quadrant (RLQ) echogenic fat, increased hepatic periportal echogenicity, bladder debris and abscess or loculated fluid. We also recorded the characteristics of intraperitoneal fluid, indicating the relative quantity (number of abdominal regions) and quality of the fluid (simple fluid or complex fluid). We used logistic regression for correlated data to evaluate the association of diagnosis with the presence versus absence of each US finding. We conducted multivariable analysis to identify constellations of sonographic findings that were predictive of perforated appendicitis. Results: The individual US findings of abscess/loculated fluid, appendicolith, dilated bowel and increased hepatic periportal echogenicity were significantly associated with perforated appendicitis when compared with acute appendicitis (P &lt; 0.01). The sonographic observation of increased hepatic periportal echogenicity demonstrated a statistically significant association with perforated appendicitis compared with acute appendicitis (P &lt; 0.01). The presence of complex fluid yielded a specificity of 87.7% for perforated appendicitis compared with the acute appendicitis group. The US findings of ≥2 regions or ≥3 regions with fluid had specificity of 87.3% and 99.0%, respectively, for perforated appendicitis compared with the acute appendicitis group. Select combinations of sonographic findings yielded high specificity in the diagnosis of perforated appendicitis compared with acute appendicitis. These constellations yielded higher specificity than that of each individual finding in isolation. The constellation of dilated bowel, RLQ echogenic fat, and complex fluid had the highest specificity (99.5%) for perforated appendicitis (P &lt; 0.01). Conclusion: Our study demonstrates that identification of select constellations of findings using abdominal sonography, in addition to focused US examination of the right lower quadrant, can improve sonographic diagnosis of perforated appendicitis in the pediatric population.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024541</affiliation-url><afid>60024541</afid><affilname>New York University School of Medicine</affilname><name-variant>New York Univ. School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000928</affiliation-url><afid>60000928</afid><affilname>Emory University</affilname><name-variant>Emory University</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024541</affiliation-url><afid>60024541</afid><affilname>New York University School of Medicine</affilname><name-variant>New York Univ. School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52364921500</author-url><authid>52364921500</authid><authname>Tulin-Silver S.</authname><surname>Tulin-Silver</surname><given-name>Sheryl</given-name><initials>S.</initials><afid>60024541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102232878</author-url><authid>7102232878</authid><authname>Babb J.</authname><surname>Babb</surname><given-name>James</given-name><initials>J.</initials><afid>60024541</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603420003</author-url><authid>6603420003</authid><authname>Pinkney L.</authname><surname>Pinkney</surname><given-name>Lynne</given-name><initials>L.</initials><afid>60024541</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36947764500</author-url><authid>36947764500</authid><authname>Strubel N.</authname><surname>Strubel</surname><given-name>Naomi</given-name><initials>N.</initials><afid>60024541</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55950399800</author-url><authid>55950399800</authid><authname>Lala S.</authname><surname>Lala</surname><given-name>Shailee</given-name><initials>S.</initials><afid>60024541</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:28167705100</author-url><authid>28167705100</authid><authname>Milla S.</authname><surname>Milla</surname><given-name>Sarah S.</given-name><initials>S.S.</initials><afid>60000928</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35782481400</author-url><authid>35782481400</authid><authname>Tomita S.</authname><surname>Tomita</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60024541</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602794904</author-url><authid>6602794904</authid><authname>Fefferman N.</authname><surname>Fefferman</surname><given-name>Nancy R.</given-name><initials>N.R.</initials><afid>60024541</afid></author><authkeywords>Acute appendicitis | Appendix | Children | Perforated appendicitis | Ultrasound</authkeywords><intid>2036058497</intid><source-id>15753</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924942801"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924942801?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924942801&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924942801&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0959437X1500012X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924942801</prism:url><dc:identifier>SCOPUS_ID:84924942801</dc:identifier><eid>2-s2.0-84924942801</eid><dc:title>The pulmonary mesenchyme directs lung development</dc:title><dc:creator>McCulley D.</dc:creator><prism:publicationName>Current Opinion in Genetics and Development</prism:publicationName><prism:issn>0959437X</prism:issn><prism:eIssn>18790380</prism:eIssn><prism:volume>32</prism:volume><prism:pageRange>98-105</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.gde.2015.01.011</prism:doi><pii>S0959437X1500012X</pii><dc:description>© 2015 Elsevier Ltd. Each of the steps of respiratory system development relies on intricate interactions and coordinated development of the lung epithelium and mesenchyme. In the past, more attention has been paid to the epithelium than the mesenchyme. The mesenchyme is a source of specification and morphogenetic signals as well as a host of surprisingly complex cell lineages that are crucial for normal lung development and function. This review highlights recent research focusing on the mesenchyme that has revealed genetic and epigenetic mechanisms of its development in the context of other cell layers during respiratory lineage specification, branching morphogenesis, epithelial differentiation, lineage distinction, vascular development, and alveolar maturation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032179</affiliation-url><afid>60032179</afid><affilname>University of Wisconsin Madison</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603494869</author-url><authid>6603494869</authid><authname>McCulley D.</authname><surname>McCulley</surname><given-name>David</given-name><initials>D.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603494869</author-url><authid>6603494869</authid><authname>McCulley D.</authname><surname>McCulley</surname><given-name>David</given-name><initials>D.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56556896800</author-url><authid>56556896800</authid><authname>Wienhold M.</authname><surname>Wienhold</surname><given-name>Mark</given-name><initials>M.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56556896800</author-url><authid>56556896800</authid><authname>Wienhold M.</authname><surname>Wienhold</surname><given-name>Mark</given-name><initials>M.</initials><afid>60032179</afid><afid>60032179</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56019987100</author-url><authid>56019987100</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xin</given-name><initials>X.</initials><afid>60032179</afid></author><intid>1535232970</intid><source-id>22080</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923241371"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923241371?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923241371&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923241371&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0889157515000277"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923241371</prism:url><dc:identifier>SCOPUS_ID:84923241371</dc:identifier><eid>2-s2.0-84923241371</eid><dc:title>Influence of autochthonous cultures on fatty acid composition, esterase activity and sensory profile of Argentinean goat cheeses</dc:title><dc:creator>Taboada N.</dc:creator><prism:publicationName>Journal of Food Composition and Analysis</prism:publicationName><prism:issn>08891575</prism:issn><prism:volume>40</prism:volume><prism:pageRange>86-94</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jfca.2014.12.013</prism:doi><pii>S0889157515000277</pii><dc:description>© 2015 Elsevier Inc. In the present work conjugated fatty acid content, atherogenicity index, esterase activity and sensory analysis of semi-hard goat cheeses manufactured with autochthonous starter and adjunct or commercial cultures were analyzed. The comparison of cheeses obtained with or without addition of autochthonous cultures reported statistically significant differences in the fatty acid profile and estersase activity that could be due to a different degree of lipolysis in the cheeses, but did not significantly affect the gross composition of cheeses. Short chain and polyunsaturated fatty acid content was higher in products with autochthonous than commercial cultures. The inclusion of these cultures into the artisanal cheese manufacture improves the conjugated fatty acid content, flavour and the atherogenicity index of the final product. Though, conjugated linoleic acid (CLA) level, increased during ripening time in cheese containing autochthonous cultures from 0.6 to 1.0. g/100. g of fatty acids, offering for human consumers among 417-427. mg/100. g of cheese. Differences on esterase activity and atherogenicity index were also observed among cheeses, representing cheeses manufactured with autochthonous bacteria a healthier product than those elaborated with commercial cultures.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010690</affiliation-url><afid>60010690</afid><affilname>Universidad Nacional de Santiago del Estero</affilname><name-variant>Universidad Nacional de Santiago del Estero</name-variant><affiliation-city>Santiago del Estero</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032294</affiliation-url><afid>60032294</afid><affilname>Centro de Referencia Para Lactobacilos</affilname><name-variant>CERELA</name-variant><affiliation-city>San Miguel de Tucuman</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56146949200</author-url><authid>56146949200</authid><authname>Taboada N.</authname><surname>Taboada</surname><given-name>Natalia</given-name><initials>N.</initials><afid>60010690</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16204654400</author-url><authid>16204654400</authid><authname>Van Nieuwenhove C.</authname><surname>Van Nieuwenhove</surname><given-name>Carina</given-name><initials>C.</initials><afid>60032294</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56524660900</author-url><authid>56524660900</authid><authname>Alzogaray S.</authname><surname>Alzogaray</surname><given-name>Soledad López</given-name><initials>S.L.</initials><afid>60010690</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7101786431</author-url><authid>7101786431</authid><authname>Medina R.</authname><surname>Medina</surname><given-name>Roxana</given-name><initials>R.</initials><afid>60032294</afid></author><authkeywords>Artisanal goat cheeses | Atherogenicity index | Autochthonous starter cultures | Conjugated linoleic acid | Esterase activity | Fatty acid composition | Food analysis | Food Composition | Goat milk | Sensory profile of foods</authkeywords><intid>534942113</intid><source-id>20582</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928980900"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928980900?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928980900&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928980900&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928980900</prism:url><dc:identifier>SCOPUS_ID:84928980900</dc:identifier><eid>2-s2.0-84928980900</eid><dc:title>Expression of p8 in Human Oral Squamous Cell Carcinoma</dc:title><dc:creator>Bingham C.</dc:creator><prism:publicationName>Head and Neck Pathology</prism:publicationName><prism:issn>1936055X</prism:issn><prism:eIssn>19360568</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>214-222</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12105-014-0565-1</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. The present study investigated the expression of p8, a transcription factor upregulated in some human cancers, in oral squamous cell carcinomas (OSCCs). Immunohistochemical analysis of p8 expression was carried out on 20 archived surgical specimens of human OSCCs, and expression correlated with clinical outcome parameters in a retrospective study. Expression of p8 in a number of OSCC cell lines also was investigated by western blot and RT-PCR analyses. p8 was expressed in 80 % (16/20) of the samples with levels of expression exhibiting a significant difference (χ&lt;sup&gt;2&lt;/sup&gt; = 8.352, df = 3, p = 0.039) by patient age. Furthermore, greater levels of p8 immunoreactivity was significantly associated with advanced tumor grade (p = 0.008). p8 also was upregulated in OSCC cell lines. p8 is expressed in a significant proportion of OSCCs, and in human OSCC cell lines, suggesting a potential value of p8 as a diagnostic and/prognostic tool for oral cancers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114753108</affiliation-url><afid>114753108</afid><affilname>Georgia Regents University</affilname><name-variant>Georgia Regents University</name-variant><affiliation-city>Augusta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114753108</affiliation-url><afid>114753108</afid><affilname>Georgia Regents University</affilname><name-variant>Georgia Regents University</name-variant><affiliation-city>Augusta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113201104</affiliation-url><afid>113201104</afid><affilname>Georgia Reagents University</affilname><name-variant>Georgia Reagents University</name-variant><affiliation-city>Augusta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113198688</affiliation-url><afid>113198688</afid><affilname>University of Texas- Houston School of Public Health</affilname><name-variant>Medical School at Houston</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56335115200</author-url><authid>56335115200</authid><authname>Bingham C.</authname><surname>Bingham</surname><given-name>Christopher</given-name><initials>C.</initials><afid>114753108</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102730107</author-url><authid>7102730107</authid><authname>Dickinson D.</authname><surname>Dickinson</surname><given-name>Douglas</given-name><initials>D.</initials><afid>114753108</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56335095300</author-url><authid>56335095300</authid><authname>Cray J.</authname><surname>Cray</surname><given-name>James</given-name><initials>J.</initials><afid>113201104</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55615590300</author-url><authid>55615590300</authid><authname>Koli K.</authname><surname>Koli</surname><given-name>Komal</given-name><initials>K.</initials><afid>113198688</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8108467900</author-url><authid>8108467900</authid><authname>Ogbureke K.</authname><surname>Ogbureke</surname><given-name>Kalu U E</given-name><initials>K.U.E.</initials><afid>113198688</afid></author><authkeywords>Immunohistochemistry | Oral squamous cell carcinoma | OSC2 cells | p8 expression</authkeywords><intid>1035880822</intid><source-id>15500154704</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929072461"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929072461?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929072461&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929072461&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1476927115000481"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929072461</prism:url><dc:identifier>SCOPUS_ID:84929072461</dc:identifier><eid>2-s2.0-84929072461</eid><dc:title>Gene network coherence based on prior knowledge using direct and indirect relationships</dc:title><dc:creator>Gómez-Vela F.</dc:creator><prism:publicationName>Computational Biology and Chemistry</prism:publicationName><prism:issn>14769271</prism:issn><prism:volume>56</prism:volume><prism:pageRange>142-151</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiolchem.2015.03.002</prism:doi><pii>S1476927115000481</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Gene networks (GNs) have become one of the most important approaches for modeling biological processes. They are very useful to understand the different complex biological processes that may occur in living organisms. Currently, one of the biggest challenge in any study related with GN is to assure the quality of these GNs. In this sense, recent works use artificial data sets or a direct comparison with prior biological knowledge. However, these approaches are not entirely accurate as they only take into account direct gene-gene interactions for validation, leaving aside the weak (indirect) relationships. We propose a new measure, named gene network coherence (GNC), to rate the coherence of an input network according to different biological databases. In this sense, the measure considers not only the direct gene-gene relationships but also the indirect ones to perform a complete and fairer evaluation of the input network. Hence, our approach is able to use the whole information stored in the networks. A GNC JAVA-based implementation is available at: http://fgomezvela.github.io/GNC/. The results achieved in this work show that GNC outperforms the classical approaches for assessing GNs by means of three different experiments using different biological databases and input networks. According to the results, we can conclude that the proposed measure, which considers the inherent information stored in the direct and indirect gene-gene relationships, offers a new robust solution to the problem of GNs biological validation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030114</affiliation-url><afid>60030114</afid><affilname>Universidad Pablo de Olavide</affilname><name-variant>Universidad Pablo de Olavide</name-variant><affiliation-city>Sevilla</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:38961263300</author-url><authid>38961263300</authid><authname>Gómez-Vela F.</authname><surname>Gómez-Vela</surname><given-name>Francisco</given-name><initials>F.</initials><afid>60030114</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56638296000</author-url><authid>56638296000</authid><authname>Lagares J.</authname><surname>Lagares</surname><given-name>José Antonio</given-name><initials>J.A.</initials><afid>60030114</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14017761700</author-url><authid>14017761700</authid><authname>Díaz-Díaz N.</authname><surname>Díaz-Díaz</surname><given-name>Norberto</given-name><initials>N.</initials><afid>60030114</afid></author><authkeywords>Biological knowledge | Biological validation | Gene association networks | Gene network assessment | Heuristic algorithm</authkeywords><intid>1535900812</intid><source-id>24599</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930009601"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930009601?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930009601&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930009601&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930009601</prism:url><dc:identifier>SCOPUS_ID:84930009601</dc:identifier><eid>2-s2.0-84930009601</eid><dc:title>Why do electronic health records reveal oral anticoagulant prescription after haemorrhagic stroke?</dc:title><dc:creator>Forster A.</dc:creator><prism:publicationName>British Journal of Clinical Pharmacology</prism:publicationName><prism:issn>03065251</prism:issn><prism:eIssn>13652125</prism:eIssn><prism:volume>79</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1037-1039</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bcp.12570</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005518</affiliation-url><afid>60005518</afid><affilname>Guy's and St Thomas' NHS Foundation Trust</affilname><name-variant>Guy's and St. Thomas' NHS Foundation Trust</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025465</affiliation-url><afid>60025465</afid><affilname>Medicines and Health Care products Regulatory Agency</affilname><name-variant>Medicines and Healthcare Products Regulatory Agency</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003771</affiliation-url><afid>60003771</afid><affilname>University of Manchester</affilname><name-variant>University of Manchester</name-variant><affiliation-city>Manchester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16300728600</author-url><authid>16300728600</authid><authname>Forster A.</authname><surname>Forster</surname><given-name>Alice S.</given-name><initials>A.S.</initials><afid>60011520</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35195469600</author-url><authid>35195469600</authid><authname>Dregan A.</authname><surname>Dregan</surname><given-name>Alex</given-name><initials>A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35195469600</author-url><authid>35195469600</authid><authname>Dregan A.</authname><surname>Dregan</surname><given-name>Alex</given-name><initials>A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14014266800</author-url><authid>14014266800</authid><authname>Van Staa T.</authname><surname>Van Staa</surname><given-name>Tjeerd P.</given-name><initials>T.P.</initials><afid>60025465</afid><afid>60003771</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14014266800</author-url><authid>14014266800</authid><authname>Van Staa T.</authname><surname>Van Staa</surname><given-name>Tjeerd P.</given-name><initials>T.P.</initials><afid>60025465</afid><afid>60003771</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24512680300</author-url><authid>24512680300</authid><authname>McDermott L.</authname><surname>McDermott</surname><given-name>Lisa</given-name><initials>L.</initials><afid>60011520</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:37861852000</author-url><authid>37861852000</authid><authname>McCann G.</authname><surname>McCann</surname><given-name>Gerard</given-name><initials>G.</initials><afid>60025465</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102520568</author-url><authid>7102520568</authid><authname>Wolfe C.</authname><surname>Wolfe</surname><given-name>Charles D A</given-name><initials>C.D.A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102520568</author-url><authid>7102520568</authid><authname>Wolfe C.</authname><surname>Wolfe</surname><given-name>Charles D A</given-name><initials>C.D.A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:19337989900</author-url><authid>19337989900</authid><authname>Rudd A.</authname><surname>Rudd</surname><given-name>Anthony</given-name><initials>A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:19337989900</author-url><authid>19337989900</authid><authname>Rudd A.</authname><surname>Rudd</surname><given-name>Anthony</given-name><initials>A.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006445136</author-url><authid>7006445136</authid><authname>Gulliford M.</authname><surname>Gulliford</surname><given-name>Martin C.</given-name><initials>M.C.</initials><afid>60011520</afid><afid>60005518</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006445136</author-url><authid>7006445136</authid><authname>Gulliford M.</authname><surname>Gulliford</surname><given-name>Martin C.</given-name><initials>M.C.</initials><afid>60011520</afid><afid>60005518</afid></author><intid>1786050486</intid><source-id>20082</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927671090"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927671090?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927671090&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927671090&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213597915000051"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927671090</prism:url><dc:identifier>SCOPUS_ID:84927671090</dc:identifier><eid>2-s2.0-84927671090</eid><dc:title>Photoacoustic imaging driven by an interstitial irradiation source</dc:title><dc:creator>Mitcham T.</dc:creator><prism:publicationName>Photoacoustics</prism:publicationName><prism:issn>22135979</prism:issn><prism:volume>3</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>45-54</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pacs.2015.02.002</prism:doi><pii>S2213597915000051</pii><dc:description>© 2015 The Authors. Photoacoustic (PA) imaging has shown tremendous promise in providing valuable diagnostic and therapy-monitoring information in select clinical procedures. Many of these pursued applications, however, have been relatively superficial due to difficulties with delivering light deep into tissue. To address this limitation, this work investigates generating a PA image using an interstitial irradiation source with a clinical ultrasound (US) system, which was shown to yield improved PA signal quality at distances beyond 13. mm and to provide improved spectral fidelity. Additionally, interstitially driven multi-wavelength PA imaging was able to provide accurate spectra of gold nanoshells and deoxyhemoglobin in excised prostate and liver tissue, respectively, and allowed for clear visualization of a wire at 7. cm in excised liver. This work demonstrates the potential of using a local irradiation source to extend the depth capabilities of future PA imaging techniques for minimally invasive interventional radiology procedures.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Texas MD Anderson Cancer Center</affilname><name-variant>Department of Imaging Physics</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Texas MD Anderson Cancer Center</affilname><name-variant>Department of Interventional Radiology</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Texas at Houston</affilname><name-variant>Graduate School of Biomedical Sciences</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55832525000</author-url><authid>55832525000</authid><authname>Mitcham T.</authname><surname>Mitcham</surname><given-name>Trevor</given-name><initials>T.</initials><afid/><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55832525000</author-url><authid>55832525000</authid><authname>Mitcham T.</authname><surname>Mitcham</surname><given-name>Trevor</given-name><initials>T.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56593219800</author-url><authid>56593219800</authid><authname>Dextraze K.</authname><surname>Dextraze</surname><given-name>Katherine</given-name><initials>K.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56593219800</author-url><authid>56593219800</authid><authname>Dextraze K.</authname><surname>Dextraze</surname><given-name>Katherine</given-name><initials>K.</initials><afid/><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56592697400</author-url><authid>56592697400</authid><authname>Taghavi H.</authname><surname>Taghavi</surname><given-name>Houra</given-name><initials>H.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16316930300</author-url><authid>16316930300</authid><authname>Melancon M.</authname><surname>Melancon</surname><given-name>Marites</given-name><initials>M.</initials><afid/><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16316930300</author-url><authid>16316930300</authid><authname>Melancon M.</authname><surname>Melancon</surname><given-name>Marites</given-name><initials>M.</initials><afid/><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9737284900</author-url><authid>9737284900</authid><authname>Bouchard R.</authname><surname>Bouchard</surname><given-name>Richard</given-name><initials>R.</initials><afid/><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9737284900</author-url><authid>9737284900</authid><authname>Bouchard R.</authname><surname>Bouchard</surname><given-name>Richard</given-name><initials>R.</initials><afid/><afid/></author><authkeywords>Improved penetration depth | Interstitial source | Interventional radiology | Multi-wavelength imaging | Optical fiber | Photoacoustic imaging</authkeywords><intid>1535646834</intid><source-id>21100237606</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84916896308"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84916896308?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84916896308&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84916896308&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647414000373"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84916896308</prism:url><dc:identifier>SCOPUS_ID:84916896308</dc:identifier><eid>2-s2.0-84916896308</eid><dc:title>Skeletal muscle microvascular function in girls with Turner syndrome</dc:title><dc:creator>West S.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>25-30</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2014.12.002</prism:doi><pii>S2214647414000373</pii><dc:description>© 2014. Background: Exercise intolerance is prevalent in individuals with Turner Syndrome (TS). We recently demonstrated that girls with TS have normal aerobic but altered skeletal muscle anaerobic metabolism compared to healthy controls (HC). The purpose of this study was to compare peripheral skeletal muscle microvascular function in girls with TS to HC after exercise. We hypothesized that girls with TS would have similar muscle blood-oxygen level-dependent (BOLD) magnetic resonance imaging (MRI) signal responses during recovery from exercise compared to HC. Methods: Thirteen TS participants and 8 HC completed testing. BOLD MRI was used to measure skeletal muscle microvascular response during 60. second recovery, following 60. s of exercise at 65% of maximal workload. Exercise and recovery were repeated four times, and the BOLD signal time course was fit to a four-parameter sigmoid function. Results: Participants were 13.7 ± 3.1. years old and weighed 47.9 ± 14.6. kg. The mean change in BOLD signal intensity following exercise at the end of recovery, the mean response time of the function/the washout of deoxyhemoglobin, and the mean half-time of recovery were similar between the TS and HC groups. Conclusions: Our results demonstrate that compared to HC, peripheral skeletal muscle microvascular function following exercise in girls with TS is not impaired. General significance: This study supports the idea that the aerobic energy pathway is not impaired in children with TS in response to submaximal exercise. Other mechanisms are likely responsible for exercise intolerance in TS; this needs to be further investigated.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009602</affiliation-url><afid>60009602</afid><affilname>University of Limerick</affilname><name-variant>University of Limerick</name-variant><affiliation-city>Limerick</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56443410500</author-url><authid>56443410500</authid><authname>West S.</authname><surname>West</surname><given-name>Sarah L.</given-name><initials>S.L.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56443410500</author-url><authid>56443410500</authid><authname>West S.</authname><surname>West</surname><given-name>Sarah L.</given-name><initials>S.L.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14121825300</author-url><authid>14121825300</authid><authname>O'Gorman C.</authname><surname>O'Gorman</surname><given-name>Clodagh S.</given-name><initials>C.S.</initials><afid>60030319</afid><afid>60030319</afid><afid>60009602</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14121825300</author-url><authid>14121825300</authid><authname>O'Gorman C.</authname><surname>O'Gorman</surname><given-name>Clodagh S.</given-name><initials>C.S.</initials><afid>60030319</afid><afid>60030319</afid><afid>60009602</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14121825300</author-url><authid>14121825300</authid><authname>O'Gorman C.</authname><surname>O'Gorman</surname><given-name>Clodagh S.</given-name><initials>C.S.</initials><afid>60030319</afid><afid>60030319</afid><afid>60009602</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36126105900</author-url><authid>36126105900</authid><authname>Elzibak A.</authname><surname>Elzibak</surname><given-name>Alyaa H.</given-name><initials>A.H.</initials><afid>60030319</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55754578200</author-url><authid>55754578200</authid><authname>Caterini J.</authname><surname>Caterini</surname><given-name>Jessica</given-name><initials>J.</initials><afid>60016849</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701776288</author-url><authid>6701776288</authid><authname>Noseworthy M.</authname><surname>Noseworthy</surname><given-name>Michael D.</given-name><initials>M.D.</initials><afid>60031828</afid><afid>60031828</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701776288</author-url><authid>6701776288</authid><authname>Noseworthy M.</authname><surname>Noseworthy</surname><given-name>Michael D.</given-name><initials>M.D.</initials><afid>60031828</afid><afid>60031828</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13612920200</author-url><authid>13612920200</authid><authname>Rayner T.</authname><surname>Rayner</surname><given-name>Tammy</given-name><initials>T.</initials><afid>60030319</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56443259800</author-url><authid>56443259800</authid><authname>Hamilton J.</authname><surname>Hamilton</surname><given-name>Jill</given-name><initials>J.</initials><afid>60030319</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24069546500</author-url><authid>24069546500</authid><authname>Wells G.</authname><surname>Wells</surname><given-name>Greg D.</given-name><initials>G.D.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24069546500</author-url><authid>24069546500</authid><authname>Wells G.</authname><surname>Wells</surname><given-name>Greg D.</given-name><initials>G.D.</initials><afid>60016849</afid><afid>60030319</afid></author><authkeywords>BOLD MRI | Exercise | Microvascular function | Pediatric | Skeletal muscle | Turner syndrome</authkeywords><intid>2033884031</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926320694"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926320694?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926320694&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926320694&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014480015000520"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926320694</prism:url><dc:identifier>SCOPUS_ID:84926320694</dc:identifier><eid>2-s2.0-84926320694</eid><dc:title>Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas</dc:title><dc:creator>Xie Y.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>98</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>446-454</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.03.017</prism:doi><pii>S0014480015000520</pii><dc:description>© 2015. Soft tissue sarcomas (STSs) are comparatively rare malignant tumors with poor prognosis. STSs predominantly arise from mesenchymal differentiation. MicroRNA-34b/c, the transcriptional targets of tumor suppressor p53, possesses tumor suppressing property. Hypermethylation of miR-34b/c has been associated with tumorigenesis and the progression of various cancers. To determine whether aberrant miR-34b/c methylation occurs in STSs, we quantitatively evaluated the methylation level of miR-34b/c in 57 STS samples and 20 cases of peripheral blood from healthy volunteers serving as normal controls by using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. We found that miRNA34b/c is more frequently methylated in STSs (0.157. ±. 0.028) than in normal controls (0.098. ±. 0.012, p. =. 0.038). Furthermore, the methylation levels of CpG_1.2.3, CpG_4.5.6.7, and CpG_11.12.13 of miR-34b/c were significantly higher in the STS group than in the normal control group (p. &lt;. 0.001). No significant differences in the methylation levels within miR-34b/c were observed between specific reciprocal translocations in STSs and nonspecific reciprocal translocations in STSs (0.146. ±. 0.039 vs. 0.168. ±. 0.035, p. &gt;. 0.05). The methylation levels of miR-34b/c in STSs were associated with clinical stage. The methylation levels of CpG_1.2.3, CpG_4.5.6.7, CpG_9.10, CpG_11.12.13, and CpG_14 in tumor-stage III/IV tissues were significantly higher than those in tumor-stage I/II tissues. Our findings indicated that DNA hypermethylation of the miR-34b/c is a relatively common event in STSs and is significantly correlated with late clinical stage in patients with STSs. Hypermethylation of the miR-34b/c may be pivotal in the oncogenesis and progression of STSs and may be a potential prognostic factor for STSs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030922</affiliation-url><afid>60030922</afid><affilname>Shihezi University</affilname><name-variant>Shihezi University</name-variant><affiliation-city>Shihezi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001604</affiliation-url><afid>60001604</afid><affilname>Ministry of Education China</affilname><name-variant>Ministry of Education</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030922</affiliation-url><afid>60030922</afid><affilname>Shihezi University</affilname><name-variant>Shihezi University</name-variant><affiliation-city>Shihezi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">27</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56135028000</author-url><authid>56135028000</authid><authname>Xie Y.</authname><surname>Xie</surname><given-name>Yuwen</given-name><initials>Y.</initials><afid>60030922</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56581672600</author-url><authid>56581672600</authid><authname>Zong P.</authname><surname>Zong</surname><given-name>Peizhi</given-name><initials>P.</initials><afid>60030922</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56134304400</author-url><authid>56134304400</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Weiwei</given-name><initials>W.</initials><afid>60030922</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55831739200</author-url><authid>55831739200</authid><authname>Liu D.</authname><surname>Liu</surname><given-name>Dong</given-name><initials>D.</initials><afid>60030922</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56135786000</author-url><authid>56135786000</authid><authname>Li B.</authname><surname>Li</surname><given-name>Bingcheng</given-name><initials>B.</initials><afid>60030922</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56137138300</author-url><authid>56137138300</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yuanyuan</given-name><initials>Y.</initials><afid>60030922</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56271713600</author-url><authid>56271713600</authid><authname>Hu J.</authname><surname>Hu</surname><given-name>Jianming</given-name><initials>J.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56271713600</author-url><authid>56271713600</authid><authname>Hu J.</authname><surname>Hu</surname><given-name>Jianming</given-name><initials>J.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56271713600</author-url><authid>56271713600</authid><authname>Hu J.</authname><surname>Hu</surname><given-name>Jianming</given-name><initials>J.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56383271400</author-url><authid>56383271400</authid><authname>Ren Y.</authname><surname>Ren</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56383271400</author-url><authid>56383271400</authid><authname>Ren Y.</authname><surname>Ren</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56383271400</author-url><authid>56383271400</authid><authname>Ren Y.</authname><surname>Ren</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56580975700</author-url><authid>56580975700</authid><authname>Qi Y.</authname><surname>Qi</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56580975700</author-url><authid>56580975700</authid><authname>Qi Y.</authname><surname>Qi</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56580975700</author-url><authid>56580975700</authid><authname>Qi Y.</authname><surname>Qi</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55681494300</author-url><authid>55681494300</authid><authname>Cui X.</authname><surname>Cui</surname><given-name>Xiaobin</given-name><initials>X.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55681494300</author-url><authid>55681494300</authid><authname>Cui X.</authname><surname>Cui</surname><given-name>Xiaobin</given-name><initials>X.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55681494300</author-url><authid>55681494300</authid><authname>Cui X.</authname><surname>Cui</surname><given-name>Xiaobin</given-name><initials>X.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55883035100</author-url><authid>55883035100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yunzhao</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55883035100</author-url><authid>55883035100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yunzhao</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55883035100</author-url><authid>55883035100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yunzhao</given-name><initials>Y.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7409790244</author-url><authid>7409790244</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chunxia</given-name><initials>C.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7409790244</author-url><authid>7409790244</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chunxia</given-name><initials>C.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7409790244</author-url><authid>7409790244</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chunxia</given-name><initials>C.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56468117100</author-url><authid>56468117100</authid><authname>Li F.</authname><surname>Li</surname><given-name>Feng</given-name><initials>F.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56468117100</author-url><authid>56468117100</authid><authname>Li F.</authname><surname>Li</surname><given-name>Feng</given-name><initials>F.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56468117100</author-url><authid>56468117100</authid><authname>Li F.</authname><surname>Li</surname><given-name>Feng</given-name><initials>F.</initials><afid>60030922</afid><afid>60001604</afid><afid>60030922</afid></author><authkeywords>Methylation | MircroRNA-34b/c | Soft tissue sarcomas | Translocation | Tumorigenesis</authkeywords><intid>35432457</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928789960"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928789960?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928789960&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928789960&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014483515001281"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928789960</prism:url><dc:identifier>SCOPUS_ID:84928789960</dc:identifier><eid>2-s2.0-84928789960</eid><dc:title>A novel imidazopyridine derivative, X22, prevents the retinal ischemia-reperfusion injury via inhibition of MAPKs</dc:title><dc:creator>Bian Y.</dc:creator><prism:publicationName>Experimental Eye Research</prism:publicationName><prism:issn>00144835</prism:issn><prism:eIssn>10960007</prism:eIssn><prism:volume>135</prism:volume><prism:pageRange>26-36</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exer.2015.04.010</prism:doi><pii>S0014483515001281</pii><dc:description>© 2015 Elsevier Ltd. Inflammation is a pathological hallmark of ischemia reperfusion (I/R) injury. The present study was conducted to explore the ability of a new anti-inflammatory compound, X22, to attenuate retinal I/R injury via cytokine-inhibitory mechanism. For the invitro experiment, ARPE-19 cells were pretreated with X22 (5 or 10μM) or saline for 2h, followed by stimulation with tert-butyl hydroperoxide (TBHP, 1000μM) for an indicated amount of time. The expression of inflammatory mediators, cell viability, and cell apoptosis were evaluated. For the invivo experiment, the rats were randomized to receive treatment with saline or X22 (0.1μM/kg, 3μL) before the induction of I/R injury. Histological evaluation, apoptosis of retinal cells, macrophage infiltration, and retina functional changes were further determined. Our data showed that pretreatment with X22 significantly inhibited TBHP-induced inflammatory cytokine expression in ARPE-19 cells. The anti-inflammatory activity of X22 may be associated with its inhibition on MAPKs, rather than NF-κB. Subsequently, our data proved that TBHP induced apoptosis in ARPE-19 cells, while pretreatment of X22 significantly suppressed TBHP-caused ARPE-19 apoptosis. Finally, the invivo data revealed that X22 administration maintained better inner retinal layer structures, reduced apoptosis of retinal ganglion cell, and improved retinal function in retinal I/R rat models, which were accompanied with a remarkable decrease in retinal macrophage infiltration. These results suggest that the novel compound X22 is a potential agent for the treatment of retinal I/R-related diseases via the MAPKs-targeting anti-inflammatory mechanism and deserves the further development.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114389325</affiliation-url><afid>114389325</afid><affilname>Wenzhou Medical University</affilname><name-variant>Wenzhou Medical University</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56460872000</author-url><authid>56460872000</authid><authname>Bian Y.</authname><surname>Bian</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56460872000</author-url><authid>56460872000</authid><authname>Bian Y.</authname><surname>Bian</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56612702900</author-url><authid>56612702900</authid><authname>Ren L.</authname><surname>Ren</surname><given-name>Luqing</given-name><initials>L.</initials><afid>60008073</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56612713700</author-url><authid>56612713700</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Lei</given-name><initials>L.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56612713700</author-url><authid>56612713700</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Lei</given-name><initials>L.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56612542200</author-url><authid>56612542200</authid><authname>Xu S.</authname><surname>Xu</surname><given-name>Shanmei</given-name><initials>S.</initials><afid>60008073</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56612699900</author-url><authid>56612699900</authid><authname>Tao J.</authname><surname>Tao</surname><given-name>Jianjian</given-name><initials>J.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56612699900</author-url><authid>56612699900</authid><authname>Tao J.</authname><surname>Tao</surname><given-name>Jianjian</given-name><initials>J.</initials><afid>60008073</afid><afid>60008073</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55933597200</author-url><authid>55933597200</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiuhua</given-name><initials>X.</initials><afid>60008073</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56612543300</author-url><authid>56612543300</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60008073</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56612648800</author-url><authid>56612648800</authid><authname>Qian Y.</authname><surname>Qian</surname><given-name>Yuanyuan</given-name><initials>Y.</initials><afid>60008073</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56612859600</author-url><authid>56612859600</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xin</given-name><initials>X.</initials><afid>60008073</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56612644900</author-url><authid>56612644900</authid><authname>Song Z.</authname><surname>Song</surname><given-name>Zongming</given-name><initials>Z.</initials><afid>60008073</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:23974961400</author-url><authid>23974961400</authid><authname>Wu W.</authname><surname>Wu</surname><given-name>Wencan</given-name><initials>W.</initials><afid>60008073</afid><afid>114389325</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:23974961400</author-url><authid>23974961400</authid><authname>Wu W.</authname><surname>Wu</surname><given-name>Wencan</given-name><initials>W.</initials><afid>60008073</afid><afid>114389325</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56638782100</author-url><authid>56638782100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60008073</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56612717700</author-url><authid>56612717700</authid><authname>Liang G.</authname><surname>Liang</surname><given-name>Guang</given-name><initials>G.</initials><afid>60008073</afid></author><authkeywords>Apoptosis | Inflammation | MAPKs | NF-κB | Retinal ischemia-reperfusion injury</authkeywords><intid>1785851797</intid><source-id>13866</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929989905"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929989905?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929989905&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929989905&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929989905</prism:url><dc:identifier>SCOPUS_ID:84929989905</dc:identifier><eid>2-s2.0-84929989905</eid><dc:title>Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients</dc:title><dc:creator>Grimes R.</dc:creator><prism:publicationName>British Journal of Clinical Pharmacology</prism:publicationName><prism:issn>03065251</prism:issn><prism:eIssn>13652125</prism:eIssn><prism:volume>79</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1000-1009</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bcp.12573</prism:doi><dc:description>© 2014 The British Pharmacological Society. Aims The aim was to describe the utilization of antidiabetic agents, in terms of persistence and regimen change, in the management of a cohort of newly treated type 2 diabetes patients and to investigate associated socio-demographic and treatment factors. Methods A population-based retrospective cohort study was conducted using the national pharmacy claims database in Ireland. Subjects were analyzed for persistence and regimen change. Cox proportional hazards regression examined associations of socio-demographic and treatment factors on treatment patterns. Hazard ratios (HR) and 95% CIs are presented. Results A total of 20947 subjects were identified in the study over a 2 year period. Most were initiated on metformin (76%) or sulphonylureas (22%) and 77% were persistent with therapy 12 months after initiation. The likelihood of non-persistence was significantly lower in the youngest (40-49 years) age groups (reference 60-69 years) (HR 1.62, 95% CI 1.42, 1.84) and those on sulphonylureas (HR 1.49, 95% CI 1.36, 1.64). The likelihood of receiving a regimen change was significantly lower in the older (80+ years) age groups (HR 0.63, 95% CI 0.56, 0.71), females (HR 0.91, 95% CI 0.86, 0.95), and those with pre-existing CVD (1 vs. 0 CVD medicines) (HR 0.82, 95% CI 0.74, 0.90), and higher in those on sulphonylureas (HR 1.83, 95% CI 1.73, 1.94). Conclusions Type of treatment, pre-existing CVD and demographic factors are shown to be associated with the observed treatment patterns. Guideline recommended agents were widely used on treatment initiation though a substantial minority were not initiated on the recommended first line agent. Use of guideline recommended agents was not as evident during treatment progression. Further optimization of initial and subsequent antidiabetic agent prescribing may be possible.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011149</affiliation-url><afid>60011149</afid><affilname>Trinity College Dublin</affilname><name-variant>Trinity College Dublin</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011149</affiliation-url><afid>60011149</afid><affilname>Trinity College Dublin</affilname><name-variant>Trinity College Dublin</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011149</affiliation-url><afid>60011149</afid><affilname>Trinity College Dublin</affilname><name-variant>Trinity College Dublin</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000050</affiliation-url><afid>60000050</afid><affilname>Royal College of Surgeons in Ireland</affilname><name-variant>Royal College of Surgeons</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011149</affiliation-url><afid>60011149</afid><affilname>Trinity College Dublin</affilname><name-variant>Trinity College Dublin</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658340000</author-url><authid>56658340000</authid><authname>Grimes R.</authname><surname>Grimes</surname><given-name>Ronan T.</given-name><initials>R.T.</initials><afid>60011149</afid><afid>60011149</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658340000</author-url><authid>56658340000</authid><authname>Grimes R.</authname><surname>Grimes</surname><given-name>Ronan T.</given-name><initials>R.T.</initials><afid>60011149</afid><afid>60011149</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23079596400</author-url><authid>23079596400</authid><authname>Bennett K.</authname><surname>Bennett</surname><given-name>Kathleen</given-name><initials>K.</initials><afid>60011149</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56252421700</author-url><authid>56252421700</authid><authname>Tilson L.</authname><surname>Tilson</surname><given-name>Lesley</given-name><initials>L.</initials><afid>60011149</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55934700100</author-url><authid>55934700100</authid><authname>Usher C.</authname><surname>Usher</surname><given-name>Cara</given-name><initials>C.</initials><afid>60011149</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55702303900</author-url><authid>55702303900</authid><authname>Smith S.</authname><surname>Smith</surname><given-name>Susan M.</given-name><initials>S.M.</initials><afid>60000050</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56359811200</author-url><authid>56359811200</authid><authname>Henman M.</authname><surname>Henman</surname><given-name>Martin C.</given-name><initials>M.C.</initials><afid>60011149</afid></author><authkeywords>real world treatment patterns | treatment progression | type 2 diabetes mellitus</authkeywords><intid>1036044690</intid><source-id>20082</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928978368"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928978368?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928978368&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928978368&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1357272515000059"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928978368</prism:url><dc:identifier>SCOPUS_ID:84928978368</dc:identifier><eid>2-s2.0-84928978368</eid><dc:title>Energy metabolism disorders in rare and common diseases. Toward bioenergetic modulation therapy and the training of a new generation of European scientists</dc:title><dc:creator>Rossignol R.</dc:creator><prism:publicationName>International Journal of Biochemistry and Cell Biology</prism:publicationName><prism:issn>13572725</prism:issn><prism:eIssn>18785875</prism:eIssn><prism:volume>63</prism:volume><prism:pageRange>2-9</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biocel.2015.01.003</prism:doi><pii>S1357272515000059</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Energy metabolism alterations are found in a large number of rare and common diseases of genetic or environmental origin. The number of patients that could benefit from bioenergetic modulation therapy (BIOMET) is therefore very important and includes individuals with pathologies as diverse as mitochondrial diseases, acute coronary syndrome, chronic kidney disease, asthma or even cancer. Although, the alteration of energy metabolism is disease specific and sometimes patient specific, the strategies for BIOMET could be common and target a series of bioenergetic regulatory mechanisms discussed in this article. An excellent training of scientists in the field of energy metabolism, related human diseases and drug discovery is also crucial to form a young generation of MDs, PHDs and Pharma or CRO-group leaders who will discover novel personalized bioenergetic medicines, through pharmacology, genetics, nutrition or adapted exercise training. The Mitochondrial European Educational Training (MEET) consortium was created to pursue this goal, and we dedicated here a special issue of Organelle in Focus (OiF) to highlight their objectives. A total of 10 OiFs articles constitute this Directed Issue on Mitochondrial Medicine. As part of this editorial article, we asked timely questions to the PR. Jan W. Smeitink, professor of Mitochondrial Medicine and CEO of Khondrion, a mitochondrial medicine company. He shared with us his objectives and strategies for the study of mitochondrial diseases and the identification of future treatments. This article is part of a Directed Issue entitled: Energy Metabolism Disorders and Therapies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603323536</author-url><authid>6603323536</authid><authname>Rossignol R.</authname><surname>Rossignol</surname><given-name>Rodrigue</given-name><initials>R.</initials><afid>60102125</afid></author><authkeywords>Bioenergetics | Drug development | Metabolic therapy | Regulation</authkeywords><intid>535877240</intid><source-id>17542</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926464851"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926464851?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926464851&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926464851&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1381117715000703"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926464851</prism:url><dc:identifier>SCOPUS_ID:84926464851</dc:identifier><eid>2-s2.0-84926464851</eid><dc:title>Kinetic characterization of tyrosinase containing mushroom (Agaricus bisporus) cells immobilized in silica alginate</dc:title><dc:creator>Kampmann M.</dc:creator><prism:publicationName>Journal of Molecular Catalysis B: Enzymatic</prism:publicationName><prism:issn>13811177</prism:issn><prism:eIssn>18733158</prism:eIssn><prism:volume>116</prism:volume><prism:pageRange>124-133</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.molcatb.2015.03.013</prism:doi><pii>S1381117715000703</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. A tyrosinase containing cell preparation from the edible mushroom Agaricus bisporus was immobilized in silica alginate matrix capsules. This catalyst system was characterized in terms of its reaction kinetics using the orthohydroxylation of bisphenol A (BPA) as a model system. The effect of BPA concentration on the reaction rate could be described with the Michaelis-Menten kinetics with an apparent Michaelis-Menten constant of K&lt;inf&gt;m&lt;/inf&gt; = 50.4 μmol/l. The reaction rate was proportional to the immobilized cell concentration in the investigated range. The highest observed apparent maximal reaction rate v&lt;inf&gt;max&lt;/inf&gt; related to the wet weight of matrix capsules at 30 °C was 51.5 nmol/(min g)). The diffusion coefficient D of BPA within the matrix capsules was determined to 4.9 × 10&lt;sup&gt;-10&lt;/sup&gt; m&lt;sup&gt;2&lt;/sup&gt;/s ±10% at 30 °C. The studies revealed that the observed reaction rate was not limited by the BPA diffusion rate in the matrix material. The immobilized cells exhibited tyrosinase activity over the whole examined pH range (pH 3-11) with a broad maximum between pH 6 and pH 10. The apparent activation energy E&lt;inf&gt;A&lt;/inf&gt; for the BPA conversion was determined to 37.6 kJ/mol, whereas the apparent activation energy E&lt;inf&gt;A,inact&lt;/inf&gt; for the thermal inactivation of the catalyst was determined to 71.7 kJ/mol. It was demonstrated that the determined parameter values were suitable to predict the change of the BPA concentration with respect to time under different reaction conditions and therefore could be useful for future applications of the catalyst, for example in synthesis of o-diphenols or bioremediation processes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032991</affiliation-url><afid>60032991</afid><affilname>Universitat Dortmund</affilname><name-variant>Universität Dortmund</name-variant><affiliation-city>Dortmund</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56114232900</author-url><authid>56114232900</authid><authname>Kampmann M.</authname><surname>Kampmann</surname><given-name>Markus</given-name><initials>M.</initials><afid>60032991</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56584372900</author-url><authid>56584372900</authid><authname>Hoffrichter A.</authname><surname>Hoffrichter</surname><given-name>Ann Catrin</given-name><initials>A.C.</initials><afid>60032991</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56584681000</author-url><authid>56584681000</authid><authname>Stalinski D.</authname><surname>Stalinski</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60032991</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006140360</author-url><authid>7006140360</authid><authname>Wichmann R.</authname><surname>Wichmann</surname><given-name>Rolf</given-name><initials>R.</initials><afid>60032991</afid></author><authkeywords>Bisphenol A | Immobilization | Mushroom cells | Reaction kinetics | Tyrosinase</authkeywords><intid>35455823</intid><source-id>17619</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928554304"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928554304?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928554304&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928554304&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091305715001215"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928554304</prism:url><dc:identifier>SCOPUS_ID:84928554304</dc:identifier><eid>2-s2.0-84928554304</eid><dc:title>Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study</dc:title><dc:creator>Gao L.</dc:creator><prism:publicationName>Pharmacology Biochemistry and Behavior</prism:publicationName><prism:issn>00913057</prism:issn><prism:eIssn>18735177</prism:eIssn><prism:volume>133</prism:volume><prism:pageRange>155-163</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pbb.2015.04.004</prism:doi><pii>S0091305715001215</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Baicalein, a flavonoid from Scutellaria baicalensis Georgi, has been shown to possess neuroprotective properties. The purpose of this study was to explore the effects of baicalein on motor behavioral deficits and gene expression in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease (PD). The behavioral results showed that baicalein significantly improves the abnormal behaviors in MPTP-induced mice model of PD, as manifested by shortening the total time for climbing down the pole, prolonging the latent periods of rotarod, and increasing the vertical movements. Using cDNA microarray and subsequent bioinformatic analyses, it was found that baicalein significantly promotes the biological processes including neurogenesis, neuroblast proliferation, neurotrophin signaling pathway, walking and locomotor behaviors, and inhibits dopamine metabolic process through regulation of gene expressions. Based on analysis of gene co-expression networks, the results indicated that the regulation of genes such as LIMK1, SNCA and GLRA1 by baicalein might play central roles in the network. Our results provide experimental evidence for the potential use of baicalein in the treatment of PD, and revealed gene expression profiles, biological processes and pathways influenced by baicalein in MPTP-treated mice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60057894</affiliation-url><afid>60057894</afid><affilname>Chinese Academy of Medical Sciences</affilname><name-variant>Chinese Academy of Medical Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002222</affiliation-url><afid>60002222</afid><affilname>Shanxi University</affilname><name-variant>Shanxi University</name-variant><affiliation-city>Taiyuan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115044881</affiliation-url><afid>115044881</afid><affilname>Beijing Key Laboratory of Drug Target Research and Drug Screening</affilname><name-variant>Beijing Key Laboratory of Drug Target Research and Drug Screening</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114013299</affiliation-url><afid>114013299</afid><affilname>State Key Laboratory of Bioactive Substance and Function of Natural Medicines</affilname><name-variant>State Key Laboratory of Bioactive Substance and Function of Natural Medicines</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56447535600</author-url><authid>56447535600</authid><authname>Gao L.</authname><surname>Gao</surname><given-name>Li</given-name><initials>L.</initials><afid>60057894</afid><afid>60002222</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56447535600</author-url><authid>56447535600</authid><authname>Gao L.</authname><surname>Gao</surname><given-name>Li</given-name><initials>L.</initials><afid>60057894</afid><afid>60002222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56447823300</author-url><authid>56447823300</authid><authname>Li C.</authname><surname>Li</surname><given-name>Chao</given-name><initials>C.</initials><afid>60057894</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55816424800</author-url><authid>55816424800</authid><authname>Yang R.</authname><surname>Yang</surname><given-name>Ran Yao</given-name><initials>R.Y.</initials><afid>60057894</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56492439400</author-url><authid>56492439400</authid><authname>Lian W.</authname><surname>Lian</surname><given-name>Wen Wen</given-name><initials>W.W.</initials><afid>60057894</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55751614400</author-url><authid>55751614400</authid><authname>Fang J.</authname><surname>Fang</surname><given-name>Jian Song</given-name><initials>J.S.</initials><afid>60057894</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56443396300</author-url><authid>56443396300</authid><authname>Pang X.</authname><surname>Pang</surname><given-name>Xiao Cong</given-name><initials>X.C.</initials><afid>60057894</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12345143600</author-url><authid>12345143600</authid><authname>Qin X.</authname><surname>Qin</surname><given-name>Xue Mei</given-name><initials>X.M.</initials><afid>60002222</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14048755600</author-url><authid>14048755600</authid><authname>Liu A.</authname><surname>Liu</surname><given-name>Ai Lin</given-name><initials>A.L.</initials><afid>60057894</afid><afid>115044881</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14048755600</author-url><authid>14048755600</authid><authname>Liu A.</authname><surname>Liu</surname><given-name>Ai Lin</given-name><initials>A.L.</initials><afid>60057894</afid><afid>115044881</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13103739800</author-url><authid>13103739800</authid><authname>Du G.</authname><surname>Du</surname><given-name>Guan Hua</given-name><initials>G.H.</initials><afid>60057894</afid><afid>114013299</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13103739800</author-url><authid>13103739800</authid><authname>Du G.</authname><surname>Du</surname><given-name>Guan Hua</given-name><initials>G.H.</initials><afid>60057894</afid><afid>114013299</afid></author><authkeywords>Baicalein | Biological process | Gene expression | MPTP | Parkinson's disease</authkeywords><intid>1535802691</intid><source-id>21197</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928739481"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928739481?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928739481&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928739481&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0890623815000568"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928739481</prism:url><dc:identifier>SCOPUS_ID:84928739481</dc:identifier><eid>2-s2.0-84928739481</eid><dc:title>Contributions from extracellular sources of adenosine to the ethanol toxicity in zebrafish larvae</dc:title><dc:creator>Lutte A.</dc:creator><prism:publicationName>Reproductive Toxicology</prism:publicationName><prism:issn>08906238</prism:issn><prism:eIssn>18731708</prism:eIssn><prism:volume>53</prism:volume><prism:pageRange>82-91</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.reprotox.2015.04.001</prism:doi><pii>S0890623815000568</pii><dc:description>© 2015 Elsevier Inc. The effects of ethanol exposure on extracellular adenosine sources in zebrafish were evaluated. In the acute treatment, the embryos were exposed to 2% ethanol on day 1 post-fertilization (dpf). In the chronic treatment, the exposure was continued for 2. h/day up to 6dpf. Ecto-5'-nucleotidase activity was assessed by colorimetric method and gene expression determined by RT-qPCR in 7. dpf zebrafish. Body length, ocular distance and surface area of the eyes were registered in animals acutely exposed to ethanol and pretreated with AOPCP (5-500. nM), an ecto-5'-nucleotidase inhibitor, or dipyridamole (10-100. μM), a blocker of nucleoside transport. Both ethanol exposures promoted increased ecto-5'-nucleotidase activity, impaired locomotion and morphology. Ecto-5'-nucleotidase expression was not affected. AOPCP promoted mild prevention of morphological defects caused by acute treatment, while dipyridamole worsened these defects. Early ethanol exposure altered adenosinergic tonus, especially through nucleoside transporters, contributing to morphological defects produced by ethanol in zebrafish.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015760</affiliation-url><afid>60015760</afid><affilname>Pontificia Universidade Catolica do Rio Grande do Sul</affilname><name-variant>Pontifícia Universidade Católica do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015760</affiliation-url><afid>60015760</afid><affilname>Pontificia Universidade Catolica do Rio Grande do Sul</affilname><name-variant>Pontifícia Universidade Católica do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113057382</affiliation-url><afid>113057382</afid><affilname>Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM)</affilname><name-variant>Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM)</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8859531300</author-url><authid>8859531300</authid><authname>Lutte A.</authname><surname>Lutte</surname><given-name>Aline Haab</given-name><initials>A.H.</initials><afid>60015760</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36088849900</author-url><authid>36088849900</authid><authname>Capiotti K.</authname><surname>Capiotti</surname><given-name>Katiucia Marques</given-name><initials>K.M.</initials><afid>60015760</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56611401000</author-url><authid>56611401000</authid><authname>Silva N.</authname><surname>Silva</surname><given-name>Nicole Luize Garcia da</given-name><initials>N.L.G.d.</initials><afid>60015760</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56611216100</author-url><authid>56611216100</authid><authname>Silva C.</authname><surname>Silva</surname><given-name>Carolina Silveira de Oliveira da</given-name><initials>C.S.d.O.d.</initials><afid>60015760</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36461176600</author-url><authid>36461176600</authid><authname>Kist L.</authname><surname>Kist</surname><given-name>Luiza Wilges</given-name><initials>L.W.</initials><afid>60015760</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003737445</author-url><authid>7003737445</authid><authname>Bogo M.</authname><surname>Bogo</surname><given-name>Maurício Reis</given-name><initials>M.R.</initials><afid>60015760</afid><afid>113057382</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003737445</author-url><authid>7003737445</authid><authname>Bogo M.</authname><surname>Bogo</surname><given-name>Maurício Reis</given-name><initials>M.R.</initials><afid>60015760</afid><afid>113057382</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56611229400</author-url><authid>56611229400</authid><authname>Silva R.</authname><surname>Silva</surname><given-name>Rosane Souza Da</given-name><initials>R.S.D.</initials><afid>60015760</afid><afid>113057382</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56611229400</author-url><authid>56611229400</authid><authname>Silva R.</authname><surname>Silva</surname><given-name>Rosane Souza Da</given-name><initials>R.S.D.</initials><afid>60015760</afid><afid>113057382</afid></author><authkeywords>Adenosine | Ecto-5'-nucleotidase, ethanol | Zebrafish</authkeywords><intid>1035834673</intid><source-id>24028</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930202150"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930202150?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930202150&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930202150&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930202150</prism:url><dc:identifier>SCOPUS_ID:84930202150</dc:identifier><eid>2-s2.0-84930202150</eid><dc:title>Hypercondensation of an amino acid: Synthesis and characterization of a black glycine polymer</dc:title><dc:creator>Fox S.</dc:creator><prism:publicationName>Chemistry - A European Journal</prism:publicationName><prism:issn>09476539</prism:issn><prism:eIssn>15213765</prism:eIssn><prism:volume>21</prism:volume><prism:issueIdentifier>24</prism:issueIdentifier><prism:pageRange>8897-8904</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/chem.201500820</prism:doi><dc:description>© 2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim. A granular material was obtained by thermal polymerization of glycine at 200°C. It has been named "thermomelanoid" because of its strikingly deep-black color. The polymerization process is mainly a dehydration condensation leading to conventional amide bonds, and also C-C double bonds that are formed from C-O and CH&lt;inf&gt;2&lt;/inf&gt; groups ("hypercondensation"). Spectroscopic data, in particular from &lt;sup&gt;13&lt;/sup&gt;C and &lt;sup&gt;15&lt;/sup&gt;N solid-state cross-polarization magic angle spinning (CP-MAS) NMR spectra, suggest that the black color is due to (cross-)conjugated C-C, C-O, and NH groups. Small glycine peptides, especially triglycine, appear to be key intermediates in the formation of the thermomelanoid. This has been concluded by comparing the thermal behavior of gly&lt;inf&gt;n&lt;/inf&gt; homopeptides (n=2-6) and glycine. The glycine polymerization was accompanied by the formation of small amounts of byproducts. Notably, a few percent of alanine and aspartic acid could be detected in the polymer. By using &lt;sup&gt;13&lt;/sup&gt;C-labeled glycine, it was shown that these two amino acids formed through a common pathway, namely Cα-Cα bond formation between glycine molecules. The thermomelanoid is hydrolyzed by strong acids and bases at room temperature, forming brown solutions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018373</affiliation-url><afid>60018373</afid><affilname>Universitat Hohenheim</affilname><name-variant>University of Hohenheim</name-variant><affiliation-city>Stuttgart</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7401924383</author-url><authid>7401924383</authid><authname>Fox S.</authname><surname>Fox</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60018373</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56613526700</author-url><authid>56613526700</authid><authname>Dalai P.</authname><surname>Dalai</surname><given-name>Punam</given-name><initials>P.</initials><afid>60018373</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401837125</author-url><authid>7401837125</authid><authname>Lambert J.</authname><surname>Lambert</surname><given-name>Jean François</given-name><initials>J.F.</initials><afid>60001422</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56613239100</author-url><authid>56613239100</authid><authname>Strasdeit H.</authname><surname>Strasdeit</surname><given-name>Henry</given-name><initials>H.</initials><afid>60018373</afid></author><authkeywords>amino acids | condensation reactions | peptides | polymers | structure elucidation</authkeywords><intid>2036082054</intid><source-id>23392</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928678742"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928678742?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928678742&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928678742&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352187215000030"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928678742</prism:url><dc:identifier>SCOPUS_ID:84928678742</dc:identifier><eid>2-s2.0-84928678742</eid><dc:title>Influences of nutrition and adiposity on bone mineral density in individuals with chronic spinal cord injury: A cross-sectional, observational study</dc:title><dc:creator>Doubelt I.</dc:creator><prism:publicationName>Bone Reports</prism:publicationName><prism:eIssn>23521872</prism:eIssn><prism:volume>2</prism:volume><prism:pageRange>26-31</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bonr.2015.02.002</prism:doi><pii>S2352187215000030</pii><dc:description>© 2015 The Authors. Background: Dietary inadequacy and adiposity, both prevalent in the chronic spinal cord injury (SCI) population, are known to influence bone turnover and may be potential modifiable risk factors for the development of sublesional osteoporosis following SCI. This pilot study in an SCI cohort aimed to assess measures of nutrition and obesity, to determine if these measures were associated with bone mineral density (BMD), and to compare these measures to a non-SCI control cohort. Methods: In a cross-sectional observational study, volunteers with chronic SCI (&gt;. 1. year post-injury, lesions from C1 to T12 and severity category A-D by the American Spinal Injury Association Impairment Scale) were assessed, and 8 non-SCI individuals were recruited as a comparison group. BMD at the femoral neck (FN) and lumbar spine (LS), and an estimate of visceral adipose tissue (VAT) from lumbar vertebrae 1 through 4 were measured using dual energy X-ray absorptiometry (DXA); nutrient intake of calcium, vitamins D &amp; K, and protein were estimated using a food frequency questionnaire; plasma 25-hydroxyvitamin D (25(OH)D) was analyzed using ultra-high performance liquid chromatography/tandem mass spectroscopy; and serum leptin, adiponectin and insulin were analyzed using a multiplex assay. Results: A total of 34 individuals with SCI (n = 22 tetraplegic; n = 12 paraplegic; 94% male) who averaged 12.7 (9.0) years post-injury, age 40.0 (10.9) years and % body fat of 28.4 (7.3) were assessed. Multiple linear regression analyses in the SCI cohort showed significant associations between BMD at the FN and LS with leptin (FN: r = 0.529, p = 0.005; LS: r = 0.392, p = 0.05), insulin (FN: r = 0.544, p = 0.003; LS: r = 0.388, p = 0.05), and VAT percent (FN: r = 0.444, p = 0.02; LS: r = 0.381, p = 0.05). Adiponectin was only correlated with LS BMD (r = 0.429, p = 0.03). No significant relationships were found between BMD and serum 25(OH)D, or intakes of calcium, vitamins D &amp; K, and protein. Intake of vitamin D was adequate in 69% of participants with SCI, where 91% of those persons consumed either vitamin D and/or multivitamin supplements. Vitamin D status was similar between SCI and non-SCI groups as was sub-optimal status (25(OH)D. &lt;. 75. nmol/L) (60% of SCI compared to 50% of non-SCI). Participants with SCI had significantly lower FN BMD in comparison to non-SCI controls (p = 0.001). Conclusions: Compromised BMD among individuals with SCI was not associated with a deficiency of vitamin D or other bone nutrients. The observed positive associations between BMD and leptin, insulin, adiponectin and VAT provide a framework to evaluate links between adiposity and bone health in a larger SCI cohort.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56610337800</author-url><authid>56610337800</authid><authname>Doubelt I.</authname><surname>Doubelt</surname><given-name>Irena</given-name><initials>I.</initials><afid>60031828</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506975779</author-url><authid>6506975779</authid><authname>de Zepetnek J.</authname><surname>de Zepetnek</surname><given-name>Julia Totosy</given-name><initials>J.T.</initials><afid>60031828</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34971710200</author-url><authid>34971710200</authid><authname>MacDonald M.</authname><surname>MacDonald</surname><given-name>Maureen J.</given-name><initials>M.J.</initials><afid>60031828</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202602912</author-url><authid>7202602912</authid><authname>Atkinson S.</authname><surname>Atkinson</surname><given-name>Stephanie A.</given-name><initials>S.A.</initials><afid>60031828</afid></author><authkeywords>Adiposity | Bone mineral density | Nutritional status | Spinal cord injury | Sublesional osteoporosis</authkeywords><intid>535823722</intid><source-id>21100386862</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928662606"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928662606?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928662606&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928662606&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928662606</prism:url><dc:identifier>SCOPUS_ID:84928662606</dc:identifier><eid>2-s2.0-84928662606</eid><dc:title>Urtica dioica leaves modulates muscarinic cholinergic system in the hippocampus of streptozotocin-induced diabetic mice</dc:title><dc:creator>Patel S.</dc:creator><prism:publicationName>Metabolic Brain Disease</prism:publicationName><prism:issn>08857490</prism:issn><prism:eIssn>15737365</prism:eIssn><prism:volume>30</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>803-811</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11011-014-9646-9</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Diabetes mellitus is a chronic metabolic disorder and has been associated with cognitive dysfunction. In our earlier study, chronic Urtica dioica (UD) treatment significantly ameliorated diabetes induced associative and spatial memory deficit in mice. The present study was designed to explore the effect of UD leaves extract on muscarinic cholinergic system, which has long been known to be involved in cognition. Streptozotocin (STZ) (50 mg/kg, i.p., consecutively for 5 days) was used to induce diabetes followed by treatment with UD extract (50 mg/kg, oral) or rosiglitazone (5 mg/kg, oral) for 8 weeks. STZ-induced diabetic mice showed significant reduction in hippocampal muscarinic acetylcholine receptor-1 and choline acetyltransferase expressions. Chronic diabetes significantly up-regulated the protein expression of acetylcholinesterase associated with oxidative stress in hippocampus. Besides, STZ-induced diabetic mice showed hypolocomotion with up-regulation of muscarinic acetylcholine receptor-4 expression in striatum. Chronic UD treatment significantly attenuated the cholinergic dysfunction and oxidative stress in the hippocampus of diabetic mice. UD had no effect on locomotor activity and muscarinic acetylcholine receptor-4 expression in striatum. In conclusion, UD leaves extract has potential to reverse diabetes mediated alteration in muscarinic cholinergic system in hippocampus and thereby improve memory functions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104116</affiliation-url><afid>60104116</afid><affilname>Jaypee University of Information Technology</affilname><name-variant>Jaypee University of Information Technology</name-variant><affiliation-city>Solan</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109859446</affiliation-url><afid>109859446</afid><affilname>Lakshmi Narain College of Pharmacy</affilname><name-variant>Lakshmi Narain College of Pharmacy</name-variant><affiliation-city>Bhopal</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36673617300</author-url><authid>36673617300</authid><authname>Patel S.</authname><surname>Patel</surname><given-name>Sita Sharan</given-name><initials>S.S.</initials><afid>60104116</afid><afid>109859446</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36673617300</author-url><authid>36673617300</authid><authname>Patel S.</authname><surname>Patel</surname><given-name>Sita Sharan</given-name><initials>S.S.</initials><afid>60104116</afid><afid>109859446</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56609961400</author-url><authid>56609961400</authid><authname>Parashar A.</authname><surname>Parashar</surname><given-name>Arun</given-name><initials>A.</initials><afid>60104116</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24451352300</author-url><authid>24451352300</authid><authname>Udayabanu M.</authname><surname>Udayabanu</surname><given-name>Malairaman</given-name><initials>M.</initials><afid>60104116</afid></author><authkeywords>Choline acetyltransferase | Cognition | Diabetes mellitus | Locomotor activity | Muscarinic receptors | Urtica dioica</authkeywords><intid>1785825372</intid><source-id>19015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928958192"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928958192?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928958192&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928958192&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928958192</prism:url><dc:identifier>SCOPUS_ID:84928958192</dc:identifier><eid>2-s2.0-84928958192</eid><dc:title>Increased Risk of Surgical Site Infection Among Breast-Conserving Surgery Re-excisions</dc:title><dc:creator>Olsen M.</dc:creator><prism:publicationName>Annals of Surgical Oncology</prism:publicationName><prism:issn>10689265</prism:issn><prism:eIssn>15344681</prism:eIssn><prism:volume>22</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>2003-2009</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1245/s10434-014-4200-x</prism:doi><dc:description>© 2014, Society of Surgical Oncology. Methods: We established a retrospective cohort of women aged 18–64 years with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure or Current Procedural Terminology, 4th edition (CPT-4) codes for BCS from 29 June 2004 to 31 December 2010. Prior insurance plan enrollment of at least 180 days was required to establish the index BCS; subsequent re-excisions within 180 days were identified. SSIs occurring 2–90 days after BCS were identified by ICD-9-CM diagnosis codes. The attributable surgery was defined based on SSI onset compared with the BCS date(s). A χ&lt;sup&gt;2&lt;/sup&gt; test and generalized estimating equations model were used to compare the incidence of SSI after index and re-excision BCS procedures. Purpose: The aim of this study was to determine the risk of surgical site infection (SSI) after primary breast-conserving surgery (BCS) versus re-excision among women with carcinoma in situ or invasive breast cancer. Results: Overall, 23,001 women with 28,827 BCSs were identified; 23.2 % of women had more than one BCS. The incidence of SSI was 1.82 % (418/23,001) for the index BCS and 2.44 % (142/5,826) for re-excision BCS (p = 0.002). The risk of SSI after re-excision remained significantly higher after accounting for multiple procedures within a woman (odds ratio 1.34, 95 % confidence interval 1.07–1.68). Conclusions: Surgeons need to be aware of the increased risk of SSI after re-excision BCS compared with the initial procedure. Our results suggest that risk adjustment of SSI rates for re-excision would allow for better comparison of BCS SSI rates between institutions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022756</affiliation-url><afid>60022756</afid><affilname>Washington University in St. Louis, School of Medicine</affilname><name-variant>Washington University, School of Medicine</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022756</affiliation-url><afid>60022756</afid><affilname>Washington University in St. Louis, School of Medicine</affilname><name-variant>Washington University, School of Medicine</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022756</affiliation-url><afid>60022756</afid><affilname>Washington University in St. Louis, School of Medicine</affilname><name-variant>Washington University, School of Medicine</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112587174</affiliation-url><afid>112587174</afid><affilname>HealthCore Inc.</affilname><name-variant>HealthCore Inc.</name-variant><affiliation-city>Wilmington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022756</affiliation-url><afid>60022756</afid><affilname>Washington University in St. Louis, School of Medicine</affilname><name-variant>Washington University, School of Medicine</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56189835700</author-url><authid>56189835700</authid><authname>Olsen M.</authname><surname>Olsen</surname><given-name>Margaret A.</given-name><initials>M.A.</initials><afid>60022756</afid><afid>60022756</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56189835700</author-url><authid>56189835700</authid><authname>Olsen M.</authname><surname>Olsen</surname><given-name>Margaret A.</given-name><initials>M.A.</initials><afid>60022756</afid><afid>60022756</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:38862624500</author-url><authid>38862624500</authid><authname>Nickel K.</authname><surname>Nickel</surname><given-name>Katelin B.</given-name><initials>K.B.</initials><afid>60022756</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701457357</author-url><authid>6701457357</authid><authname>Margenthaler J.</authname><surname>Margenthaler</surname><given-name>Julie A.</given-name><initials>J.A.</initials><afid>60022756</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23768524100</author-url><authid>23768524100</authid><authname>Wallace A.</authname><surname>Wallace</surname><given-name>Anna E.</given-name><initials>A.E.</initials><afid>112587174</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603405525</author-url><authid>6603405525</authid><authname>Mines D.</authname><surname>Mines</surname><given-name>Daniel</given-name><initials>D.</initials><afid>112587174</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55547139457</author-url><authid>55547139457</authid><authname>Miller J.</authname><surname>Miller</surname><given-name>J. Philip</given-name><initials>J.P.</initials><afid>60022756</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15042176800</author-url><authid>15042176800</authid><authname>Fraser V.</authname><surname>Fraser</surname><given-name>Victoria J.</given-name><initials>V.J.</initials><afid>60022756</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202134016</author-url><authid>7202134016</authid><authname>Warren D.</authname><surname>Warren</surname><given-name>David K.</given-name><initials>D.K.</initials><afid>60022756</afid></author><intid>2035871352</intid><source-id>39465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924043933"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924043933?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924043933&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924043933&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0169204615000286"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924043933</prism:url><dc:identifier>SCOPUS_ID:84924043933</dc:identifier><eid>2-s2.0-84924043933</eid><dc:title>The benefits of nature experience: Improved affect and cognition</dc:title><dc:creator>Bratman G.</dc:creator><prism:publicationName>Landscape and Urban Planning</prism:publicationName><prism:issn>01692046</prism:issn><prism:volume>138</prism:volume><prism:pageRange>41-50</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.landurbplan.2015.02.005</prism:doi><pii>S0169204615000286</pii><dc:description>© 2015 Elsevier B.V. This study investigated the impact of nature experience on affect and cognition. We randomly assigned sixty participants to a 50-min walk in either a natural or an urban environment in and around Stanford, California. Before and after their walk, participants completed a series of psychological assessments of affective and cognitive functioning. Compared to the urban walk, the nature walk resulted in affective benefits (decreased anxiety, rumination, and negative affect, and preservation of positive affect) as well as cognitive benefits (increased working memory performance). This study extends previous research by demonstrating additional benefits of nature experience on affect and cognition through assessments of anxiety, rumination, and a complex measure of working memory (operation span task). These findings further our understanding of the influence of relatively brief nature experiences on affect and cognition, and help to lay the foundation for future research on the mechanisms underlying these effects.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085748</affiliation-url><afid>60085748</afid><affilname>University of San Francisco</affilname><name-variant>University of San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55028845000</author-url><authid>55028845000</authid><authname>Bratman G.</authname><surname>Bratman</surname><given-name>Gregory N.</given-name><initials>G.N.</initials><afid>60012708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004469735</author-url><authid>7004469735</authid><authname>Daily G.</authname><surname>Daily</surname><given-name>Gretchen C.</given-name><initials>G.C.</initials><afid>60012708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56535928600</author-url><authid>56535928600</authid><authname>Levy B.</authname><surname>Levy</surname><given-name>Benjamin J.</given-name><initials>B.J.</initials><afid>60085748</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402751884</author-url><authid>7402751884</authid><authname>Gross J.</authname><surname>Gross</surname><given-name>James J.</given-name><initials>J.J.</initials><afid>60012708</afid></author><authkeywords>Emotion regulation | Nature | Negative affect repair | Psychological ecosystem services | Rumination</authkeywords><intid>2035076978</intid><source-id>19041</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924083377"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924083377?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924083377&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924083377&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0959437X15000039"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924083377</prism:url><dc:identifier>SCOPUS_ID:84924083377</dc:identifier><eid>2-s2.0-84924083377</eid><dc:title>Regulation of tissue morphodynamics: An important role for actomyosin contractility</dc:title><dc:creator>Siedlik M.</dc:creator><prism:publicationName>Current Opinion in Genetics and Development</prism:publicationName><prism:issn>0959437X</prism:issn><prism:eIssn>18790380</prism:eIssn><prism:volume>32</prism:volume><prism:pageRange>80-85</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.gde.2015.01.002</prism:doi><pii>S0959437X15000039</pii><dc:description>© 2015 Elsevier Ltd. Forces arising from contractile actomyosin filaments help shape tissue form during morphogenesis. Developmental events that result from actomyosin contractility include tissue elongation, bending, budding, and collective migration. Here, we highlight recent insights into these morphogenetic processes from the perspective of actomyosin contractility as a key regulator. Emphasis is placed on a range of results obtained through live imaging, culture, and computational methods. Combining these approaches in the future has the potential to generate a robust, quantitative understanding of tissue morphodynamics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003269</affiliation-url><afid>60003269</afid><affilname>Princeton University</affilname><name-variant>Princeton University</name-variant><affiliation-city>Princeton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003269</affiliation-url><afid>60003269</afid><affilname>Princeton University</affilname><name-variant>Princeton University</name-variant><affiliation-city>Princeton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55308053600</author-url><authid>55308053600</authid><authname>Siedlik M.</authname><surname>Siedlik</surname><given-name>Michael J.</given-name><initials>M.J.</initials><afid>60003269</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403704252</author-url><authid>7403704252</authid><authname>Nelson C.</authname><surname>Nelson</surname><given-name>Celeste M.</given-name><initials>C.M.</initials><afid>60003269</afid><afid>60003269</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403704252</author-url><authid>7403704252</authid><authname>Nelson C.</authname><surname>Nelson</surname><given-name>Celeste M.</given-name><initials>C.M.</initials><afid>60003269</afid><afid>60003269</afid></author><intid>2035077694</intid><source-id>22080</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926377307"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926377307?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926377307&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926377307&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926377307</prism:url><dc:identifier>SCOPUS_ID:84926377307</dc:identifier><eid>2-s2.0-84926377307</eid><dc:title>Personhood and Pathology: The Jungian Psyche and Maximian Anthropology</dc:title><dc:creator>Alexander D.</dc:creator><prism:publicationName>Pastoral Psychology</prism:publicationName><prism:issn>00312789</prism:issn><prism:eIssn>15736679</prism:eIssn><prism:volume>64</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>287-295</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11089-014-0629-x</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. This paper explores connections between the psychic anthropology of C. G. Jung and that of Maximus the Confessor, a 7th-century Eastern Christian philosopher. Both saw the ability to fully bear one’s experiences without avoidance through fantasy as a key to human health and the target of therapy. Maximus understood avoidance of experience as a partly conscious turning of the self away from God in order to create fantastic fields of control, and Jung understood the phenomenon as a movement of the unconscious motivated by involuntary reactions to shadow material. Both encouraged humans to fully embrace reality in each moment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56581162500</author-url><authid>56581162500</authid><authname>Alexander D.</authname><surname>Alexander</surname><given-name>David W.</given-name><initials>D.W.</initials><afid/></author><authkeywords>Anthropology | Desert fathers | Jung | Maximus | Psyche</authkeywords><intid>1035425857</intid><source-id>12792</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930085060"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930085060?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930085060&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930085060&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930085060</prism:url><dc:identifier>SCOPUS_ID:84930085060</dc:identifier><eid>2-s2.0-84930085060</eid><dc:title>Do Adverse Childhood Experiences Affect Surgical Weight Loss Outcomes?</dc:title><dc:creator>Lodhia N.</dc:creator><prism:publicationName>Journal of Gastrointestinal Surgery</prism:publicationName><prism:issn>1091255X</prism:issn><prism:volume>19</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>993-998</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11605-015-2810-7</prism:doi><dc:description>© 2015, The Society for Surgery of the Alimentary Tract. Bariatric surgery is an effective and enduring treatment for obesity; however, variation in weight loss may occur following surgery. Many factors beyond technical considerations may influence postoperative outcomes. A better understanding of the influence of adverse childhood experiences (ACE) on surgical weight loss may improve preoperative care. Demographic and preoperative and postoperative data were prospectively obtained for 223 patients undergoing bariatric surgery. All cases were completed laparoscopically without serious complication. Patients completed the ACE questionnaire, which assesses childhood maltreatment. Patients had an average age of 48 years and 77 % were female. There was a significant reduction from preoperative to 12-month postoperative BMI (45 to 31 kg/m&lt;sup&gt;2&lt;/sup&gt;, p ≤ 0.01). The average ACE score was 2.9 and these patients were more likely than population norms to have an ACE score ≥4 (35.9 vs. 12.5 %, p &lt; 0.001). There was a positive correlation between the number of preoperative comorbidities and preoperative ACE score (R = 0.112, p = 0.09). Patients with a high ACE score (≥6) vs. patients low ACE scores had a higher postoperative BMI at 6-months (36.9 vs. 33.4 kg/m&lt;sup&gt;2&lt;/sup&gt;, p = 0.03) and 12-months postoperatively (34.5 vs. 30.5 kg/m&lt;sup&gt;2&lt;/sup&gt;, p = 0.07). High ACE patients had higher total cholesterol (191 vs. 169 mg/dL, p = 0.02) and LDL cholesterol (116 vs. 94 mg/dL, p = 0.02) than low ACE patients 12-months postoperatively. A high preoperative ACE score decreases weight loss following bariatric surgery and may warrant an increased preoperative counseling.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032838</affiliation-url><afid>60032838</afid><affilname>Stanford University School of Medicine</affilname><name-variant>Stanford University School of Medicine</name-variant><affiliation-city>Stanford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032838</affiliation-url><afid>60032838</afid><affilname>Stanford University School of Medicine</affilname><name-variant>Stanford University School of Medicine</name-variant><affiliation-city>Stanford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55441225500</author-url><authid>55441225500</authid><authname>Lodhia N.</authname><surname>Lodhia</surname><given-name>Nayna A.</given-name><initials>N.A.</initials><afid>60032838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56580351400</author-url><authid>56580351400</authid><authname>Rosas U.</authname><surname>Rosas</surname><given-name>Ulysses S.</given-name><initials>U.S.</initials><afid>60032838</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56579543300</author-url><authid>56579543300</authid><authname>Moore M.</authname><surname>Moore</surname><given-name>Michelle</given-name><initials>M.</initials><afid>60032838</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55984613600</author-url><authid>55984613600</authid><authname>Glaseroff A.</authname><surname>Glaseroff</surname><given-name>Alan</given-name><initials>A.</initials><afid>60032838</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16633321500</author-url><authid>16633321500</authid><authname>Azagury D.</authname><surname>Azagury</surname><given-name>Dan</given-name><initials>D.</initials><afid>60032838</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003427457</author-url><authid>7003427457</authid><authname>Rivas H.</authname><surname>Rivas</surname><given-name>Homero</given-name><initials>H.</initials><afid>60032838</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402301956</author-url><authid>7402301956</authid><authname>Morton J.</authname><surname>Morton</surname><given-name>John M.</given-name><initials>J.M.</initials><afid>60032838</afid></author><authkeywords>Adverse childhood experiences | Bariatric surgery | Obesity</authkeywords><intid>1536063616</intid><source-id>21679</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929174527"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929174527?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929174527&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929174527&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929174527</prism:url><dc:identifier>SCOPUS_ID:84929174527</dc:identifier><eid>2-s2.0-84929174527</eid><dc:title>Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic</dc:title><dc:creator>Valenti R.</dc:creator><prism:publicationName>Aging Clinical and Experimental Research</prism:publicationName><prism:issn>15940667</prism:issn><prism:eIssn>17208319</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>345-350</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s40520-014-0284-1</prism:doi><dc:description>© 2014, Springer International Publishing Switzerland. Background: Mild cognitive impairment (MCI) is an abnormal condition defined by the presence of cognitive decline not severe enough to fit dementia criteria. According to Winblad et al.’s criteria, the clinical distinction of MCI subtypes (amnestic/non-amnestic, single/multiple domain) is based on the cognitive profiling (conventional diagnosis) and infers possible different MCI etiologies. MCI prodromic of vascular dementia (Vasc-MCI) is thought to be characterized by a multiple domain profile. In our outpatient clinic (the “Florence VAS-COG clinic”), the diagnosis of MCI and of its different subtypes (vascular, degenerative, mixed) is based on a comprehensive evaluation of clinical and neuroimaging features (pragmatic diagnosis). Aims: To compare the pragmatic and conventional diagnoses in terms of etiologic subtyping of MCI. Methods: We retrospectively assessed the agreement between the two diagnoses in 30 MCI patients. Agreement was considered present when degenerative MCI was of the amnestic type (single or multiple domain) and Vasc-MCI was of the multiple domain type (amnestic or non-amnestic MCI). Results: In 15/30 (50 %) patients, the diagnoses were in disagreement: 5/9 (56 %) patients diagnosed with a degenerative MCI type presented a non-amnestic cognitive profile (4 single domain and 1 multiple domain); 10/21 (48 %) Vasc-MCI were classified as non-amnestic single domain. Conclusions: The application of MCI etiologic subtyping using pragmatic or conventional diagnoses leads to different results. In our setting, not all the Vasc-MCI patients have a multiple domain profile. Our preliminary study suggests that the cognitive profile of Vasc-MCI is more heterogeneous than previously suggested.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021859</affiliation-url><afid>60021859</afid><affilname>Universita degli Studi di Firenze</affilname><name-variant>Università di Firenze</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112981670</affiliation-url><afid>112981670</afid><affilname>Stroke Unit and Neurology</affilname><name-variant>Stroke Unit and Neurology</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25226195700</author-url><authid>25226195700</authid><authname>Valenti R.</authname><surname>Valenti</surname><given-name>R.</given-name><initials>R.</initials><afid>60021859</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14527949400</author-url><authid>14527949400</authid><authname>Salvadori E.</authname><surname>Salvadori</surname><given-name>E.</given-name><initials>E.</initials><afid>60021859</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:13611408200</author-url><authid>13611408200</authid><authname>Poggesi A.</authname><surname>Poggesi</surname><given-name>A.</given-name><initials>A.</initials><afid>60021859</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26026838700</author-url><authid>26026838700</authid><authname>Ciolli L.</authname><surname>Ciolli</surname><given-name>L.</given-name><initials>L.</initials><afid>60021859</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12792717400</author-url><authid>12792717400</authid><authname>Pescini F.</authname><surname>Pescini</surname><given-name>F.</given-name><initials>F.</initials><afid>112981670</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26027160200</author-url><authid>26027160200</authid><authname>Nannucci S.</authname><surname>Nannucci</surname><given-name>S.</given-name><initials>S.</initials><afid>60021859</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55644655100</author-url><authid>55644655100</authid><authname>Inzitari D.</authname><surname>Inzitari</surname><given-name>D.</given-name><initials>D.</initials><afid>60021859</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004486153</author-url><authid>7004486153</authid><authname>Pantoni L.</authname><surname>Pantoni</surname><given-name>L.</given-name><initials>L.</initials><afid>112981670</afid></author><authkeywords>Cognitive profile | Criteria | Diagnosis | Mild cognitive impairment | Subtypes</authkeywords><intid>1035912590</intid><source-id>28496</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927168628"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927168628?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927168628&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927168628&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0963996915001040"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927168628</prism:url><dc:identifier>SCOPUS_ID:84927168628</dc:identifier><eid>2-s2.0-84927168628</eid><dc:title>Sensory profiles and consumer acceptability of a range of sugar-reduced products on the UK market</dc:title><dc:creator>Markey O.</dc:creator><prism:publicationName>Food Research International</prism:publicationName><prism:issn>09639969</prism:issn><prism:volume>72</prism:volume><prism:pageRange>133-139</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodres.2015.03.012</prism:doi><pii>S0963996915001040</pii><dc:description>© 2015 Elsevier Ltd. Current UK intake of non-milk extrinsic sugars (NMES) is above recommendations. Reducing the sugar content of processed high sugar foods through reformulation is one option for reducing consumption of NMES at a population level. However, reformulation can alter the sensory attributes of food products and influence consumer liking. This study evaluated consumer acceptance of a selection of products that are commercially-available in the UK; these included regular and sugar-reduced baked beans, strawberry jam, milk chocolate, cola and cranberry &amp; raspberry juice. Sweeteners were present in the reformulated chocolate (maltitol), cola (aspartame and acesulfame-K) and juice (sucralose) samples. Healthy, non-smoking consumers (n=116; 55 men, 61 women, age: 33±9years; BMI: 25.7±4.6kg/m&lt;sup&gt;2&lt;/sup&gt;) rated the products for overall liking and on liking of appearance, flavor and texture using a nine-point hedonic scale. There were significant differences between standard and reduced sugar products in consumers' overall liking and on liking of each modality (appearance, flavor and texture; all P&lt;0.0001). For overall liking, only the regular beans and cola were significantly more liked than their reformulated counterparts (P&lt;0.0001). Cluster analysis identified three consumer clusters that were representative of different patterns of consumer liking. For the largest cluster (cluster 3: 45%), there was a significant difference in mean liking scores across all products, except jam. Differences in liking were predominantly driven by sweet taste in 2 out of 3 clusters. The current research has demonstrated that a high proportion of consumers prefer conventional products over sugar-reduced products across a wide range of product types (45%) or across selected products (27%), when tasted unbranded, and so there is room for further optimization of commercial reduced sugar products that were evaluated in the current study. Future work should evaluate strategies to facilitate compliance to dietary recommendations on NMES and free sugars, such as the impact of sugar-reduced food exposure on their acceptance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Reading</affilname><name-variant>Hugh Sinclair Unit of Human Nutrition</name-variant><name-variant>Department of Food and Nutritional Sciences</name-variant><name-variant>Food and Pharmacy</name-variant><affiliation-city>Whiteknights, Reading, Berkshire</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Reading</affilname><name-variant>Institute for Cardiovascular and Metabolic Research (ICMR)</name-variant><affiliation-city>Whiteknights, Reading, Berkshire</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:51261298500</author-url><authid>51261298500</authid><authname>Markey O.</authname><surname>Markey</surname><given-name>Oonagh</given-name><initials>O.</initials><afid/><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:51261298500</author-url><authid>51261298500</authid><authname>Markey O.</authname><surname>Markey</surname><given-name>Oonagh</given-name><initials>O.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005019601</author-url><authid>7005019601</authid><authname>Lovegrove J.</authname><surname>Lovegrove</surname><given-name>Julie A.</given-name><initials>J.A.</initials><afid/><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005019601</author-url><authid>7005019601</authid><authname>Lovegrove J.</authname><surname>Lovegrove</surname><given-name>Julie A.</given-name><initials>J.A.</initials><afid/><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16424615900</author-url><authid>16424615900</authid><authname>Methven L.</authname><surname>Methven</surname><given-name>Lisa</given-name><initials>L.</initials><afid/></author><authkeywords>Artificial sweeteners | Consumer acceptance | Sensory profile | Sugar | Sugar reformulation | Sugar-reduced products</authkeywords><intid>1535569110</intid><source-id>23180</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924255485"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924255485?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924255485&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924255485&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000168"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924255485</prism:url><dc:identifier>SCOPUS_ID:84924255485</dc:identifier><eid>2-s2.0-84924255485</eid><dc:title>Effect of omega-3 fatty acid oxidation products on the cellular and mitochondrial toxicity of BDE 47</dc:title><dc:creator>Yeh A.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>672-680</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.01.015</prism:doi><pii>S0887233315000168</pii><dc:description>© 2015 Elsevier Ltd. High levels of the flame retardant 2,2',4,4'-tetrabromodiphenyl ether (BDE 47) have been detected in Pacific salmon sampled near urban areas, raising concern over the safety of salmon consumption. However, salmon fillets also contain the antioxidants eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), whose oxidation products induce cellular antioxidant responses. Because oxidative stress is a mechanism of BDE 47 toxicity, we hypothesized that oxidized EPA and DHA can ameliorate the cellular and mitochondrial toxicity of BDE 47. HepG2 cells were treated with a mixture of oxidized EPA and DHA (oxEPA/oxDHA) at a ratio relevant to salmon consumption (1.5/1 oxEPA/oxDHA) followed by exposure to 100. μM BDE 47. Pretreatment with oxEPA/oxDHA for 12. h prior to BDE 47 exposure prevented BDE 47-mediated depletion of glutathione, and increased expression of antioxidant response genes. oxEPA/oxDHA also reduced the level of reactive oxygen species production by BDE 47. The oxEPA/oxDHA antioxidant responses were associated with partial protection against BDE 47-induced loss of viability and also mitochondrial membrane potential. Mitochondrial electron transport system functional analysis revealed extensive inhibition of State 3 respiration and maximum respiratory capacity by BDE 47 were partially reversed by oxEPA/oxDHA. Our findings indicate that the antioxidant effects of oxEPA/oxDHA protect against short exposures to BDE 47, including a protective role of these compounds on maintaining cellular and mitochondrial function.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028548</affiliation-url><afid>60028548</afid><affilname>University of Washington School of Medicine</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56539451300</author-url><authid>56539451300</authid><authname>Yeh A.</authname><surname>Yeh</surname><given-name>Andrew</given-name><initials>A.</initials><afid>60015481</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23989272000</author-url><authid>23989272000</authid><authname>Kruse S.</authname><surname>Kruse</surname><given-name>Shane E.</given-name><initials>S.E.</initials><afid>60028548</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56564309900</author-url><authid>56564309900</authid><authname>Marcinek D.</authname><surname>Marcinek</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60028548</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56564293100</author-url><authid>56564293100</authid><authname>Gallagher E.</authname><surname>Gallagher</surname><given-name>Evan P.</given-name><initials>E.P.</initials><afid>60015481</afid></author><authkeywords>BDE 47 | Mitochondria | Omega-3 polyunsaturated fatty acids | Oxidative stress | PBDE | Salmon</authkeywords><intid>35102431</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926218324"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926218324?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926218324&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926218324&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0096300315003392"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926218324</prism:url><dc:identifier>SCOPUS_ID:84926218324</dc:identifier><eid>2-s2.0-84926218324</eid><dc:title>Difficulties in detecting chaos in a complex system</dc:title><dc:creator>Petkov B.</dc:creator><prism:publicationName>Applied Mathematics and Computation</prism:publicationName><prism:issn>00963003</prism:issn><prism:volume>260</prism:volume><prism:pageRange>35-47</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.amc.2015.03.034</prism:doi><pii>S0096300315003392</pii><dc:description>© 2015 ElsevierInc.Allrightsreserved. The sequences, given by a 7D map, are analysed by means of the methods, widely used to detect chaos in the real world in order to test their sensitivity to chaotic features of a non-linear system, determined by comparatively high number of parameters. The same diagnostic approaches are applied to the 3D Lorenz map for comparison. The results show that for some of the sequences yielded from the 7D map, the adopted methods are not able to give a straightforward answer to the question if the system is chaotic as in the 3D case. Since the sequences, subject to the analysis, are not contaminated by noise and are sufficiently long, it could be assumed that such difficulties arise likely due to specific internal features of the more complex system. It is found also that an increase from 0.01 to 0.5 of the sampling step, determining the sequences obtained from the 7D map, masks the chaos in some of them.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008124</affiliation-url><afid>60008124</afid><affilname>Institute of Atmospheric Sciences and Climate, Bologna</affilname><name-variant>CNR-ISAC</name-variant><affiliation-city>Bologna</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602554488</author-url><authid>6602554488</authid><authname>Petkov B.</authname><surname>Petkov</surname><given-name>Boyan H.</given-name><initials>B.H.</initials><afid>60008124</afid></author><authkeywords>Complex chaotic systems | Correlation dimension | Detection of chaos | Embedding dimension | Lyapunov exponents</authkeywords><intid>35406091</intid><source-id>25170</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928679297"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928679297?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928679297&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928679297&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003347215001256"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928679297</prism:url><dc:identifier>SCOPUS_ID:84928679297</dc:identifier><eid>2-s2.0-84928679297</eid><dc:title>Dense, small and male-biased cages exacerbate male-male competition and reduce female choosiness in Bicyclus anynana</dc:title><dc:creator>Holveck M.</dc:creator><prism:publicationName>Animal Behaviour</prism:publicationName><prism:issn>00033472</prism:issn><prism:volume>104</prism:volume><prism:pageRange>229-245</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.anbehav.2015.03.025</prism:doi><pii>S0003347215001256</pii><dc:description>© 2015 The Association for the Study of Animal Behaviour. Sexual selection is increasingly recognized to depend upon, and to fluctuate with, major ecological factors in natural environments. The operational sex ratio (OSR) and population density can affect the opportunity for, and strength of, sexual selection but their effects are rarely taken into account in laboratory behavioural studies. In Bicyclus anynana, a model butterfly for mate choice studies, the experimental set-up widely used in laboratories often involves very high densities compared to the field, male-biased sex ratios and small cage volumes. We hypothesized that these conditions impede the proper expression of female mating preference by promoting male competition and sexual harassment of females. Using various cage volumes, we separately manipulated OSR and density to cover the range of values used in B.anynana laboratory mating experiments and to approach field values. Male competition, quantified by the number and duration of courtships aborted by males, became stronger with increasing densities, specifically under more male-biased sex ratios, and decreasing cage volumes. Thus, male eagerness to mate was essentially due to the use of small cage volumes and very high experimental densities. Concomitantly, female choosiness, quantified by the proportion of rejections of male mating attempts, decreased with increasing densities under a male-biased sex ratio. Females also accepted more matings with decreasing cage volume, and mated more rapidly with increasing density. We conclude that the laboratory social environments frequently used to test mate choice in B.anynana, with unnaturally high densities and male-biased sex ratios, exacerbate male-male competition and strongly hinder female choice, biasing the estimates of the strength and direction of sexual selection that were shaped under very different natural environments in the wild. We propose a set-up for B.anynana mate choice studies that allows the assessment of female choosiness in statistically robust mating experiments.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60081471</affiliation-url><afid>60081471</afid><affilname>Biodiversity Research Center (UCL)</affilname><name-variant>Université catholique de Louvain</name-variant><affiliation-city>Louvain-la-Neuve</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14527230800</author-url><authid>14527230800</authid><authname>Holveck M.</authname><surname>Holveck</surname><given-name>Marie Jeanne</given-name><initials>M.J.</initials><afid>60081471</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56609846800</author-url><authid>56609846800</authid><authname>Gauthier A.</authname><surname>Gauthier</surname><given-name>Anne Laure</given-name><initials>A.L.</initials><afid>60081471</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507305826</author-url><authid>6507305826</authid><authname>Nieberding C.</authname><surname>Nieberding</surname><given-name>Caroline M.</given-name><initials>C.M.</initials><afid>60081471</afid></author><authkeywords>Bicyclus anynana | Choosiness | Competition | Density | Mating preference | Mating success | Sex ratio</authkeywords><intid>2035819205</intid><source-id>24580</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926512119"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926512119?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926512119&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926512119&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003269715001220"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926512119</prism:url><dc:identifier>SCOPUS_ID:84926512119</dc:identifier><eid>2-s2.0-84926512119</eid><dc:title>Using carboxyfluorescein diacetate succinimidyl ester to monitor intracellular protein glycation</dc:title><dc:creator>Boucher J.</dc:creator><prism:publicationName>Analytical Biochemistry</prism:publicationName><prism:issn>00032697</prism:issn><prism:eIssn>10960309</prism:eIssn><prism:volume>478</prism:volume><prism:pageRange>73-81</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ab.2015.03.017</prism:doi><pii>S0003269715001220</pii><dc:description>© 2015 Published by Elsevier Inc. All rights reserved. Protein glycation is a ubiquitous process involved in vascular complications observed in diabetes. Glyoxal (GO), an intracellular reactive oxoaldehyde that is one of the most potent glycation agents, readily reacts with amines present on proteins to produce the lysine-derived adduct carboxymethyllysine, which is a prevalent advanced glycation end-product (AGE). Our group previously showed that cell exposure to GO leads to an alteration in the cell contractile activity that could occur as a result of the glycation of various proteins regulating the cell contractile machinery. Here, we measured the extent of glycation on three functionally distinct proteins known to participate in cell contraction and cytoskeletal organization - Rho-kinase (ROCK), actin, and gelsolin (GSN) - using an assay based on the reaction of the cell membrane-permeable fluorescent probe carboxyfluorescein diacetate succinimidyl ester (CFDA-SE), which reacts with primary amine groups of proteins. By combining CFDA-SE fluorescence and Western blot detection, we observed (following GO incubation) increased glycation of actin and ROCK as well as an increased interaction between actin and GSN as observed by co-immunoprecipitation. Thus, we conclude that the use of the fluorescent probe CFDA-SE offers an interesting alternative to perform a comparative analysis of the extent of intracellular protein glycation in live cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011832</affiliation-url><afid>60011832</afid><affilname>Universite de Sherbrooke</affilname><name-variant>University of Sherbrooke</name-variant><affiliation-city>Sherbrooke</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55824142500</author-url><authid>55824142500</authid><authname>Boucher J.</authname><surname>Boucher</surname><given-name>Julie</given-name><initials>J.</initials><afid>60011832</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24598088600</author-url><authid>24598088600</authid><authname>Simard É.</authname><surname>Simard</surname><given-name>Élie</given-name><initials>É.</initials><afid>60011832</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24597035300</author-url><authid>24597035300</authid><authname>Froehlich U.</authname><surname>Froehlich</surname><given-name>Ulrike</given-name><initials>U.</initials><afid>60011832</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007180278</author-url><authid>7007180278</authid><authname>D'Orléans-Juste P.</authname><surname>D'Orléans-Juste</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60011832</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701633823</author-url><authid>6701633823</authid><authname>Grandbois M.</authname><surname>Grandbois</surname><given-name>Michel</given-name><initials>M.</initials><afid>60011832</afid></author><authkeywords>Actin | Carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) | Cellular protein glycation | Gelsolin | Glyoxal | Rho-kinase</authkeywords><intid>1035449405</intid><source-id>16789</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930206187"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930206187?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930206187&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930206187&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930206187</prism:url><dc:identifier>SCOPUS_ID:84930206187</dc:identifier><eid>2-s2.0-84930206187</eid><dc:title>Cold exposure inhibits hypothalamic Kiss-1 gene expression, serum leptin concentration, and delays reproductive development in male Brandt’s vole (Lasiopodomys brandtii)</dc:title><dc:creator>Zhang Q.</dc:creator><prism:publicationName>International Journal of Biometeorology</prism:publicationName><prism:issn>00207128</prism:issn><prism:volume>59</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>679-691</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00484-014-0879-4</prism:doi><dc:description>© 2014, ISB. Cold commonly affects growth and reproductive development in small mammals. Here, we test the hypothesis that low ambient temperature will affect growth and puberty onset, associated with altered hypothalamic Kiss-1 gene expression and serum leptin concentration in wild rodents. Male Brandt’s voles (Lasiopodomys brandtii) were exposed to cold (4 ± 1 °C) and warm (23 ± 1 °C) conditions from the birth and sacrificed on different developmental stages (day 26, day 40, day 60, and day 90, respectively). Brandt’s voles increased the thermogenic capacity of brown adipose tissue, mobilized body fat, decreased serum leptin levels, and delayed the reproductive development especially on day 40 in the cold condition. They increased food intake to compensate for the high energy demands in the cold. The hypothalamic Kiss-1 gene expression on day 26 was decreased, associated with lower wet testis mass and testis testosterone concentration on day 40, in the cold-exposed voles compared to that in the warm. Serum leptin was positively correlated with body fat, testis mass, and testosterone concentration. These data suggested that cold exposure inhibited hypothalamic Kiss-1 gene expression during the early stage of development, decreased serum leptin concentration, and delayed reproductive development in male Brandt’s voles.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019499</affiliation-url><afid>60019499</afid><affilname>Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114826660</affiliation-url><afid>114826660</afid><affilname>Zunyi Normal College</affilname><name-variant>Zunyi Normal College</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019499</affiliation-url><afid>60019499</afid><affilname>Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55627873071</author-url><authid>55627873071</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60019499</afid><afid>114826660</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55627873071</author-url><authid>55627873071</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60019499</afid><afid>114826660</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56327161700</author-url><authid>56327161700</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60019499</afid><afid>60019499</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56327161700</author-url><authid>56327161700</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60019499</afid><afid>60019499</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25949168300</author-url><authid>25949168300</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xue Ying</given-name><initials>X.Y.</initials><afid>60019499</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55672306900</author-url><authid>55672306900</authid><authname>Wang D.</authname><surname>Wang</surname><given-name>De Hua</given-name><initials>D.H.</initials><afid>60019499</afid></author><authkeywords>Brandt’s voles (Lasiopodomys brandtii) | Cold exposure | Kiss-1 | Leptin | Reproductive development</authkeywords><intid>36085719</intid><source-id>13506</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930189587"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930189587?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930189587&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930189587&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415001626"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930189587</prism:url><dc:identifier>SCOPUS_ID:84930189587</dc:identifier><eid>2-s2.0-84930189587</eid><dc:title>Forebrain neuropeptide regulation of pair association and behavior in cooperating cleaner fish</dc:title><dc:creator>Cardoso S.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>145</prism:volume><prism:pageRange>1-7</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.03.024</prism:doi><pii>S0031938415001626</pii><dc:description>© 2015 Elsevier Inc. Animals establish privileged relationships with specific partners, which are treated differently from other conspecifics, and contribute to behavioral variation. However, there is limited information on the underlying physiological mechanisms involved in the establishment of these privileged ties and their relationship to individual cooperation levels. The Indo-Pacific bluestreak cleaner wrasse Labroides dimidiatus often forages in mixed-sex pairs when cleaning fish clients. Intra-couple conflicts often arise during a joint client inspection, which may alter the overall quality of cleaning service provided. Here we tested two hypotheses: a) whether intra-pair association (i.e. association index), measured with joint interspecific cleaning and intraspecific behavior, is correlated with neuroendocrine mechanisms involving forebrain neuropeptides arginine vasotocin (AVT) and isotocin (IT) and b) whether these neuropeptide level shifts relate to an individual's interspecific service quality. We found that partner support (number of cleaning interactions and tactile stimulation) received by male cleaners increased with association index. When cleaners inspected clients alone, cleaners' cheating decreased with association index for females but not males. AVT levels did not differ according to sex or association level. Forebrain IT levels increased with association index for males, whereas no relationship was found for females. Finally, cleaner cheating varied between sex and forebrain IT levels. Findings indicate that variation in pairs' relationships influences male and female cleaner fish differently and contributes to the variation of brain neuropeptide levels, which is linked to distinct cooperative outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028300</affiliation-url><afid>60028300</afid><affilname>Instituto Universitário de Lisboa</affilname><name-variant>ISCTE</name-variant><affiliation-city>Lisbon</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031004</affiliation-url><afid>60031004</afid><affilname>University of Queensland</affilname><name-variant>The University of Queensland</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012061</affiliation-url><afid>60012061</afid><affilname>Institute of Oceanology of the Polish Academy of Sciences</affilname><name-variant>Polish Academy of Sciences</name-variant><affiliation-city>Sopot</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16202123900</author-url><authid>16202123900</authid><authname>Cardoso S.</authname><surname>Cardoso</surname><given-name>Sónia C.</given-name><initials>S.C.</initials><afid>60028300</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16202123900</author-url><authid>16202123900</authid><authname>Cardoso S.</authname><surname>Cardoso</surname><given-name>Sónia C.</given-name><initials>S.C.</initials><afid>60028300</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003634149</author-url><authid>7003634149</authid><authname>Grutter A.</authname><surname>Grutter</surname><given-name>Alexandra S.</given-name><initials>A.S.</initials><afid>60031004</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56567745000</author-url><authid>56567745000</authid><authname>Paula J.</authname><surname>Paula</surname><given-name>José R.</given-name><initials>J.R.</initials><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56567615600</author-url><authid>56567615600</authid><authname>André G.</authname><surname>André</surname><given-name>Gonçalo I.</given-name><initials>G.I.</initials><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56578414700</author-url><authid>56578414700</authid><authname>Messias J.</authname><surname>Messias</surname><given-name>João P.</given-name><initials>J.P.</initials><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603115362</author-url><authid>6603115362</authid><authname>Gozdowska M.</authname><surname>Gozdowska</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60012061</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56179686100</author-url><authid>56179686100</authid><authname>Kulczykowska E.</authname><surname>Kulczykowska</surname><given-name>Ewa</given-name><initials>E.</initials><afid>60012061</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:16203894900</author-url><authid>16203894900</authid><authname>Soares M.</authname><surname>Soares</surname><given-name>Marta C.</given-name><initials>M.C.</initials><afid>60007249</afid></author><authkeywords>Arginine-vasotocin | Behavioral variation | Cleaner fish | Cooperative behavior | Forebrain | Isotocin | Male-female partnerships</authkeywords><intid>36079096</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928884113"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928884113?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928884113&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928884113&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928884113</prism:url><dc:identifier>SCOPUS_ID:84928884113</dc:identifier><eid>2-s2.0-84928884113</eid><dc:title>Selenium Deficiency Facilitates Inflammation Through the Regulation of TLR4 and TLR4-Related Signaling Pathways in the Mice Uterus</dc:title><dc:creator>Zhang Z.</dc:creator><prism:publicationName>Inflammation</prism:publicationName><prism:issn>03603997</prism:issn><prism:eIssn>15732576</prism:eIssn><prism:volume>38</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>1347-1356</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10753-014-0106-9</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Selenium (Se) is an essential nutritional trace element that affects the development and function of the reproductive system. Endometritis is a reproductive obstacle disease that can seriously reduce the reproductive capacity of animal. To study the effects of dietary Se deficiency on lipopolysaccharide (LPS)-induced mice endometritis, we generated a model of LPS-induced mice endometritis. The Se content in uterine tissues was detected by fluorescence spectrophotometry. The levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 were measured by enzyme-linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (qRT-PCR). The extent of phosphorylation of IκBα, NF-κB p65, ERK, JNK, and p38 and the expression of Toll-like receptor 4 (TLR4) were detected with Western blots. The TLR4 messenger RNA (mRNA) was analyzed with qRT-PCR. The results indicated that dietary Se intake significantly influenced Se levels in uterine tissues. The Se-deficient mice model was successfully replicated, and Se deficiency exacerbated uterine tissue histopathology; increased the expression of TNF-α, IL-1β, and IL-6; facilitated the activation of TLR4; and enhanced the phosphorylation of IκBα, p65, ERK, JNK, and p38 in LPS-induced mice endometritis. Also, the effects were inhibited by a supplement of Se. In conclusion, our studies demonstrated that Se deficiency makes mice uterus more prone to inflammation. An appropriate Se supplement could enhance the immune condition of the uterus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007711</affiliation-url><afid>60007711</afid><affilname>Jilin University</affilname><name-variant>Jilin University</name-variant><affiliation-city>Changchun</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032955</affiliation-url><afid>60032955</afid><affilname>Huazhong Agricultural University</affilname><name-variant>Huazhong Agricultural University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56182320100</author-url><authid>56182320100</authid><authname>Zhang Z.</authname><surname>Zhang</surname><given-name>Zecai</given-name><initials>Z.</initials><afid>60007711</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56621737100</author-url><authid>56621737100</authid><authname>Gao X.</authname><surname>Gao</surname><given-name>Xuejiao</given-name><initials>X.</initials><afid>60007711</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56215958500</author-url><authid>56215958500</authid><authname>Cao Y.</authname><surname>Cao</surname><given-name>Yongguo</given-name><initials>Y.</initials><afid>60007711</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55914625500</author-url><authid>55914625500</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Haichao</given-name><initials>H.</initials><afid>60007711</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55914674200</author-url><authid>55914674200</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tiancheng</given-name><initials>T.</initials><afid>60007711</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56621776600</author-url><authid>56621776600</authid><authname>Song X.</authname><surname>Song</surname><given-name>Xiaojing</given-name><initials>X.</initials><afid>60007711</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55317020000</author-url><authid>55317020000</authid><authname>Guo M.</authname><surname>Guo</surname><given-name>Mengyao</given-name><initials>M.</initials><afid>60032955</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23026447100</author-url><authid>23026447100</authid><authname>Zhang N.</authname><surname>Zhang</surname><given-name>Naisheng</given-name><initials>N.</initials><afid>60007711</afid></author><authkeywords>endometritis | inflammation | selenium | signaling pathway | TLR4</authkeywords><intid>535863261</intid><source-id>14688</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926658826"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926658826?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926658826&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926658826&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001112"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926658826</prism:url><dc:identifier>SCOPUS_ID:84926658826</dc:identifier><eid>2-s2.0-84926658826</eid><dc:title>Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway</dc:title><dc:creator>Gu X.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>149-158</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.034</prism:doi><pii>S0891584915001112</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. An increasing number of studies have focused on the phenomenon that mitochondrial DNA (mtDNA) activates innate immunity responses. However, the specific role of mtDNA in inflammatory lung disease remains elusive. This study was designed to examine the proinflammatory effects of mtDNA in lungs and to investigate the putative mechanisms. C57BL/6 mice were challenged intratracheally with mtDNA with or without pretreatment with chloroquine. Changes in pulmonary histopathology, cytokine concentrations, and phosphorylation levels of p38 MAPK were assayed at four time points. In in vitro experiments, THP-1 macrophages were pretreated or not pretreated with chloroquine, TLR9 siRNA, p38 MAPK siRNA, or SB203580 and then incubated with mtDNA. The levels of cytokines and p-p38 MAPK were detected by ELISA and Western blot, respectively. The intratracheal administration of mtDNA induced infiltration of inflammatory cells, production of proinflammatory cytokines (including IL-1β, IL-6, and TNF-α), and activation of p38 MAPK. The chloroquine pretreatment resulted in an abatement of mtDNA-induced local lung inflammation. In vitro experiments showed that the exposure of THP-1 macrophages to mtDNA also led to a significant upregulation of IL-1β, IL-6, and TNF-α and the activation of p38 MAPK. And these responses were inhibited either by chloroquine and TLR9 siRNA or by SB203580 and p38 MAPK siRNA pretreatment. The intratracheal administration of mtDNA induced a local inflammatory response in the mouse lung that depended on the interactions of mtDNA with TLR9 and may be correlated with infiltrating macrophages that could be activated by mtDNA exposure via the TLR9-p38 MAPK signal transduction pathway.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033100</affiliation-url><afid>60033100</afid><affilname>Nanjing University</affilname><name-variant>Nanjing University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033100</affiliation-url><afid>60033100</afid><affilname>Nanjing University</affilname><name-variant>Nanjing University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55460575800</author-url><authid>55460575800</authid><authname>Gu X.</authname><surname>Gu</surname><given-name>Xiaoling</given-name><initials>X.</initials><afid>60033100</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55830071900</author-url><authid>55830071900</authid><authname>Wu G.</authname><surname>Wu</surname><given-name>Guannan</given-name><initials>G.</initials><afid>60033100</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:52664538100</author-url><authid>52664538100</authid><authname>Yao Y.</authname><surname>Yao</surname><given-name>Yanwen</given-name><initials>Y.</initials><afid>60033100</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56585198600</author-url><authid>56585198600</authid><authname>Zeng J.</authname><surname>Zeng</surname><given-name>Junli</given-name><initials>J.</initials><afid>60033100</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56585230500</author-url><authid>56585230500</authid><authname>Shi D.</authname><surname>Shi</surname><given-name>Donghong</given-name><initials>D.</initials><afid>60033100</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26027050000</author-url><authid>26027050000</authid><authname>Lv T.</authname><surname>Lv</surname><given-name>Tangfeng</given-name><initials>T.</initials><afid>60033100</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:39762298700</author-url><authid>39762298700</authid><authname>Luo L.</authname><surname>Luo</surname><given-name>Liang</given-name><initials>L.</initials><afid>60018310</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35197019800</author-url><authid>35197019800</authid><authname>Song Y.</authname><surname>Song</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60033100</afid></author><authkeywords>Freeradicals | Inflammation | Lung | Mitochondrial DNA | pathway | TLR9p38 MAPKsignaltransduction</authkeywords><intid>35484617</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928408657"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928408657?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928408657&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928408657&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000799"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928408657</prism:url><dc:identifier>SCOPUS_ID:84928408657</dc:identifier><eid>2-s2.0-84928408657</eid><dc:title>Structure-function analysis of peroxidasin provides insight into the mechanism of collagen IV crosslinking</dc:title><dc:creator>Lázár E.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>273-282</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.015</prism:doi><pii>S0891584915000799</pii><dc:description>©2015 Published by Elsevier Inc. Basement membranes provide structural support and convey regulatory signals to cells in diverse tissues. Assembly of collagen IV into a sheet-like network is a fundamental mechanism during the formation of basement membranes. Peroxidasin (PXDN) was recently described to catalyze crosslinking of collagen IV through the formation of sulfilimine bonds. Despite the significance of this pathway in tissue genesis, our understanding of PXDN function is far from complete. In this work we demonstrate that collagen IV crosslinking is a physiological function of mammalian PXDN. Moreover, we carried out structure-function analysis of PXDN to gain a better insight into its role in collagen IV synthesis. We identify conserved cysteines in PXDN that mediate the oligomerization of the protein into a trimeric complex. We also demonstrate that oligomerization is not an absolute requirement for enzymatic activity, but optimal collagen IV coupling is only catalyzed by the PXDN trimers. Localization experiments of different PXDN mutants in two different cell models revealed that PXDN oligomers, but not monomers, adhere on the cell surface in "hot spots," which represent previously unknown locations of collagen IV crosslinking.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024812</affiliation-url><afid>60024812</afid><affilname>Semmelweis Egyetem</affilname><name-variant>Semmelweis University</name-variant><affiliation-city>Budapest</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024812</affiliation-url><afid>60024812</afid><affilname>Semmelweis Egyetem</affilname><name-variant>Semmelweis University</name-variant><affiliation-city>Budapest</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026434</affiliation-url><afid>60026434</afid><affilname>Biological Research Center at Hungarian Academy of Sciences</affilname><name-variant>Biological Research Center</name-variant><affiliation-city>Szeged</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56604787000</author-url><authid>56604787000</authid><authname>Lázár E.</authname><surname>Lázár</surname><given-name>Eniko</given-name><initials>E.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56604787000</author-url><authid>56604787000</authid><authname>Lázár E.</authname><surname>Lázár</surname><given-name>Eniko</given-name><initials>E.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16245882400</author-url><authid>16245882400</authid><authname>Péterfi Z.</authname><surname>Péterfi</surname><given-name>Zalán</given-name><initials>Z.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16245882400</author-url><authid>16245882400</authid><authname>Péterfi Z.</authname><surname>Péterfi</surname><given-name>Zalán</given-name><initials>Z.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506620278</author-url><authid>6506620278</authid><authname>Sirokmány G.</authname><surname>Sirokmány</surname><given-name>Gábor</given-name><initials>G.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506620278</author-url><authid>6506620278</authid><authname>Sirokmány G.</authname><surname>Sirokmány</surname><given-name>Gábor</given-name><initials>G.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56048361800</author-url><authid>56048361800</authid><authname>Kovács H.</authname><surname>Kovács</surname><given-name>Hajnal A.</given-name><initials>H.A.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56048361800</author-url><authid>56048361800</authid><authname>Kovács H.</authname><surname>Kovács</surname><given-name>Hajnal A.</given-name><initials>H.A.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650199000</author-url><authid>56650199000</authid><authname>Klement E.</authname><surname>Klement</surname><given-name>Eva</given-name><initials>E.</initials><afid>60026434</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006541287</author-url><authid>7006541287</authid><authname>Medzihradszky K.</authname><surname>Medzihradszky</surname><given-name>Katalin F.</given-name><initials>K.F.</initials><afid>60023691</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56650190300</author-url><authid>56650190300</authid><authname>Geiszt M.</authname><surname>Geiszt</surname><given-name>Miklós</given-name><initials>M.</initials><afid>60024812</afid><afid>60024812</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56650190300</author-url><authid>56650190300</authid><authname>Geiszt M.</authname><surname>Geiszt</surname><given-name>Miklós</given-name><initials>M.</initials><afid>60024812</afid><afid>60024812</afid></author><authkeywords>Collagen IV | Crosslink | Peroxidase | Peroxidasin | Reactive oxygen species</authkeywords><intid>2035773858</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928157169"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928157169?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928157169&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928157169&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000842"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928157169</prism:url><dc:identifier>SCOPUS_ID:84928157169</dc:identifier><eid>2-s2.0-84928157169</eid><dc:title>Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer</dc:title><dc:creator>Cieslak J.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>227-237</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.018</prism:doi><pii>S0891584915000842</pii><dc:description>Pharmacological ascorbate (AscH&lt;sup&gt;-&lt;/sup&gt;) selectively induces cytotoxicity in pancreatic cancer cells vs normal cells via the generation of extracellular hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;), producing double-stranded DNA breaks and ultimately cell death. Catalytic manganoporphyrins (MnPs) can enhance ascorbate-induced cytotoxicity by increasing the rate of AscH&lt;sup&gt;-&lt;/sup&gt; oxidation and therefore the rate of generation of H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;. We hypothesized that combining MnPs and AscH&lt;sup&gt;-&lt;/sup&gt; with the chemotherapeutic agent gemcitabine would further enhance pancreatic cancer cell cytotoxicity without increasing toxicity in normal pancreatic cells or other organs. Redox-active MnPs were combined with AscH&lt;sup&gt;-&lt;/sup&gt; and administered with or without gemcitabine to human pancreatic cancer cell lines, as well as immortalized normal pancreatic ductal epithelial cells. The MnPs MnT2EPyP (Mn(III)meso-tetrakis(N-ethylpyridinium-2-yl) porphyrin pentachloride) and MnT4MPyP (Mn(III)tetrakis(N-methylpyridinium-4-yl) porphyrin pentachloride) were investigated. Clonogenic survival was significantly decreased in all pancreatic cancer cell lines studied when treated with MnP + AscH&lt;sup&gt;-&lt;/sup&gt; + gemcitabine, whereas nontumorigenic cells were resistant. The concentration of ascorbate radical (Asc&lt;sup&gt;•-&lt;/sup&gt;, an indicator of oxidative flux) was significantly increased in treatment groups containing MnP and AscH&lt;sup&gt;-&lt;/sup&gt;. Furthermore, MnP + AscH&lt;sup&gt;-&lt;/sup&gt; increased double-stranded DNA breaks in gemcitabine-treated cells. These results were abrogated by extracellular catalase, further supporting the role of the flux of H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;. In vivo growth was inhibited and survival increased in mice treated with MnT2EPyP, AscH&lt;sup&gt;-&lt;/sup&gt;, and gemcitabine without a concomitant increase in systemic oxidative stress. These data suggest a promising role for the use of MnPs in combination with pharmacologic AscH&lt;sup&gt;-&lt;/sup&gt; and chemotherapeutics in pancreatic cancer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009788</affiliation-url><afid>60009788</afid><affilname>University of Iowa Caver College of Medicine</affilname><name-variant>University of Iowa College of Medicine</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009788</affiliation-url><afid>60009788</afid><affilname>University of Iowa Caver College of Medicine</affilname><name-variant>University of Iowa College of Medicine</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024324</affiliation-url><afid>60024324</afid><affilname>University of Iowa</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005469</affiliation-url><afid>60005469</afid><affilname>University of Iowa Healthcare</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006455</affiliation-url><afid>60006455</afid><affilname>University of Iowa Hospitals &amp; Clinics</affilname><name-variant>University of Iowa Hospitals and Clinics</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36761988200</author-url><authid>36761988200</authid><authname>Cieslak J.</authname><surname>Cieslak</surname><given-name>John A.</given-name><initials>J.A.</initials><afid>60009788</afid><afid>60009788</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36761988200</author-url><authid>36761988200</authid><authname>Cieslak J.</authname><surname>Cieslak</surname><given-name>John A.</given-name><initials>J.A.</initials><afid>60009788</afid><afid>60009788</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56600424900</author-url><authid>56600424900</authid><authname>Strother R.</authname><surname>Strother</surname><given-name>Robert K.</given-name><initials>R.K.</initials><afid>60009788</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55831238800</author-url><authid>55831238800</authid><authname>Rawal M.</authname><surname>Rawal</surname><given-name>Malvika</given-name><initials>M.</initials><afid>60009788</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56599481700</author-url><authid>56599481700</authid><authname>Du J.</authname><surname>Du</surname><given-name>Juan</given-name><initials>J.</initials><afid>60009788</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56422516000</author-url><authid>56422516000</authid><authname>Doskey C.</authname><surname>Doskey</surname><given-name>Claire M.</given-name><initials>C.M.</initials><afid>60024324</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36998023100</author-url><authid>36998023100</authid><authname>Schroeder S.</authname><surname>Schroeder</surname><given-name>Samuel R.</given-name><initials>S.R.</initials><afid>60009788</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55204015600</author-url><authid>55204015600</authid><authname>Button A.</authname><surname>Button</surname><given-name>Anna</given-name><initials>A.</initials><afid>60005469</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402577974</author-url><authid>7402577974</authid><authname>Wagner B.</authname><surname>Wagner</surname><given-name>Brett A.</given-name><initials>B.A.</initials><afid>60009788</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006542640</author-url><authid>7006542640</authid><authname>Buettner G.</authname><surname>Buettner</surname><given-name>Garry R.</given-name><initials>G.R.</initials><afid>60009788</afid><afid>60005469</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006542640</author-url><authid>7006542640</authid><authname>Buettner G.</authname><surname>Buettner</surname><given-name>Garry R.</given-name><initials>G.R.</initials><afid>60009788</afid><afid>60005469</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201996527</author-url><authid>7201996527</authid><authname>Cullen J.</authname><surname>Cullen</surname><given-name>Joseph J.</given-name><initials>J.J.</initials><afid>60009788</afid><afid>60005469</afid><afid>60014232</afid><afid>60006455</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201996527</author-url><authid>7201996527</authid><authname>Cullen J.</authname><surname>Cullen</surname><given-name>Joseph J.</given-name><initials>J.J.</initials><afid>60009788</afid><afid>60005469</afid><afid>60014232</afid><afid>60006455</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201996527</author-url><authid>7201996527</authid><authname>Cullen J.</authname><surname>Cullen</surname><given-name>Joseph J.</given-name><initials>J.J.</initials><afid>60009788</afid><afid>60005469</afid><afid>60014232</afid><afid>60006455</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201996527</author-url><authid>7201996527</authid><authname>Cullen J.</authname><surname>Cullen</surname><given-name>Joseph J.</given-name><initials>J.J.</initials><afid>60009788</afid><afid>60005469</afid><afid>60014232</afid><afid>60006455</afid></author><intid>1035728063</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927671652"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927671652?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927671652&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927671652&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S187493991500070X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927671652</prism:url><dc:identifier>SCOPUS_ID:84927671652</dc:identifier><eid>2-s2.0-84927671652</eid><dc:title>Transforming growth factor-β3 regulates cell junction restructuring via MAPK-mediated mRNA destabilization and Smad-dependent protein degradation of junctional adhesion molecule B (JAM-B)</dc:title><dc:creator>Zhang X.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Gene Regulatory Mechanisms</prism:publicationName><prism:issn>18749399</prism:issn><prism:eIssn>18764320</prism:eIssn><prism:volume>1849</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>601-611</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbagrm.2015.03.005</prism:doi><pii>S187493991500070X</pii><dc:description>© 2015 Elsevier B.V. Junctional adhesion molecule-B (JAM-B) is found between Sertoli cells at the blood-testis barrier (BTB) as well as between Sertoli and germ cells at the apical ectoplasmic specializations (ES) in the testis. The expression of JAM-B is tightly regulated to modulate the passage of spermatocytes across the BTB as well as the release of mature spermatozoa from the seminiferous epithelium. Transforming growth factor beta (TGF-β) family is implicated in the regulation of testicular cell junction dynamics during spermatogenesis. This study aims to investigate the effects of TGF-β3 on the expression of JAM-B as well as the underlying mechanisms on how TGF-β3 regulates JAM-B expression to facilitate the disassembly of the BTB and apical ES. Our results revealed that TGF-β3 suppresses JAM-B at post-transcriptional and post-translational levels. Inhibitor, siRNA knockdown and co-immunoprecipitation have shown that TGF-β3 induces JAM-B protein degradation via ubiquitin-proteasome pathway. Immunofluorescence staining further confirmed that blockage of ubiquitin-proteasome pathway could abrogate TGF-β3-induced loss of JAM-B at the cell-cell interface. siRNA knockdown and immunofluorescence staining also demonstrated that activation of Smad signaling is required for TGF-β3-induced JAM-B protein degradation. In addition, TGF-β3 reduces JAM-B mRNA levels, at least in part, via post-transcriptional regulation. mRNA stability assay has confirmed that TGF-β3 promotes the degradation of JAM-B transcript and TGF-β3-mediated mRNA destabilization requires the activation of ERK1/2 and p54 JNK signal cascades. Taken together, TGF-β3 significantly downregulates JAM-B expression via post-transcriptional and post-translational modulation and results in the disruption of BTB and apical ES.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56308294600</author-url><authid>56308294600</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xu</given-name><initials>X.</initials><afid>60006541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35220192400</author-url><authid>35220192400</authid><authname>Lui W.</authname><surname>Lui</surname><given-name>Wing Yee</given-name><initials>W.Y.</initials><afid>60006541</afid></author><authkeywords>Cell junction | Cytokine | JAM-B | Spermatogenesis | TGF-beta</authkeywords><intid>2035642989</intid><source-id>11200153524</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927548925"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927548925?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927548925&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927548925&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0008874915000763"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927548925</prism:url><dc:identifier>SCOPUS_ID:84927548925</dc:identifier><eid>2-s2.0-84927548925</eid><dc:title>Diversified phenotype of antigen specific CD8+ T cells responding to the immunodominant epitopes of IE and pp65 antigens of human cytomegalovirus</dc:title><dc:creator>Xu J.</dc:creator><prism:publicationName>Cellular Immunology</prism:publicationName><prism:issn>00088749</prism:issn><prism:eIssn>10902163</prism:eIssn><prism:volume>295</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>105-111</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cellimm.2015.03.008</prism:doi><pii>S0008874915000763</pii><dc:description>© 2015. To study the cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HLA A&lt;sup&gt;*&lt;/sup&gt;1101, A&lt;sup&gt;*&lt;/sup&gt;0201 and A&lt;sup&gt;*&lt;/sup&gt;2402, our findings showed that peptide SK-10-2, KI-10 and KV-10 of CMV IE and pp65 antigens were immunodominant in 198 individuals with HLA A&lt;sup&gt;*&lt;/sup&gt;1101, A&lt;sup&gt;*&lt;/sup&gt;0201 and A&lt;sup&gt;*&lt;/sup&gt;2402, the most frequent genotypes in Chinese. Interestingly, SK-10-2 induced the strongest T cell response to produce IFN-γ whereas the others did not induce prominent IFN-γ production despite they all induced remarkable T cell proliferation. The peptides induced different phenotypes including IFN-γ&lt;sup&gt;high&lt;/sup&gt;TNF-α&lt;sup&gt;low&lt;/sup&gt; and TNF-α&lt;sup&gt;low&lt;/sup&gt;Foxp3&lt;sup&gt;low&lt;/sup&gt;. It suggests that only some of CMV-reactive CD8+ T cells are real protective IFN-γ&lt;sup&gt;high&lt;/sup&gt; cytotoxic T cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010170</affiliation-url><afid>60010170</afid><affilname>Shanghai University of Traditional Chinese Medicine</affilname><name-variant>Shanghai University of Traditional Chinese Medicine</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010170</affiliation-url><afid>60010170</afid><affilname>Shanghai University of Traditional Chinese Medicine</affilname><name-variant>Shanghai University of Traditional Chinese Medicine</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115149229</affiliation-url><afid>115149229</afid><affilname>LifeTek, Co. Ltd.</affilname><name-variant>LifeTek, Co. Ltd.</name-variant><affiliation-city>Suzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56202674600</author-url><authid>56202674600</authid><authname>Xu J.</authname><surname>Xu</surname><given-name>Jian</given-name><initials>J.</initials><afid>60010170</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56589339200</author-url><authid>56589339200</authid><authname>Wu R.</authname><surname>Wu</surname><given-name>Rong</given-name><initials>R.</initials><afid>60010170</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56589561200</author-url><authid>56589561200</authid><authname>Xiang F.</authname><surname>Xiang</surname><given-name>Fenfen</given-name><initials>F.</initials><afid>60010170</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56589477200</author-url><authid>56589477200</authid><authname>Kong Q.</authname><surname>Kong</surname><given-name>Qianqian</given-name><initials>Q.</initials><afid>60010170</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56589296300</author-url><authid>56589296300</authid><authname>Hong J.</authname><surname>Hong</surname><given-name>Jian</given-name><initials>J.</initials><afid>60010170</afid><afid>115149229</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56589296300</author-url><authid>56589296300</authid><authname>Hong J.</authname><surname>Hong</surname><given-name>Jian</given-name><initials>J.</initials><afid>60010170</afid><afid>115149229</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36662501100</author-url><authid>36662501100</authid><authname>Kang X.</authname><surname>Kang</surname><given-name>Xiangdong</given-name><initials>X.</initials><afid>60010170</afid><afid>60010170</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36662501100</author-url><authid>36662501100</authid><authname>Kang X.</authname><surname>Kang</surname><given-name>Xiangdong</given-name><initials>X.</initials><afid>60010170</afid><afid>60010170</afid></author><authkeywords>CD8 | Cytomegalovirus | Epitope | HLA class I | Immune response | Interferon-γ</authkeywords><intid>35633250</intid><source-id>20712</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923036888"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923036888?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923036888&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923036888&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0959437X15000118"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923036888</prism:url><dc:identifier>SCOPUS_ID:84923036888</dc:identifier><eid>2-s2.0-84923036888</eid><dc:title>Developing pressures: FLUID forces driving morphogenesis</dc:title><dc:creator>Navis A.</dc:creator><prism:publicationName>Current Opinion in Genetics and Development</prism:publicationName><prism:issn>0959437X</prism:issn><prism:eIssn>18790380</prism:eIssn><prism:volume>32</prism:volume><prism:pageRange>24-30</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.gde.2015.01.010</prism:doi><pii>S0959437X15000118</pii><dc:description>© 2015 Elsevier Ltd. Over several decades genetic studies have unraveled many molecular mechanisms that underlie the signaling networks guiding morphogenesis, but the mechanical forces at work remain much less well understood. Accumulation of fluid within a luminal space can generate outward hydrostatic pressure capable of shaping morphogenesis at several scales, ranging from individual organs to the entire vertebrate body-plan. Here, we focus on recent work that uncovered mechanical roles for fluid secretion during morphogenesis. Identifying the roles and regulation of fluid secretion will be instrumental for understanding the mechanics of morphogenesis as well as many human diseases of complex genetic and environmental origin including secretory diarrheas and scoliosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003269</affiliation-url><afid>60003269</afid><affilname>Princeton University</affilname><name-variant>Princeton University</name-variant><affiliation-city>Princeton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36628956900</author-url><authid>36628956900</authid><authname>Navis A.</authname><surname>Navis</surname><given-name>Adam</given-name><initials>A.</initials><afid>60005200</afid><afid>60003269</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36628956900</author-url><authid>36628956900</authid><authname>Navis A.</authname><surname>Navis</surname><given-name>Adam</given-name><initials>A.</initials><afid>60005200</afid><afid>60003269</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602220177</author-url><authid>6602220177</authid><authname>Bagnat M.</authname><surname>Bagnat</surname><given-name>Michel</given-name><initials>M.</initials><afid>60005200</afid></author><intid>534908700</intid><source-id>22080</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927511927"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927511927?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927511927&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927511927&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0278691515001003"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927511927</prism:url><dc:identifier>SCOPUS_ID:84927511927</dc:identifier><eid>2-s2.0-84927511927</eid><dc:title>Acute and sub-chronic toxicity of glucose-cysteine Maillard reaction products in Sprague-Dawley rats</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>Food and Chemical Toxicology</prism:publicationName><prism:issn>02786915</prism:issn><prism:eIssn>18736351</prism:eIssn><prism:volume>80</prism:volume><prism:pageRange>271-276</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fct.2015.03.021</prism:doi><pii>S0278691515001003</pii><dc:description>© 2015 Elsevier Ltd. Maillard reaction products (MRPs) derived from glucose-cysteine reactions have excellent anti-browning ability. However, there is a lack of information about their acute and sub-chronic toxicities. To our knowledge, the present study is the first to evaluate the acute and sub-chronic toxicities of MRPs in experimental animals. Acute toxicity testing and analysis by Horn's method showed that the median lethal oral dose (LD&lt;inf&gt;50&lt;/inf&gt;) of MRPs in rats was 6.81 g/kg body weight. The sub-chronic toxicity test involved feeding rats with diet containing 0, 0.43, 0.85, or 1.70% (w/w) MRPs for 90 days. These treatments did not affect mortality, gross pathology, histology, hematology, or blood chemistry, and there were no dose-dependent changes in feed consumption. Based on these results, the dietary no-observed-adverse-effect level (NOAEL) for 90-day exposure was 1.29 and 1.51 g MRPs/kg body weight/day for male and female rats, respectively.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60083514</affiliation-url><afid>60083514</afid><affilname>Chinese Academy of Tropical Agricultural Sciences</affilname><name-variant>Chinese Academy of Tropical Agricultural Science</name-variant><affiliation-city>Danzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115149057</affiliation-url><afid>115149057</afid><affilname>Hainan Center for Disease Control and oPrevention</affilname><name-variant>Hainan Center for Disease Control and oPrevention</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55800117800</author-url><authid>55800117800</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yixing</given-name><initials>Y.</initials><afid>60083514</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56589383500</author-url><authid>56589383500</authid><authname>Su L.</authname><surname>Su</surname><given-name>Linliang</given-name><initials>L.</initials><afid>115149057</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55799542600</author-url><authid>55799542600</authid><authname>Li F.</authname><surname>Li</surname><given-name>Fenfang</given-name><initials>F.</initials><afid>60083514</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56589308600</author-url><authid>56589308600</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chaozheng</given-name><initials>C.</initials><afid>60083514</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55152476400</author-url><authid>55152476400</authid><authname>Yuan D.</authname><surname>Yuan</surname><given-name>Debao</given-name><initials>D.</initials><afid>60083514</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55800197900</author-url><authid>55800197900</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jiao</given-name><initials>J.</initials><afid>60083514</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55799930000</author-url><authid>55799930000</authid><authname>Tan L.</authname><surname>Tan</surname><given-name>Lin</given-name><initials>L.</initials><afid>60083514</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56523760700</author-url><authid>56523760700</authid><authname>Jin Z.</authname><surname>Jin</surname><given-name>Zhiqiang</given-name><initials>Z.</initials><afid>60083514</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35201628800</author-url><authid>35201628800</authid><authname>Ma W.</authname><surname>Ma</surname><given-name>Weihong</given-name><initials>W.</initials><afid>60083514</afid></author><authkeywords>Acute oral toxicity | Maillard reaction products | Sub-chronic toxicity | Toxicity</authkeywords><intid>1035629844</intid><source-id>25096</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925002935"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925002935?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925002935&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925002935&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0890623815000209"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925002935</prism:url><dc:identifier>SCOPUS_ID:84925002935</dc:identifier><eid>2-s2.0-84925002935</eid><dc:title>Major differences in the levels of redox status and antioxidant defence markers in the erythrocytes of pre- and full-term neonates with intrauterine growth restriction</dc:title><dc:creator>Ferencz Á.</dc:creator><prism:publicationName>Reproductive Toxicology</prism:publicationName><prism:issn>08906238</prism:issn><prism:eIssn>18731708</prism:eIssn><prism:volume>53</prism:volume><prism:pageRange>10-14</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.reprotox.2015.02.008</prism:doi><pii>S0890623815000209</pii><dc:description>© 2015 Elsevier Inc. Intrauterine growth restriction (IUGR) is a pleiotropic complication of pregnancy. Prematurity and growth abnormalities are common risk factors for perinatal morbidity and mortality. Free radical damage has been recognized as a common pathogenic mechanism of many neonatal diseases. The aim of the present study was to characterize the possible links between the level of maturity, the birthweight and the antioxidant status of neonates born with IUGR. Our data suggest that the stress markers measured on the cord blood of neonates with IUGR and mature, healthy neonates do not necessarily reflect the extent of oxidative stress. However, significant correlations were found between the maturity of the neonates with IUGR and the oxidative damage. The mature IUGRs exhibited ONOO- accumulation and increased lipid peroxidation more frequently as compared with the pre-term group. The results suggest that the oxidative injury in IUGR may depend on the level of maturity and the birthweight.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112877111</affiliation-url><afid>112877111</afid><affilname>Faculty of Science and Informatics</affilname><name-variant>Faculty of Science and Informatics</name-variant><affiliation-city>Szeged</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027332</affiliation-url><afid>60027332</afid><affilname>Szegedi Tudomanyegyetem</affilname><name-variant>University of Szeged</name-variant><affiliation-city>Szeged</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24460720300</author-url><authid>24460720300</authid><authname>Ferencz Á.</authname><surname>Ferencz</surname><given-name>Ágnes</given-name><initials>Á.</initials><afid>112877111</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603763391</author-url><authid>6603763391</authid><authname>Orvos H.</authname><surname>Orvos</surname><given-name>Hajnalka</given-name><initials>H.</initials><afid>60027332</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602863935</author-url><authid>6602863935</authid><authname>Hermesz E.</authname><surname>Hermesz</surname><given-name>Edit</given-name><initials>E.</initials><afid>112877111</afid></author><authkeywords>Antioxidant defence | IUGR | Oxidative stress | Peroxynitrite | Umbilical cord blood</authkeywords><intid>2035228994</intid><source-id>24028</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928656014"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928656014?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928656014&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928656014&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015001380"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928656014</prism:url><dc:identifier>SCOPUS_ID:84928656014</dc:identifier><eid>2-s2.0-84928656014</eid><dc:title>Acute vascular effects of waterpipe smoking: Importance of physical activity and fitness status</dc:title><dc:creator>Alomari M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>472-476</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.02.047</prism:doi><pii>S0021915015001380</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: While new forms of tobacco, including waterpipe (WP) smoking, continue to gain popularity, limited literature has examined the vascular health consequences. The purpose of the current study was to examine: (i) the acute WP-induced changes in vascular function; (ii) whether acute changes in vascular function are modified by lifestyle behaviors (habitual physical activity, physical fitness). Methods: Fifty three (22.7y, 36% F, 23.4kg/m&lt;sup&gt;2&lt;/sup&gt;) otherwise healthy WP smokers were recruited. Strain-gauge plethysmography was used to measure forearm blood flow, vascular resistance, venous capacitance, and venous outflow at rest and following occlusion. Habitual physical activity was determined using the Arabic version of short-form international physical activity questionnaire, while physical fitness was assessed using the 6min walk test and handgrip strength. Partial correlations were used to examine the relationships between post-smoking vascular function and lifestyle behaviors, controlling for pre-smoking vascular measures. Results: (i) WP had a small effect on forearm post-occlusion blood flow (. d=-0.19), a moderate effect on venous outflow (. d=0.30), and a moderate effect on post-occlusion vascular resistance (. d=0.32). (ii) Total habitual physical activity strongly correlated with resting blood flow (r=0.50) and moderately with vascular resistance (r=-0.40). Handgrip strength moderately correlated with venous capacitance (r=0.30) and post-occlusion blood flow (r=0.30), while 6min walked distance moderately correlated with resting venous capacitance (r=0.30). Conclusion: Waterpipe smoking is associated with immediate changes in vascular function, which are exacerbated in individuals with low habitual physical activity and physical fitness levels in young otherwise healthy individuals.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60051534</affiliation-url><afid>60051534</afid><affilname>Jordan University of Science and Technology</affilname><name-variant>Jordan University of Science and Technology</name-variant><affiliation-city>Irbid</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60051534</affiliation-url><afid>60051534</afid><affilname>Jordan University of Science and Technology</affilname><name-variant>Jordan University of Science and Technology</name-variant><affiliation-city>Irbid</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008920</affiliation-url><afid>60008920</afid><affilname>Taibah University</affilname><name-variant>Taibah University</name-variant><affiliation-city>Madinah</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60051534</affiliation-url><afid>60051534</afid><affilname>Jordan University of Science and Technology</affilname><name-variant>Jordan University of Science and Technology</name-variant><affiliation-city>Irbid</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60051534</affiliation-url><afid>60051534</afid><affilname>Jordan University of Science and Technology</affilname><name-variant>Jordan University of Science and Technology</name-variant><affiliation-city>Irbid</affiliation-city><affiliation-country>Jordan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008221</affiliation-url><afid>60008221</afid><affilname>Massey University</affilname><name-variant>Massey University</name-variant><affiliation-city>Palmerston North</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506342333</author-url><authid>6506342333</authid><authname>Alomari M.</authname><surname>Alomari</surname><given-name>Mahmoud A.</given-name><initials>M.A.</initials><afid>60051534</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506863680</author-url><authid>6506863680</authid><authname>Khabour O.</authname><surname>Khabour</surname><given-name>Omar F.</given-name><initials>O.F.</initials><afid>60051534</afid><afid>60008920</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506863680</author-url><authid>6506863680</authid><authname>Khabour O.</authname><surname>Khabour</surname><given-name>Omar F.</given-name><initials>O.F.</initials><afid>60051534</afid><afid>60008920</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8579544200</author-url><authid>8579544200</authid><authname>Alzoubi K.</authname><surname>Alzoubi</surname><given-name>Karem H.</given-name><initials>K.H.</initials><afid>60051534</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55217819300</author-url><authid>55217819300</authid><authname>Shqair D.</authname><surname>Shqair</surname><given-name>Dana M.</given-name><initials>D.M.</initials><afid>60051534</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004757555</author-url><authid>7004757555</authid><authname>Stoner L.</authname><surname>Stoner</surname><given-name>Lee</given-name><initials>L.</initials><afid>60008221</afid></author><authkeywords>Blood flow | Cardiovascular disease | Lifestyle behavior | Pleythsmography | Tobacco | Vascular function | Vascular resistance | Waterpipe</authkeywords><intid>35824646</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929989499"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929989499?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929989499&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929989499&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929989499</prism:url><dc:identifier>SCOPUS_ID:84929989499</dc:identifier><eid>2-s2.0-84929989499</eid><dc:title>Assessment of radiation dose in nuclear cardiovascular imaging using realistic computational models</dc:title><dc:creator>Xie T.</dc:creator><prism:publicationName>Medical Physics</prism:publicationName><prism:issn>00942405</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>2955-2966</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1118/1.4921364</prism:doi><dc:description>© 2015 American Association of Physicists in Medicine. Purpose: Nuclear cardiology plays an important role in clinical assessment and has enormous impact on the management of a variety of cardiovascular diseases. Pediatric patients at different age groups are exposed to a spectrum of radiation dose levels and associated cancer risks different from those of adults in diagnostic nuclear medicine procedures. Therefore, comprehensive radiation dosimetry evaluations for commonly used myocardial perfusion imaging (MPI) and viability radiotracers in target population (children and adults) at different age groups are highly desired. Methods: Using Monte Carlo calculations and biological effects of ionizing radiation VII model, we calculate the S-values for a number of radionuclides (Tl-201, Tc-99m, I-123, C-11, N-13, O-15, F-18, and Rb-82) and estimate the absorbed dose and effective dose for 12 MPI radiotracers in computational models including the newborn, 1-, 5-, 10-, 15-yr-old, and adult male and female computational phantoms. Results: For most organs, &lt;sup&gt;201&lt;/sup&gt;Tl produces the highest absorbed dose whereas &lt;sup&gt;82&lt;/sup&gt;Rb and &lt;sup&gt;15&lt;/sup&gt;O-water produce the lowest absorbed dose. For the newborn baby and adult patient, the effective dose of &lt;sup&gt;82&lt;/sup&gt;Rb is 48% and 77% lower than that of &lt;sup&gt;99m&lt;/sup&gt;Tc-tetrofosmin (rest), respectively. Conclusions: &lt;sup&gt;82&lt;/sup&gt;Rb results in lower effective dose in adults compared to &lt;sup&gt;99m&lt;/sup&gt;Tc-labeled tracers. However, this advantage is less apparent in children. The produced dosimetric databases for various radiotracers used in cardiovascular imaging, using new generation of computational models, can be used for risk-benefit assessment of a spectrum of patient population in clinical nuclear cardiology practice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009963</affiliation-url><afid>60009963</afid><affilname>Hopitaux universitaires de Geneve</affilname><name-variant>Geneva University Hospital</name-variant><affiliation-city>Geneve</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013409</affiliation-url><afid>60013409</afid><affilname>National Cancer Institute</affilname><name-variant>NIH</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013959</affiliation-url><afid>60013959</afid><affilname>University of Florida</affilname><name-variant>University of Florida</name-variant><affiliation-city>Gainesville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004718</affiliation-url><afid>60004718</afid><affilname>Universite de Geneve</affilname><name-variant>Université de Genève</name-variant><affiliation-city>Geneve</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658270000</author-url><authid>56658270000</authid><authname>Xie T.</authname><surname>Xie</surname><given-name>Tianwu</given-name><initials>T.</initials><afid>60009963</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12140557500</author-url><authid>12140557500</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Choonsik</given-name><initials>C.</initials><afid>60013409</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35232422500</author-url><authid>35232422500</authid><authname>Bolch W.</authname><surname>Bolch</surname><given-name>Wesley E.</given-name><initials>W.E.</initials><afid>60013959</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004977873</author-url><authid>7004977873</authid><authname>Zaidi H.</authname><surname>Zaidi</surname><given-name>Habib</given-name><initials>H.</initials><afid>60004718</afid><afid>60006027</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004977873</author-url><authid>7004977873</authid><authname>Zaidi H.</authname><surname>Zaidi</surname><given-name>Habib</given-name><initials>H.</initials><afid>60004718</afid><afid>60006027</afid></author><authkeywords>cardiovascular imaging | Monte Carlo | PET | radiation dosimetry | SPECT</authkeywords><intid>1536050140</intid><source-id>17871</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928998571"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928998571?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928998571&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928998571&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928998571</prism:url><dc:identifier>SCOPUS_ID:84928998571</dc:identifier><eid>2-s2.0-84928998571</eid><dc:title>Isolation of human dermis derived mesenchymal stem cells using explants culture method: expansion and phenotypical characterization</dc:title><dc:creator>Park J.</dc:creator><prism:publicationName>Cell and Tissue Banking</prism:publicationName><prism:issn>13899333</prism:issn><prism:volume>16</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>209-218</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10561-014-9471-8</prism:doi><dc:description>© 2014, Springer Science+Business Media Dordrecht. Recent studies have reported that stem cells can be isolated from a wide range of tissues including bone marrow, fatty tissue, adipose tissue and placenta. Moreover, several studies also suggest that skin dermis could serve as a source of stem cells, but are of unclear phenotype. Therefore, we isolated and investigated to determine the potential of stem cell within human skin dermis. We isolated cells from human dermis, termed here as human dermis-derived mesenchymal stem cells (hDMSCs) which is able to be isolated by using explants culture method. Our method has an advantage over the enzymatic method as it is easier, less expensive and less cell damage. hDMSCs were maintained in basal culture media and proliferation potential was measured. hDMSCs were highly proliferative and successfully expanded with no additional growth factor. In addition, hDMSCs revealed normal karyotype and expressed high levels of CD90, CD73 and CD105 while did not express the surface markers for CD34, CD45 and HLA-DR. Also, we confirmed that hDMSCs possess the capacity to differentiate into multiple lineage including adipocyte, osteocyte, chondrocyte and precursor of hepatocyte lineage. Considering these results, we suggest that hDMSCs might be a valuable source of stem cells and could potentially be a useful source of clinical application.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000872</affiliation-url><afid>60000872</afid><affilname>Kangwon National University</affilname><name-variant>Kangwon National University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56155076800</author-url><authid>56155076800</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jeong Ran</given-name><initials>J.R.</initials><afid>60000872</afid><afid>60000872</afid><afid>60000872</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56155076800</author-url><authid>56155076800</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jeong Ran</given-name><initials>J.R.</initials><afid>60000872</afid><afid>60000872</afid><afid>60000872</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56155076800</author-url><authid>56155076800</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jeong Ran</given-name><initials>J.R.</initials><afid>60000872</afid><afid>60000872</afid><afid>60000872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56334902100</author-url><authid>56334902100</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eunjeong</given-name><initials>E.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56334902100</author-url><authid>56334902100</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eunjeong</given-name><initials>E.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56155351700</author-url><authid>56155351700</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jungwon</given-name><initials>J.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56155351700</author-url><authid>56155351700</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jungwon</given-name><initials>J.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56155140000</author-url><authid>56155140000</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Hanbyeol</given-name><initials>H.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56155140000</author-url><authid>56155140000</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Hanbyeol</given-name><initials>H.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34769814700</author-url><authid>34769814700</authid><authname>Hong S.</authname><surname>Hong</surname><given-name>Seok Ho</given-name><initials>S.H.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34769814700</author-url><authid>34769814700</authid><authname>Hong S.</authname><surname>Hong</surname><given-name>Seok Ho</given-name><initials>S.H.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15733309600</author-url><authid>15733309600</authid><authname>Woo H.</authname><surname>Woo</surname><given-name>Heung Myong</given-name><initials>H.M.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15733309600</author-url><authid>15733309600</authid><authname>Woo H.</authname><surname>Woo</surname><given-name>Heung Myong</given-name><initials>H.M.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56155357000</author-url><authid>56155357000</authid><authname>Park S.</authname><surname>Park</surname><given-name>Sung Min</given-name><initials>S.M.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56155357000</author-url><authid>56155357000</authid><authname>Park S.</authname><surname>Park</surname><given-name>Sung Min</given-name><initials>S.M.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55489142900</author-url><authid>55489142900</authid><authname>Na S.</authname><surname>Na</surname><given-name>Sunghun</given-name><initials>S.</initials><afid>60000872</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13604831500</author-url><authid>13604831500</authid><authname>Yang S.</authname><surname>Yang</surname><given-name>Se Ran</given-name><initials>S.R.</initials><afid>60000872</afid><afid>60000872</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:13604831500</author-url><authid>13604831500</authid><authname>Yang S.</authname><surname>Yang</surname><given-name>Se Ran</given-name><initials>S.R.</initials><afid>60000872</afid><afid>60000872</afid></author><authkeywords>Differentiation potential | Explants culture method | Human dermis | Mesenchymal stem cells</authkeywords><intid>535885943</intid><source-id>18439</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929945116"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929945116?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929945116&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929945116&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009912015000648"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929945116</prism:url><dc:identifier>SCOPUS_ID:84929945116</dc:identifier><eid>2-s2.0-84929945116</eid><dc:title>The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators-A pilot study</dc:title><dc:creator>Kucera M.</dc:creator><prism:publicationName>Clinical Biochemistry</prism:publicationName><prism:issn>00099120</prism:issn><prism:eIssn>18732933</prism:eIssn><prism:volume>48</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>557-561</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clinbiochem.2015.02.010</prism:doi><pii>S0009912015000648</pii><dc:description>© 2015 The Canadian Society of Clinical Chemists. Objectives: The mean platelet volume (MPV) and red cell distribution width (RDW) have recently arisen interest because of their association with an increased cardiovascular risk. The aim of our study was, therefore, to determine whether an association exists between MPV, RDW and lipoprotein sub-fractions, and to show the impact of statin therapy on these new possible biomarkers of atherosclerotic risk. Design and methods: A cohort of 40 patients with hypercholesterolaemia (29 females, mean age 62.9. ±. 9. years), without previous hypolipidaemic treatment were enrolled. The patients were treated with atorvastatin 40. mg/day for 12. weeks. Total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density cholesterol (HDL-C), triglycerides (TG), LDL-C sub-fractions [large LDL-C 1-2 and small dense (sd)-LDL-C 3-7], apolipoproteins (apoA1, apoB), apoB/apoA1 ratio, atherogenic index of plasma (AIP), haematological parameters (including MPV, RDW) and safety parameters (renal, hepatic) were measured before and after 12. weeks of atorvastatin treatment. Results: At baseline, a strong correlation between HDL-C, TG, sd-LDL-C, apoB, apoB/apoA1, and AIP with MPV (. r=. -. 0.55, p&lt;. 0.001; r=. 0.57, p&lt;. 0.001; r=. 0.73, p&lt;. 0.001; r=. 0.41, p&lt;. 0.05; r=. 0.52, p&lt;. 0.001; r=. 0.61, p&lt;. 0.001, respectively) and RDW (. r=. -. 0.49, p&lt;. 0.001; r=. 0.62, p&lt;. 0.001; r=. 0.67, p&lt;. 0.001; r=. 0.41, p&lt;. 0.05; r=. 0.43, p&lt;. 0.05; r=. 0.65, p&lt;. 0.001, respectively) was found. After 12. weeks of treatment with atorvastatin, MPV and RDW values underwent significant modification only in those patients displaying the strongest lipid-lowering effect. Conclusions: Values of MPV and RDW seem to reflect a pro-atherogenic lipoprotein profile mainly represented by the presence of sd-LDL-C.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60079030</affiliation-url><afid>60079030</afid><affilname>University Hospital in Bratislava</affilname><name-variant>University Hospital Bratislava</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029543</affiliation-url><afid>60029543</afid><affilname>Masaryk University</affilname><name-variant>Masaryk University</name-variant><affiliation-city>Brno</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031236</affiliation-url><afid>60031236</afid><affilname>Pavol Jozef Safarik University in Kosice</affilname><affiliation-city>Kosice</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015197</affiliation-url><afid>60015197</afid><affilname>Universita degli Studi di Pavia</affilname><name-variant>Università di Pavia</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112795312</affiliation-url><afid>112795312</afid><affilname>Central University Hospital of Asturias (HUCA)</affilname><name-variant>Central University Hospital of Asturias (HUCA)</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006234</affiliation-url><afid>60006234</afid><affilname>Victoria University Melbourne</affilname><name-variant>Victoria University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001987</affiliation-url><afid>60001987</afid><affilname>Comenius University</affilname><name-variant>Comenius University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60079030</affiliation-url><afid>60079030</afid><affilname>University Hospital in Bratislava</affilname><name-variant>University Hospital Bratislava</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36473249000</author-url><authid>36473249000</authid><authname>Kucera M.</authname><surname>Kucera</surname><given-name>Marek</given-name><initials>M.</initials><afid>60079030</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55948742700</author-url><authid>55948742700</authid><authname>Balaz D.</authname><surname>Balaz</surname><given-name>David</given-name><initials>D.</initials><afid>60079030</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35731716000</author-url><authid>35731716000</authid><authname>Kruzliak P.</authname><surname>Kruzliak</surname><given-name>Peter</given-name><initials>P.</initials><afid>60029543</afid><afid>60031236</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35731716000</author-url><authid>35731716000</authid><authname>Kruzliak P.</authname><surname>Kruzliak</surname><given-name>Peter</given-name><initials>P.</initials><afid>60029543</afid><afid>60031236</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35478543500</author-url><authid>35478543500</authid><authname>Ciccocioppo R.</authname><surname>Ciccocioppo</surname><given-name>Rachele</given-name><initials>R.</initials><afid>60015197</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602121003</author-url><authid>6602121003</authid><authname>Oravec S.</authname><surname>Oravec</surname><given-name>Stanislav</given-name><initials>S.</initials><afid>60079030</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004380789</author-url><authid>7004380789</authid><authname>Rodrigo L.</authname><surname>Rodrigo</surname><given-name>Luis</given-name><initials>L.</initials><afid>112795312</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603539924</author-url><authid>6603539924</authid><authname>Zulli A.</authname><surname>Zulli</surname><given-name>Anthony</given-name><initials>A.</initials><afid>60006234</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6505841938</author-url><authid>6505841938</authid><authname>Hirnerova E.</authname><surname>Hirnerova</surname><given-name>Eva</given-name><initials>E.</initials><afid>60079030</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:39161982200</author-url><authid>39161982200</authid><authname>Sabaka P.</authname><surname>Sabaka</surname><given-name>Peter</given-name><initials>P.</initials><afid>60079030</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56565639200</author-url><authid>56565639200</authid><authname>Komornikova A.</authname><surname>Komornikova</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60079030</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56565034800</author-url><authid>56565034800</authid><authname>Sabo J.</authname><surname>Sabo</surname><given-name>Jan</given-name><initials>J.</initials><afid>112795312</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56565033000</author-url><authid>56565033000</authid><authname>Slezak P.</authname><surname>Slezak</surname><given-name>Peter</given-name><initials>P.</initials><afid>60001987</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7102412214</author-url><authid>7102412214</authid><authname>Gaspar L.</authname><surname>Gaspar</surname><given-name>Ludovit</given-name><initials>L.</initials><afid>60079030</afid><afid>60079030</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7102412214</author-url><authid>7102412214</authid><authname>Gaspar L.</authname><surname>Gaspar</surname><given-name>Ludovit</given-name><initials>L.</initials><afid>60079030</afid><afid>60079030</afid></author><authkeywords>Atherogenic dyslipidaemia | Atorvastatin | Dense LDL | Mean platelet volume | Red cell distribution width | Small</authkeywords><intid>36041206</intid><source-id>16954</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84916910878"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84916910878?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84916910878&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84916910878&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647414000336"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84916910878</prism:url><dc:identifier>SCOPUS_ID:84916910878</dc:identifier><eid>2-s2.0-84916910878</eid><dc:title>Regular consumption of black tea increases circulating kynurenine concentrations: A randomized controlled trial</dc:title><dc:creator>Gostner J.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>31-35</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2014.11.007</prism:doi><pii>S2214647414000336</pii><dc:description>© 2014 The Authors. Background: Circulating neopterin and the ratio of kynurenine to tryptophan (KYN/TRP) concentrations are biomarkers of immune activation that have been linked to cardiovascular and total mortality. Several in vitro studies indicated that tea flavonoids and other antioxidants can modulate tryptophan breakdown rates and neopterin production in immune cells. We aimed to assess the effects of regular black tea consumption on tryptophan and neopterin metabolisms in vivo. Methods: Participants were healthy individuals, with no major illnesses and having normal to mildly elevated systolic blood pressure. They were randomly assigned to consume 3. cups/day of either powdered black tea solids (tea; n = 45) or a flavonoid-free caffeine-matched beverage (control; n = 49). Serum concentrations of tryptophan, kynurenine and neopterin were assessed at baseline and again at 3 and 6. months after daily ingestion of the respective beverage. Results: Regular consumption of tea over 6. months, compared to control, did not significantly alter neopterin (p = 0.13) or tryptophan (p = 0.85) concentrations, but did result in significantly higher kynurenine (p = 0.016) and KYN/TRP (p = 0.012). Relative to the control group, in the tea group kynurenine and KYN/TRP increased during the treatment period by 0.28. μmol/L (95% CI: - 0.04, 0.60) and 3.2. μmol/mmol (95% CI: - 1.6, 8.0), respectively at 3. months, and by 0.48. μmol/L (95% CI: 0.16, 0.80) and 7.5. μmol/mmol (95% CI: 2.5, 12.5), respectively at 6. months. Conclusions: Increased circulation of kynurenine and KYN/TRP following regular black tea consumption may indicate enhanced tryptophan breakdown, possibly due to immune activation-induced tryptophan degrading enzyme indoleamine 2,3-dioxygenase. General significance: The influence of black tea consumption on biomarkers of immune system activation could relate to its general health benefits. Data suggests that the net effect strongly depends on the individual immune state, being stimulatory in healthy individuals, while acting more immune dampening in situations with an inflammatory background.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009834</affiliation-url><afid>60009834</afid><affilname>University of Western Australia Faculty of Medicine and Dentistry</affilname><name-variant>University Department of Medicine</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020828</affiliation-url><afid>60020828</afid><affilname>Flinders University of South Australia</affilname><name-variant>Flinders University of South Australia</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16636147200</author-url><authid>16636147200</authid><authname>Gostner J.</authname><surname>Gostner</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60008222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36089011800</author-url><authid>36089011800</authid><authname>Becker K.</authname><surname>Becker</surname><given-name>K.</given-name><initials>K.</initials><afid>60008222</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006668263</author-url><authid>7006668263</authid><authname>Croft K.</authname><surname>Croft</surname><given-name>K. D.</given-name><initials>K.D.</initials><afid>60009834</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102408842</author-url><authid>7102408842</authid><authname>Woodman R.</authname><surname>Woodman</surname><given-name>R. J.</given-name><initials>R.J.</initials><afid>60020828</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006116739</author-url><authid>7006116739</authid><authname>Puddey I.</authname><surname>Puddey</surname><given-name>I. B.</given-name><initials>I.B.</initials><afid>60009834</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35414205100</author-url><authid>35414205100</authid><authname>Fuchs D.</authname><surname>Fuchs</surname><given-name>D.</given-name><initials>D.</initials><afid>60008222</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55431137900</author-url><authid>55431137900</authid><authname>Hodgson J.</authname><surname>Hodgson</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60009834</afid></author><authkeywords>Black tea | Cardiovascular health | Immune system | Kynurenine | Neopterin</authkeywords><intid>1783892406</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930194951"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930194951?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930194951&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930194951&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930194951</prism:url><dc:identifier>SCOPUS_ID:84930194951</dc:identifier><eid>2-s2.0-84930194951</eid><dc:title>Stochastic modeling of driver behavior by Langevin equations</dc:title><dc:creator>Langner M.</dc:creator><prism:publicationName>European Physical Journal B</prism:publicationName><prism:issn>14346028</prism:issn><prism:eIssn>14346036</prism:eIssn><prism:volume>88</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1140/epjb/e2015-60239-6</prism:doi><dc:description>© 2015, EDP Sciences, SIF, Springer-Verlag Berlin Heidelberg. A procedure based on stochastic Langevin equations is presented and shows how a stochastic model of driver behavior can be estimated directly from given data. The Langevin analysis allows the separation of a given data-set into a stochastic diffusion- and a deterministic drift field. Form the drift field a potential can be derived. In particular the method is here applied on driving data from a simulator. We overcome typical problems like varying sampling rates, low noise levels, low data amounts, inefficient coordinate systems, and non-stationary situations. From the estimation of the drift- and diffusion vector-fields derived from the data, we show different ways how to set up Monte-Carlo simulations for the driver behavior.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012749</affiliation-url><afid>60012749</afid><affilname>Oldenburger Forschungs- Und Entwicklungsinstitut fur Informatik-Werkzeuge Und -Systeme</affilname><name-variant>OFFIS Institute for Information Technology</name-variant><affiliation-city>Oldenburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020306</affiliation-url><afid>60020306</afid><affilname>Universitat Oldenburg</affilname><name-variant>Universität Oldenburg</name-variant><affiliation-city>Oldenburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36082737900</author-url><authid>36082737900</authid><authname>Langner M.</authname><surname>Langner</surname><given-name>Michael</given-name><initials>M.</initials><afid>60012749</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004674392</author-url><authid>7004674392</authid><authname>Peinke J.</authname><surname>Peinke</surname><given-name>Joachim</given-name><initials>J.</initials><afid>60020306</afid></author><authkeywords>Statistical and Nonlinear Physics</authkeywords><intid>2036082442</intid><article-number>137</article-number><source-id>27542</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924981026"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924981026?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924981026&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924981026&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0305750X1500025X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924981026</prism:url><dc:identifier>SCOPUS_ID:84924981026</dc:identifier><eid>2-s2.0-84924981026</eid><dc:title>The Impact of Bolsa Família on Schooling</dc:title><dc:creator>de Brauw A.</dc:creator><prism:publicationName>World Development</prism:publicationName><prism:issn>0305750X</prism:issn><prism:eIssn>18735991</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>303-316</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.worlddev.2015.02.001</prism:doi><pii>S0305750X1500025X</pii><dc:description>© 2015 The Authors. We use longitudinal household data and propensity score weighting methods to assess the impact of Brazil's Bolsa Família conditional cash transfer program on schooling outcomes of children aged 6-17. years. Weak aggregate effects mask considerable heterogeneity. Among girls, the program significantly increases school participation (by 8 percentage points) and grade progression (by 10 percentage points), with large, significant effects across both younger and older girls in rural areas but concentrated among girls aged 15-17. years in urban areas. Few significant impacts are found among boys. We discuss implications and potential mechanisms for differential impacts by sex, age, and location.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112669267</affiliation-url><afid>112669267</afid><affilname>International Food Policy Research Institute</affilname><name-variant>International Food Policy Research Institute</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007776</affiliation-url><afid>60007776</afid><affilname>Cornell University</affilname><name-variant>Cornell University</name-variant><affiliation-city>Ithaca</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508388329</author-url><authid>6508388329</authid><authname>de Brauw A.</authname><surname>de Brauw</surname><given-name>Alan</given-name><initials>A.</initials><afid>112669267</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:18037265400</author-url><authid>18037265400</authid><authname>Gilligan D.</authname><surname>Gilligan</surname><given-name>Daniel O.</given-name><initials>D.O.</initials><afid>112669267</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004073128</author-url><authid>7004073128</authid><authname>Hoddinott J.</authname><surname>Hoddinott</surname><given-name>John</given-name><initials>J.</initials><afid>112669267</afid><afid>60007776</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004073128</author-url><authid>7004073128</authid><authname>Hoddinott J.</authname><surname>Hoddinott</surname><given-name>John</given-name><initials>J.</initials><afid>112669267</afid><afid>60007776</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55646805600</author-url><authid>55646805600</authid><authname>Roy S.</authname><surname>Roy</surname><given-name>Shalini</given-name><initials>S.</initials><afid>112669267</afid></author><authkeywords>Bolsa Família | Brazil | Conditional cash transfer programs | Education | Girls' schooling</authkeywords><intid>35231089</intid><source-id>30060</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928478164"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928478164?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928478164&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928478164&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320515001538"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928478164</prism:url><dc:identifier>SCOPUS_ID:84928478164</dc:identifier><eid>2-s2.0-84928478164</eid><dc:title>The S6K protein family in health and disease</dc:title><dc:creator>Tavares M.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>131</prism:volume><prism:pageRange>1-10</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2015.03.001</prism:doi><pii>S0024320515001538</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. The S6K proteins are mTOR pathway effectors and accumulative evidence suggest that mTOR/S6K signaling contributes to several pathological conditions, such as diabetes, cancer and obesity. The activation of the mTOR/S6K axis stimulates protein synthesis and cell growth. S6K1 has two well-known isoforms, p70-S6K1 and p85-S6K1, generated by alternative translation initiation sites. A third isoform, named p31-S6K1, has been characterized as a truncated type of the protein due to alternative splicing, and reports have shown its important role in cancer. Studies involving S6K2 are scarce. This article aims to review what is new in the literature about these kinases and establish differences regarding their interacting proteins, activation and function, connecting their roles in the homeostasis of the cell and in pathological conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56605888200</author-url><authid>56605888200</authid><authname>Tavares M.</authname><surname>Tavares</surname><given-name>Mariana R.</given-name><initials>M.R.</initials><afid>60029570</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56606104800</author-url><authid>56606104800</authid><authname>Pavan I.</authname><surname>Pavan</surname><given-name>Isadora C B</given-name><initials>I.C.B.</initials><afid>60029570</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56605966900</author-url><authid>56605966900</authid><authname>Amaral C.</authname><surname>Amaral</surname><given-name>Camila L.</given-name><initials>C.L.</initials><afid>60029570</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606290700</author-url><authid>56606290700</authid><authname>Meneguello L.</authname><surname>Meneguello</surname><given-name>Letícia</given-name><initials>L.</initials><afid>60029570</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15769587100</author-url><authid>15769587100</authid><authname>Luchessi A.</authname><surname>Luchessi</surname><given-name>Augusto D.</given-name><initials>A.D.</initials><afid>60029570</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15926246800</author-url><authid>15926246800</authid><authname>Simabuco F.</authname><surname>Simabuco</surname><given-name>Fernando M.</given-name><initials>F.M.</initials><afid>60029570</afid></author><authkeywords>Cancer | Diabetes | Metabolism | mTOR | Obesity | S6K1 | S6K2</authkeywords><intid>1035789293</intid><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925729049"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925729049?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925729049&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925729049&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0041010115000793"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925729049</prism:url><dc:identifier>SCOPUS_ID:84925729049</dc:identifier><eid>2-s2.0-84925729049</eid><dc:title>Toxic indole alkaloids avrainvillamide and stephacidin B produced by a biocide tolerant indoor mold Aspergillus westerdijkiae</dc:title><dc:creator>Mikkola R.</dc:creator><prism:publicationName>Toxicon</prism:publicationName><prism:issn>00410101</prism:issn><prism:eIssn>18793150</prism:eIssn><prism:volume>99</prism:volume><prism:pageRange>58-67</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxicon.2015.03.011</prism:doi><pii>S0041010115000793</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Abstract Toxic Aspergillus westerdijkiae were present in house dust and indoor air fall-out from a residence and a kindergarten where the occupants suffered from building related ill health. The A. westerdijkiae isolates produced indole alkaloids avrainvillamide (445 Da) and its dimer stephacidin B (890 Da). It grew and sporulated in presence of high concentrations of boron or polyguanidine (PHMB, PHMG) based antimicrobial biocides used to remediate mold infested buildings. The boar sperm cells were used as sensor cells to purify toxins from HPLC fractions of the fungal biomass. Submicromolar concentrations (EC50 0.3-0.4 μM) blocked boar spermatozoan motility and killed porcine kidney tubular epithelial cells (PK-15). Plate grown hyphal mass of the A. westerdijkiae isolates contained 300-750 ng of avrainvillamide and 30-300 ng of stephacidin B per mg (wet weight). The toxins induced rapid (30 min) loss of boar sperm motility, followed (24 h) by loss of mitochondrial membrane potential (ΔΨm). Apoptotic cell death was observed in PK-15 cell monolayers, prior to cessation of glucose uptake or loss of ΔΨm. Avrainvillamide and stephacidin B were 100-fold more potent towards the porcine cells than the mycotoxins stephacidin A, ochratoxin A, sterigmatocystin and citrinin. The high toxicity of stephacidin B indicates a role of nitrone group in the mechanism of toxicity. Avrainvillamide and stephacidin B represent a new class of toxins with possible a threat to human health in buildings. Furthermore, the use of biocides highly enhanced the growth of toxigenic A. westerdijkiae.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014122</affiliation-url><afid>60014122</afid><affilname>Elintarviketurvallisuusvirasto Livsmedelssakerhetsverket</affilname><name-variant>Finnish Food Safety Authority</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112074218</affiliation-url><afid>112074218</afid><affilname>School of Engineering</affilname><name-variant>School of Engineering</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603743519</author-url><authid>6603743519</authid><authname>Mikkola R.</authname><surname>Mikkola</surname><given-name>Raimo</given-name><initials>R.</initials><afid>60002952</afid><afid>112074218</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603743519</author-url><authid>6603743519</authid><authname>Mikkola R.</authname><surname>Mikkola</surname><given-name>Raimo</given-name><initials>R.</initials><afid>60002952</afid><afid>112074218</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12763066300</author-url><authid>12763066300</authid><authname>Andersson M.</authname><surname>Andersson</surname><given-name>Maria A.</given-name><initials>M.A.</initials><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36058947000</author-url><authid>36058947000</authid><authname>Hautaniemi M.</authname><surname>Hautaniemi</surname><given-name>Maria</given-name><initials>M.</initials><afid>60014122</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005913446</author-url><authid>7005913446</authid><authname>Salkinoja-Salonen M.</authname><surname>Salkinoja-Salonen</surname><given-name>Mirja S.</given-name><initials>M.S.</initials><afid>60002952</afid></author><authkeywords>Aspergillus | Biocide tolerance | Indole alkaloid | Indoor mold | Mitochondriotoxin | Nitrone</authkeywords><intid>535349675</intid><article-number>5042</article-number><source-id>22319</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927556807"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927556807?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927556807&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927556807&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010482515000992"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927556807</prism:url><dc:identifier>SCOPUS_ID:84927556807</dc:identifier><eid>2-s2.0-84927556807</eid><dc:title>Multi-class biological tissue classification based on a multi-classifier: Preliminary study of an automatic output power control for ultrasonic surgical units</dc:title><dc:creator>Youn S.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>61</prism:volume><prism:pageRange>92-100</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.03.021</prism:doi><pii>S0010482515000992</pii><dc:description>© 2015 Elsevier Ltd. Ultrasonic surgical units (USUs) have the advantage of minimizing tissue damage during surgeries that require tissue dissection by reducing problems such as coagulation and unwanted carbonization, but the disadvantage of requiring manual adjustment of power output according to the target tissue. In order to overcome this limitation, it is necessary to determine the properties of in vivo tissues automatically. We propose a multi-classifier that can accurately classify tissues based on the unique impedance of each tissue. For this purpose, a multi-classifier was built based on single classifiers with high classification rates, and the classification accuracy of the proposed model was compared with that of single classifiers for various electrode types (Type-I: 6. mm invasive; Type-II: 3. mm invasive; Type-III: surface). The sensitivity and positive predictive value (PPV) of the multi-classifier by cross checks were determined. According to the 10-fold cross validation results, the classification accuracy of the proposed model was significantly higher (p&lt;0.05 or &lt;0.01) than that of existing single classifiers for all electrode types. In particular, the classification accuracy of the proposed model was highest when the 3. mm invasive electrode (Type-II) was used (sensitivity=97.33-100.00%; PPV=96.71-100.00%). The results of this study are an important contribution to achieving automatic optimal output power adjustment of USUs according to the properties of individual tissues.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007511</affiliation-url><afid>60007511</afid><affilname>Sungkyunkwan University</affilname><name-variant>Sungkyunkwan University</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007511</affiliation-url><afid>60007511</afid><affilname>Sungkyunkwan University</affilname><name-variant>Sungkyunkwan University</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107763085</affiliation-url><afid>107763085</afid><affilname>Korea Electrotechnology Research Ins.</affilname><name-variant>Korea Electrotechnology</name-variant><affiliation-city>Ansan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104012</affiliation-url><afid>60104012</afid><affilname>University of Science and Technology (UST)</affilname><name-variant>Korea University of Science and Technology</name-variant><affiliation-city>Daejeon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115149757</affiliation-url><afid>115149757</afid><affilname>Chungwoo Co.Ltd.</affilname><name-variant>Chungwoo Co.Ltd.</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54788489200</author-url><authid>54788489200</authid><authname>Youn S.</authname><surname>Youn</surname><given-name>Su Hyun</given-name><initials>S.H.</initials><afid>60007511</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14829789800</author-url><authid>14829789800</authid><authname>Sim T.</authname><surname>Sim</surname><given-name>Taeyong</given-name><initials>T.</initials><afid>60007511</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12753511000</author-url><authid>12753511000</authid><authname>Choi A.</authname><surname>Choi</surname><given-name>Ahnryul</given-name><initials>A.</initials><afid>60007511</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55320137800</author-url><authid>55320137800</authid><authname>Song J.</authname><surname>Song</surname><given-name>Jinsung</given-name><initials>J.</initials><afid>60007511</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36718163700</author-url><authid>36718163700</authid><authname>Shin K.</authname><surname>Shin</surname><given-name>Ki Young</given-name><initials>K.Y.</initials><afid>107763085</afid><afid>60104012</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36718163700</author-url><authid>36718163700</authid><authname>Shin K.</authname><surname>Shin</surname><given-name>Ki Young</given-name><initials>K.Y.</initials><afid>107763085</afid><afid>60104012</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56589319400</author-url><authid>56589319400</authid><authname>Lee I.</authname><surname>Lee</surname><given-name>Il Kwon</given-name><initials>I.K.</initials><afid>115149757</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56589597700</author-url><authid>56589597700</authid><authname>Heo H.</authname><surname>Heo</surname><given-name>Hyun Mu</given-name><initials>H.M.</initials><afid>60007511</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56133586500</author-url><authid>56133586500</authid><authname>Lee D.</authname><surname>Lee</surname><given-name>Daeweon</given-name><initials>D.</initials><afid>60007511</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005674984</author-url><authid>7005674984</authid><authname>Mun J.</authname><surname>Mun</surname><given-name>Joung Hwan</given-name><initials>J.H.</initials><afid>60007511</afid></author><authkeywords>Impedance | Multi-classifier | Power auto-control | Tissue classification | Ultrasonic surgical units</authkeywords><intid>2035629142</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924228507"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924228507?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924228507&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924228507&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000665"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924228507</prism:url><dc:identifier>SCOPUS_ID:84924228507</dc:identifier><eid>2-s2.0-84924228507</eid><dc:title>Appetite and gut hormone responses to moderate-intensity continuous exercise versus high-intensity interval exercise, in normoxic and hypoxic conditions</dc:title><dc:creator>Bailey D.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>237-245</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.02.019</prism:doi><pii>S0195666315000665</pii><dc:description>© 2015 Elsevier Ltd. This study investigated the effects of continuous moderate-intensity exercise (MIE) and high-intensity interval exercise (HIIE) in combination with short exposure to hypoxia on appetite and plasma concentrations of acylated ghrelin, peptide YY (PYY), and glucagon-like peptide-1 (GLP-1). Twelve healthy males completed four, 2.6 h trials in a random order: (1) MIE-normoxia, (2) MIE-hypoxia, (3) HIIE-normoxia, and (4) HIIE-hypoxia. Exercise took place in an environmental chamber. During MIE, participants ran for 50 min at 70% of altitude-specific maximal oxygen uptake (VO2max) and during HIIE performed 6 × 3 min running at 90% VO2max interspersed with 6 × 3 min active recovery at 50% VO2max with a 7 min warm-up and cool-down at 70% VO2max (50 min total). In hypoxic trials, exercise was performed at a simulated altitude of 2980 m (14.5% O2). Exercise was completed after a standardised breakfast. A second meal standardised to 30% of participants' daily energy requirements was provided 45 min after exercise. Appetite was suppressed more in hypoxia than normoxia during exercise, post-exercise, and for the full 2.6 h trial period (linear mixed modelling, p &lt; 0.05). Plasma acylated ghrelin concentrations were lower in hypoxia than normoxia post-exercise and for the full 2.6 h trial period (p &lt; 0.05). PYY concentrations were higher in HIIE than MIE under hypoxic conditions during exercise (p = 0.042). No differences in GLP-1 were observed between conditions (p &gt; 0.05). These findings demonstrate that short exposure to hypoxia causes suppressions in appetite and plasma acylated ghrelin concentrations. Furthermore, appetite responses to exercise do not appear to be influenced by exercise modality.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012622</affiliation-url><afid>60012622</afid><affilname>University of Bedfordshire</affilname><name-variant>University of Bedfordshire ^</name-variant><affiliation-city>Luton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000891</affiliation-url><afid>60000891</afid><affilname>Loughborough University</affilname><name-variant>Loughborough University</name-variant><affiliation-city>Loughborough</affiliation-city><affiliation-country/></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014564</affiliation-url><afid>60014564</afid><affilname>Oxford Brookes University</affilname><name-variant>Oxford Brookes University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014145</affiliation-url><afid>60014145</afid><affilname>University of Derby</affilname><name-variant>University of Derby</name-variant><affiliation-city>Derby</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032773</affiliation-url><afid>60032773</afid><affilname>Leeds Metropolitan University</affilname><name-variant>Leeds Metropolitan University</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56277724200</author-url><authid>56277724200</authid><authname>Bailey D.</authname><surname>Bailey</surname><given-name>Daniel P.</given-name><initials>D.P.</initials><afid>60012622</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56499681300</author-url><authid>56499681300</authid><authname>Smith L.</authname><surname>Smith</surname><given-name>Lindsey R.</given-name><initials>L.R.</initials><afid>60012622</afid><afid>60014145</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56499681300</author-url><authid>56499681300</authid><authname>Smith L.</authname><surname>Smith</surname><given-name>Lindsey R.</given-name><initials>L.R.</initials><afid>60012622</afid><afid>60014145</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35084806400</author-url><authid>35084806400</authid><authname>Chrismas B.</authname><surname>Chrismas</surname><given-name>Bryna C.</given-name><initials>B.C.</initials><afid>60012622</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24282305000</author-url><authid>24282305000</authid><authname>Taylor L.</authname><surname>Taylor</surname><given-name>Lee</given-name><initials>L.</initials><afid>60012622</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602651203</author-url><authid>6602651203</authid><authname>Stensel D.</authname><surname>Stensel</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60000891</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22134016800</author-url><authid>22134016800</authid><authname>Deighton K.</authname><surname>Deighton</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60000891</afid><afid>60032773</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22134016800</author-url><authid>22134016800</authid><authname>Deighton K.</authname><surname>Deighton</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60000891</afid><afid>60032773</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56191171600</author-url><authid>56191171600</authid><authname>Douglas J.</authname><surname>Douglas</surname><given-name>Jessica A.</given-name><initials>J.A.</initials><afid>60000891</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:37461506900</author-url><authid>37461506900</authid><authname>Kerr C.</authname><surname>Kerr</surname><given-name>Catherine J.</given-name><initials>C.J.</initials><afid>60014564</afid></author><authkeywords>Acylated ghrelin | Appetite-regulating hormones | High altitude anorexia | High-intensity exercise | Hypoxia</authkeywords><intid>1035097374</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927544684"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927544684?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927544684&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927544684&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874939915000681"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927544684</prism:url><dc:identifier>SCOPUS_ID:84927544684</dc:identifier><eid>2-s2.0-84927544684</eid><dc:title>Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders</dc:title><dc:creator>Kouwenhoven E.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Gene Regulatory Mechanisms</prism:publicationName><prism:issn>18749399</prism:issn><prism:eIssn>18764320</prism:eIssn><prism:volume>1849</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>590-600</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbagrm.2015.03.003</prism:doi><pii>S1874939915000681</pii><dc:description>© 2015 Elsevier B.V. The transcription factor p63 belongs to the p53 family and is a key regulator in epithelial commitment and development. Mutations in p63 give rise to several epithelial related disorders with defects in skin, limb and orofacial structures. Since the discovery of p63, efforts have been made to identify its target genes using individual gene approaches and to understand p63 function in normal epithelial development and related diseases. Recent genome-wide approaches have identified tens of thousands of potential p63-regulated target genes and regulatory elements, and reshaped the concept of gene regulation orchestrated by p63. These data also provide insights into p63-related disease mechanisms. In this review, we discuss the regulatory role of p63 in normal and diseased epithelial development in light of these novel findings. We also propose future perspectives for dissecting the molecular mechanism of p63-mediated epithelial development and related disorders as well as for potential therapeutic strategies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016529</affiliation-url><afid>60016529</afid><affilname>Radboud University Nijmegen</affilname><name-variant>University of Nijmegen</name-variant><affiliation-city>Nijmegen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002573</affiliation-url><afid>60002573</afid><affilname>Radboud University Nijmegen Medical Centre</affilname><name-variant>University Hospital Nijmegen</name-variant><affiliation-city>Nijmegen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Department of Molecular Developmental Biology 274</affilname><affiliation-city>Nijmegen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Department of Human Genetics 855</affilname><affiliation-city>Nijmegen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15822372300</author-url><authid>15822372300</authid><authname>Kouwenhoven E.</authname><surname>Kouwenhoven</surname><given-name>Evelyn N.</given-name><initials>E.N.</initials><afid>60016529</afid><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15822372300</author-url><authid>15822372300</authid><authname>Kouwenhoven E.</authname><surname>Kouwenhoven</surname><given-name>Evelyn N.</given-name><initials>E.N.</initials><afid>60016529</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005587499</author-url><authid>7005587499</authid><authname>van Bokhoven H.</authname><surname>van Bokhoven</surname><given-name>Hans</given-name><initials>H.</initials><afid>60002573</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005587499</author-url><authid>7005587499</authid><authname>van Bokhoven H.</authname><surname>van Bokhoven</surname><given-name>Hans</given-name><initials>H.</initials><afid>60002573</afid><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12792008500</author-url><authid>12792008500</authid><authname>Zhou H.</authname><surname>Zhou</surname><given-name>Huiqing</given-name><initials>H.</initials><afid>60016529</afid><afid>60002573</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12792008500</author-url><authid>12792008500</authid><authname>Zhou H.</authname><surname>Zhou</surname><given-name>Huiqing</given-name><initials>H.</initials><afid>60016529</afid><afid>60002573</afid></author><authkeywords>Epithelial development | Epithelial-related disease | Gene regulation | P63</authkeywords><intid>35633751</intid><source-id>11200153524</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926615555"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926615555?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926615555&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926615555&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926615555</prism:url><dc:identifier>SCOPUS_ID:84926615555</dc:identifier><eid>2-s2.0-84926615555</eid><dc:title>Cinnamaldehyde and nitric oxide attenuate advanced glycation end products-induced the JAK/STAT signaling in human renal tubular cells</dc:title><dc:creator>Huang J.</dc:creator><prism:publicationName>Journal of Cellular Biochemistry</prism:publicationName><prism:issn>07302312</prism:issn><prism:eIssn>10974644</prism:eIssn><prism:volume>116</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1028-1038</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/jcb.25058</prism:doi><dc:description>© 2015 Wiley Periodicals, Inc. Cinnamaldehyde is a major and a bioactive compound isolated from the leaves of Cinnamomum osmophloeum kaneh. It possesses anti-diabetic properties in vitro and in vivo and has anti-inflammatory and anti-cancer effects. To explore whether cinnamaldehyde was linked to altered advanced glycation end products (AGE)-mediated diabetic nephropathy, the molecular mechanisms of cinnamaldehyde responsible for inhibition of AGE-reduced nitric oxide (NO) bioactivity in human renal proximal tubular cells were examined. We found that raising the ambient AGE concentration causes a dose-dependent decrease in NO generation. Cinnamaldehyde significantly reverses AGE-inhibited NO generation and induces high levels of cGMP synthesis and PKG activation. Treatments with cinnamaldehyde, the NO donor S-nitroso-N-acetylpenicillamine, and the JAK2 inhibitor AG490 markedly attenuated AGE-inhibited NOS protein levels and NO generation. Moreover, AGE-induced the JAK2-STAT1/STAT3 activation, RAGE/p27&lt;sup&gt;Kip1&lt;/sup&gt;/collagen IV protein levels, and cellular hypertrophy were reversed by cinnamaldehyde. The ability of cinnamaldehyde to suppress STAT activation was also verified by the observation that it significantly increased SCOS-3 protein level. These findings indicate for the first time that in the presence of cinnamaldehyde, the suppression of AGE-induced biological responses is probably mediated by inactivating the JAK2-STAT1/STAT3 cascade or activating the NO pathway. J. Cell. Biochem. 116: 1028-1038, 2015.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072373</affiliation-url><afid>60072373</afid><affilname>Chung Hwa College of Medical Technology Taiwan</affilname><name-variant>Chung Hwa University of Medical Technology</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021605</affiliation-url><afid>60021605</afid><affilname>Veterans General Hospital-Kaohsiung Taiwan</affilname><name-variant>Kaohsiung Veterans General Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072373</affiliation-url><afid>60072373</afid><affilname>Chung Hwa College of Medical Technology Taiwan</affilname><name-variant>Chung Hwa University of Medical Technology</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7407192906</author-url><authid>7407192906</authid><authname>Huang J.</authname><surname>Huang</surname><given-name>Jau Shyang</given-name><initials>J.S.</initials><afid>60072373</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56092317200</author-url><authid>56092317200</authid><authname>Lee Y.</authname><surname>Lee</surname><given-name>Ying Ho</given-name><initials>Y.H.</initials><afid>60072373</afid><afid>60021605</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56092317200</author-url><authid>56092317200</authid><authname>Lee Y.</authname><surname>Lee</surname><given-name>Ying Ho</given-name><initials>Y.H.</initials><afid>60072373</afid><afid>60021605</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14718929000</author-url><authid>14718929000</authid><authname>Chuang L.</authname><surname>Chuang</surname><given-name>Lea Yea</given-name><initials>L.Y.</initials><afid>60012256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005320637</author-url><authid>7005320637</authid><authname>Guh J.</authname><surname>Guh</surname><given-name>Jinn Yuh</given-name><initials>J.Y.</initials><afid>60012256</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34978854900</author-url><authid>34978854900</authid><authname>Hwang J.</authname><surname>Hwang</surname><given-name>Jean Yu</given-name><initials>J.Y.</initials><afid>60072373</afid></author><authkeywords>ADVANCED GLYCATION END PRODUCTS | CINNAMALDEHYDE | DIABETIC NEPHROPATHY | HUMAN RENAL PROXIMAL TUBULAR CELLS | JANUS KINASE 2 | NITRIC OXIDE</authkeywords><intid>1535482733</intid><source-id>17598</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928116513"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928116513?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928116513&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928116513&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S096517481500065X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928116513</prism:url><dc:identifier>SCOPUS_ID:84928116513</dc:identifier><eid>2-s2.0-84928116513</eid><dc:title>Sulfakinin is an important regulator of digestive processes in the migratory locust, Locusta migratoria</dc:title><dc:creator>Zels S.</dc:creator><prism:publicationName>Insect Biochemistry and Molecular Biology</prism:publicationName><prism:issn>09651748</prism:issn><prism:eIssn>18790240</prism:eIssn><prism:volume>61</prism:volume><prism:pageRange>8-16</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ibmb.2015.03.008</prism:doi><pii>S096517481500065X</pii><dc:description>© 2015 Elsevier Ltd. Sulfakinin (SK) is a sulfated insect neuropeptide that is best known for its function as a satiety factor. It displays structural and functional similarities with the vertebrate peptides gastrin and cholecystokinin. Peptidomic studies in multiple insects, crustaceans and arachnids have revealed the widespread occurrence of SK in the arthropod phylum. Multiple studies in hemi- and holometabolous insects revealed the pleiotropic nature of this neuropeptide: in addition to its activity as a satiety factor, SK was also reported to affect muscle contraction, digestive enzyme release, odor preference, aggression and metabolism. However, the main site of action seems to be the digestive system of insects. In this study, we have investigated whether SK can intervene in the control of nutrient uptake and digestion in the migratory locust (. Locusta migratoria). We provide evidence that sulfakinin reduces food uptake in this species. Furthermore, we discovered that SK has very pronounced effects on the main digestive enzyme secreting parts of the locust gut. It effectively reduced digestive enzyme secretion from both the midgut and gastric caeca. SK injection also elicited a reduction in absorbance and proteolytic activity of the gastric caeca contents. The characteristic sulfation of the tyrosine residue is crucial for the observed effects on digestive enzyme secretion. In an attempt to provide potential leads for the development of peptidomimetic compounds based on SK, we also tested two mimetic analogs of the natural peptide ligand in the digestive enzyme secretion assay. These analogs were able to mimic the effect of the natural SK, but their effects were milder. The results of this study provide new insights into the action of SK on the digestive system in (hemimetabolous) insects.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028657</affiliation-url><afid>60028657</afid><affilname>USDA ARS Southern Plains Agricultural Research Center</affilname><name-variant>Agricultural Research Service</name-variant><affiliation-city>College Station</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42662690000</author-url><authid>42662690000</authid><authname>Zels S.</authname><surname>Zels</surname><given-name>Sven</given-name><initials>S.</initials><afid>60025063</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55023577500</author-url><authid>55023577500</authid><authname>Dillen S.</authname><surname>Dillen</surname><given-name>Senne</given-name><initials>S.</initials><afid>60025063</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56115083800</author-url><authid>56115083800</authid><authname>Crabbé K.</authname><surname>Crabbé</surname><given-name>Katleen</given-name><initials>K.</initials><afid>60025063</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:42662508700</author-url><authid>42662508700</authid><authname>Spit J.</authname><surname>Spit</surname><given-name>Jornt</given-name><initials>J.</initials><afid>60025063</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102777706</author-url><authid>7102777706</authid><authname>Nachman R.</authname><surname>Nachman</surname><given-name>Ronald J.</given-name><initials>R.J.</initials><afid>60028657</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005594519</author-url><authid>7005594519</authid><authname>Vanden Broeck J.</authname><surname>Vanden Broeck</surname><given-name>Jozef</given-name><initials>J.</initials><afid>60025063</afid></author><authkeywords>Cholecystokinin | Digestion | Food intake | Insect gut | Peptide | Satiety</authkeywords><intid>535733793</intid><source-id>20384</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376476"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376476?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376476&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376476&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376476</prism:url><dc:identifier>SCOPUS_ID:84929376476</dc:identifier><eid>2-s2.0-84929376476</eid><dc:title>PSMPA: Patient self-controllable and multi-level privacy-preserving cooperative authentication in distributed m-healthcare cloud computing system</dc:title><dc:creator>Zhou J.</dc:creator><prism:publicationName>IEEE Transactions on Parallel and Distributed Systems</prism:publicationName><prism:issn>10459219</prism:issn><prism:volume>26</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1693-1703</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1109/TPDS.2014.2314119</prism:doi><dc:description>© 2014 IEEE. Distributed m-healthcare cloud computing system significantly facilitates efficient patient treatment for medical consultation by sharing personal health information among healthcare providers. However, it brings about the challenge of keeping both the data confidentiality and patients' identity privacy simultaneously. Many existing access control and anonymous authentication schemes cannot be straightforwardly exploited. To solve the problem, in this paper, a novel authorized accessible privacy model (AAPM) is established. Patients can authorize physicians by setting an access tree supporting flexible threshold predicates. Then, based on it, by devising a new technique of attribute-based designated verifier signature, a patient self-controllable multi-level privacy-preserving cooperative authentication scheme (PSMPA) realizing three levels of security and privacy requirement in distributed m-healthcare cloud computing system is proposed. The directly authorized physicians, the indirectly authorized physicians and the unauthorized persons in medical consultation can respectively decipher the personal health information and/or verify patients' identities by satisfying the access tree with their own attribute sets. Finally, the formal security proof and simulation results illustrate our scheme can resist various kinds of attacks and far outperforms the previous ones in terms of computational, communication and storage overhead.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021200</affiliation-url><afid>60021200</afid><affilname>East China Normal University</affilname><name-variant>East China Normal University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002146</affiliation-url><afid>60002146</afid><affilname>University of Ontario Institute of Technology</affilname><name-variant>University of Ontario</name-variant><affiliation-city>Oshawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56623561500</author-url><authid>56623561500</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jun</given-name><initials>J.</initials><afid>60021200</afid><afid>60025084</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56623561500</author-url><authid>56623561500</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jun</given-name><initials>J.</initials><afid>60021200</afid><afid>60025084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:17435253300</author-url><authid>17435253300</authid><authname>Lin X.</authname><surname>Lin</surname><given-name>Xiaodong</given-name><initials>X.</initials><afid>60002146</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401797223</author-url><authid>7401797223</authid><authname>Dong X.</authname><surname>Dong</surname><given-name>Xiaolei</given-name><initials>X.</initials><afid>60021200</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56443146000</author-url><authid>56443146000</authid><authname>Cao Z.</authname><surname>Cao</surname><given-name>Zhenfu</given-name><initials>Z.</initials><afid>60021200</afid></author><authkeywords>access control | Authentication | distributed cloud computing | m-healthcare system | security and privacy</authkeywords><intid>2035940582</intid><article-number>6779640</article-number><source-id>26098</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920177841"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920177841?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920177841&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920177841&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814614019797"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920177841</prism:url><dc:identifier>SCOPUS_ID:84920177841</dc:identifier><eid>2-s2.0-84920177841</eid><dc:title>Anti-apoptotic effects of novel phenolic antioxidant isolated from the Pacific oyster (Crassostrea gigas) on cultured human hepatocytes under oxidative stress</dc:title><dc:creator>Fuda H.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>176</prism:volume><prism:pageRange>226-233</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2014.12.066</prism:doi><pii>S0308814614019797</pii><dc:description>© 2014 Elsevier Ltd. All rights reserved. The antioxidant, and hepatoprotective properties of 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA), a natural phenolic antioxidant isolated from the Pacific oyster, were defined using cultured human hepatocyte-derived cells (C3A). DHMBA showed no cytotoxicity at 62.5-500 μM, as well as chlorogenic acid (CGA), vitamin C, and vitamin E. However, butylated hydroxytoluene, eicosapentaenoic acid, docosahexaenoic acid and catechin reduced cell viability. In the presence of the prooxidant 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH), DHMBA at 125-500 μM improved cell viability, whereas CGA had no effect. DNA ladder formation and flow-cytometric studies indicated that DHMBA inhibited AAPH-induced apoptosis and necrosis. CGA was ineffective. Thus, DHMBA is a novel, potent antioxidant, effectively protecting cultured hepatocytes from apoptosis and necrosis caused by oxidative stress. Additionally, the concentration of DHMBA was determined by mass spectrometry to be 24.4 μmol/kg wet oyster meat, and three polyphenols (gentisic acid, daidzein, and matairesinol) were newly identified in the oyster extracts.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014652</affiliation-url><afid>60014652</afid><affilname>Hokkaido University</affilname><name-variant>Hokkaido University</name-variant><affiliation-city>Sapporo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114860636</affiliation-url><afid>114860636</afid><affilname>Watanabe Oyster Laboratory Co. Ltd.</affilname><name-variant>Watanabe Oyster Laboratory Co. Ltd.</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602127482</author-url><authid>6602127482</authid><authname>Fuda H.</authname><surname>Fuda</surname><given-name>Hirotoshi</given-name><initials>H.</initials><afid>60014652</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55192414300</author-url><authid>55192414300</authid><authname>Watanabe M.</authname><surname>Watanabe</surname><given-name>Mitsugu</given-name><initials>M.</initials><afid>114860636</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202831816</author-url><authid>7202831816</authid><authname>Hui S.</authname><surname>Hui</surname><given-name>Shu Ping</given-name><initials>S.P.</initials><afid>60014652</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56465774200</author-url><authid>56465774200</authid><authname>Joko S.</authname><surname>Joko</surname><given-name>Sae</given-name><initials>S.</initials><afid>60014652</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56465417700</author-url><authid>56465417700</authid><authname>Okabe H.</authname><surname>Okabe</surname><given-name>Hiroaki</given-name><initials>H.</initials><afid>60014652</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8297786900</author-url><authid>8297786900</authid><authname>Jin S.</authname><surname>Jin</surname><given-name>Shigeki</given-name><initials>S.</initials><afid>60014652</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56429904200</author-url><authid>56429904200</authid><authname>Takeda S.</authname><surname>Takeda</surname><given-name>Seiji</given-name><initials>S.</initials><afid>60014652</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56465613300</author-url><authid>56465613300</authid><authname>Miki E.</authname><surname>Miki</surname><given-name>Emiko</given-name><initials>E.</initials><afid>114860636</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55700079400</author-url><authid>55700079400</authid><authname>Watanabe T.</authname><surname>Watanabe</surname><given-name>Takayuki</given-name><initials>T.</initials><afid>114860636</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:16179497400</author-url><authid>16179497400</authid><authname>Chiba H.</authname><surname>Chiba</surname><given-name>Hitoshi</given-name><initials>H.</initials><afid>60014652</afid></author><authkeywords>Apoptosis | Butylated hydroxytoluene | Chlorogenic acid | DHMBA | Liver | Polyphenol | Polyunsaturated fatty acid | Vitamin</authkeywords><intid>534444500</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926290154"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926290154?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926290154&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926290154&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378427415001113"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926290154</prism:url><dc:identifier>SCOPUS_ID:84926290154</dc:identifier><eid>2-s2.0-84926290154</eid><dc:title>Role of type I &amp; type II reactions in DNA damage and activation of Caspase 3 via mitochondrial pathway induced by photosensitized benzophenone</dc:title><dc:creator>Amar S.</dc:creator><prism:publicationName>Toxicology Letters</prism:publicationName><prism:issn>03784274</prism:issn><prism:eIssn>18793169</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>84-95</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxlet.2015.03.008</prism:doi><pii>S0378427415001113</pii><dc:description>© 2015 Elsevier Ireland Ltd. Sunscreen users have been increased, since excessive sun exposure increased the risk of skin diseases. Benzophenone (BP) and its derivatives are commonly used in sunscreens as UV blocker. Its photosafety is concern for human health. Our study showed the role of type-I and type-II radicals in activation of caspase 3 and phototoxicity of BP under sunlight/UV radiation. BP photodegraded and formed two photoproducts. BP generates reactive oxygen species (ROS) singlet oxygen (&lt;sup&gt;1&lt;/sup&gt;O&lt;inf&gt;2&lt;/inf&gt;), superoxide anion (O&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;) and hydroxyl radical (OH) through type-I and type-II photodynamic mechanisms. Photocytotoxicity significantly reduced cell viability under sunlight, UVB and UVA. DCF fluorescence confirmed intracellular ROS generation. BP showed single strand DNA breakage, further proved by cyclobutane pyrimidine dimmers (CPDs) formation. Lipid peroxidation and LDH leakage were enhanced by BP. P21 dependent cell cycle study showed sub G1 population which advocates apoptotic cell death, confirmed through AO/EB and annexin V/PI staining. BP decreased mitochondrial membrane potential, death protein released and activated caspase. We proposed cytochrome c regulated caspase 3 dependent apoptosis in HaCaT cell line through down regulation of Bcl2/Bax ratio. Phototoxicity potential of its photoproducts is essential to understand its total environmental fate. Hence, we conclude that BP may replace from cosmetics preparation of topical application.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60101552</affiliation-url><afid>60101552</afid><affilname>Indian Institute of Toxicology Research</affilname><name-variant>Indian Institute of Toxicology Research</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114071236</affiliation-url><afid>114071236</afid><affilname>Academy of Scientific and Innovative Research</affilname><name-variant>Academy of Scientific and Innovative Research (AcSIR)</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60101552</affiliation-url><afid>60101552</afid><affilname>Indian Institute of Toxicology Research</affilname><name-variant>Indian Institute of Toxicology Research</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55932711000</author-url><authid>55932711000</authid><authname>Amar S.</authname><surname>Amar</surname><given-name>Saroj Kumar</given-name><initials>S.K.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55932711000</author-url><authid>55932711000</authid><authname>Amar S.</authname><surname>Amar</surname><given-name>Saroj Kumar</given-name><initials>S.K.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56581217800</author-url><authid>56581217800</authid><authname>Goyal S.</authname><surname>Goyal</surname><given-name>Shruti</given-name><initials>S.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56581217800</author-url><authid>56581217800</authid><authname>Goyal S.</authname><surname>Goyal</surname><given-name>Shruti</given-name><initials>S.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:50761121300</author-url><authid>50761121300</authid><authname>Mujtaba S.</authname><surname>Mujtaba</surname><given-name>Syed Faiz</given-name><initials>S.F.</initials><afid>60101552</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006823721</author-url><authid>7006823721</authid><authname>Dwivedi A.</authname><surname>Dwivedi</surname><given-name>Ashish</given-name><initials>A.</initials><afid>60101552</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36673228900</author-url><authid>36673228900</authid><authname>Kushwaha H.</authname><surname>Kushwaha</surname><given-name>Hari Narayan</given-name><initials>H.N.</initials><afid>60101552</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37117955400</author-url><authid>37117955400</authid><authname>Verma A.</authname><surname>Verma</surname><given-name>Ankit</given-name><initials>A.</initials><afid>60101552</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:18534325100</author-url><authid>18534325100</authid><authname>Chopra D.</authname><surname>Chopra</surname><given-name>Deepti</given-name><initials>D.</initials><afid>60101552</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005701179</author-url><authid>7005701179</authid><authname>Chaturvedi R.</authname><surname>Chaturvedi</surname><given-name>Rajnish K.</given-name><initials>R.K.</initials><afid>60101552</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402178699</author-url><authid>7402178699</authid><authname>Ray R.</authname><surname>Ray</surname><given-name>Ratan Singh</given-name><initials>R.S.</initials><afid>60101552</afid></author><authkeywords>Apoptosis | Benzophenone | DNA damage | Phototoxicity | Sunscreens | UV-radiation</authkeywords><intid>1535428576</intid><source-id>25240</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925274803"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925274803?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925274803&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925274803&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010027715000396"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925274803</prism:url><dc:identifier>SCOPUS_ID:84925274803</dc:identifier><eid>2-s2.0-84925274803</eid><dc:title>Losses as ecological guides: Minor losses lead to maximization and not to avoidance</dc:title><dc:creator>Yechiam E.</dc:creator><prism:publicationName>Cognition</prism:publicationName><prism:issn>00100277</prism:issn><prism:eIssn>18737838</prism:eIssn><prism:volume>139</prism:volume><prism:pageRange>10-17</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cognition.2015.03.001</prism:doi><pii>S0010027715000396</pii><dc:description>© 2015 Elsevier B.V. Losses are commonly thought to result in a neuropsychological avoidance response. We suggest that losses also provide ecological guidance by increasing focus on the task at hand, and that this effect may override the avoidance response. This prediction was tested in a series of studies. In Study 1a we found that minor losses did not lead to an avoidance response. Instead, they guided participants to make advantageous choices (in terms of expected value) and to avoid disadvantageous choices. Moreover, losses were associated with less switching between options after the first block of exploration. In Study 1b we found that this effect was not simply a by-product of the increase in visual contrast with losses. In Study 1c we found that the effect of losses did not emerge when alternatives did not differ in their expected value but only in their risk level. In Study 2 we investigated the autonomic arousal dynamics associated with this behavioral pattern via pupillometric responses. The results showed increased pupil diameter following losses compared to gains. However, this increase was not associated with a tendency to avoid losses, but rather with a tendency to select more advantageously. These findings suggest that attention and reasoning processes induced by losses can out-weigh the influence of affective processes leading to avoidance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022403</affiliation-url><afid>60022403</afid><affilname>Technion - Israel Institute of Technology</affilname><name-variant>Technion</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55892873800</author-url><authid>55892873800</authid><authname>Yechiam E.</authname><surname>Yechiam</surname><given-name>Eldad</given-name><initials>E.</initials><afid>60022403</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56562902100</author-url><authid>56562902100</authid><authname>Retzer M.</authname><surname>Retzer</surname><given-name>Matan</given-name><initials>M.</initials><afid>60022403</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:52564459100</author-url><authid>52564459100</authid><authname>Telpaz A.</authname><surname>Telpaz</surname><given-name>Ariel</given-name><initials>A.</initials><afid>60022403</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35085076700</author-url><authid>35085076700</authid><authname>Hochman G.</authname><surname>Hochman</surname><given-name>Guy</given-name><initials>G.</initials><afid>60008724</afid></author><authkeywords>Attention | Loss attention | Loss aversion | Performance</authkeywords><intid>35277485</intid><source-id>12857</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927138462"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927138462?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927138462&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927138462&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0006320715001391"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927138462</prism:url><dc:identifier>SCOPUS_ID:84927138462</dc:identifier><eid>2-s2.0-84927138462</eid><dc:title>Natura 2000 - Solution for Eastern Europe or just a good start? The Šumava National Park as a test case</dc:title><dc:creator>Křenová Z.</dc:creator><prism:publicationName>Biological Conservation</prism:publicationName><prism:issn>00063207</prism:issn><prism:volume>186</prism:volume><prism:pageRange>268-275</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biocon.2015.03.028</prism:doi><pii>S0006320715001391</pii><dc:description>© 2015 Elsevier Ltd. Natura 2000 is a unique EU-wide network of protected areas, which aims to maintain European biodiversity or at least prevent its worsening based on two Directives: Bird Directive 79/409/EEC and Habitats Directive 92/43/EEC. It is assumed that this will assure the long-term survival of Europe's most valuable and threatened species and habitats. The new member states implemented the Natura 2000 Directives in their own legislation as a part of the EU-integration process. Here we present the practical difficulties of implementing these directives in the Czech Republic as a warning of the problems likely to be encountered in post-communist countries. Our results are mainly based on a case study of the Šumava National Park. We analyze, why Natura 2000 may not work here and look for possible solutions, which would require changes in Natura 2000 policies and their implementation in national policies. We show five examples of activities, which were performed or are still planned despite the fact that Natura 2000 evaluations have clearly shown that they have or would have had significant negative effects on Natura 2000 habitats and species. These include canoeing in pearl mussels core zones, logging of spruce stands, park zonation and management, and ski lift and tourist trails in capercaillie core zones. We deduce that the unstable political conditions together with the weak position of the state representatives in the Czech Republic result in a situation in which the last remnants of justice together with newly implemented EU directives easily disappear. We then show that the problems encountered in implementing Natura 2000 directives in the Czech Republic are likely to affect their successful implementation in most other post-communist countries. EU is supporting these countries financially, but this support should be much more conditional on full implementation of EU laws. Environmental subsidies should be conditional on fulfilment of the country's obligations to EU nature protection. Proper use of EU money should be directly controlled by central EU authorities, not left entirely to the recipients, the member states.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113093441</affiliation-url><afid>113093441</afid><affilname>Global Change Research Centre AS CR</affilname><name-variant>Global Change Research Centre AS CR</name-variant><affiliation-city>Brno</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36963237900</author-url><authid>36963237900</authid><authname>Křenová Z.</authname><surname>Křenová</surname><given-name>Zdenka</given-name><initials>Z.</initials><afid>113093441</afid><afid>60016605</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36963237900</author-url><authid>36963237900</authid><authname>Křenová Z.</authname><surname>Křenová</surname><given-name>Zdenka</given-name><initials>Z.</initials><afid>113093441</afid><afid>60016605</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55205749500</author-url><authid>55205749500</authid><authname>Kindlmann P.</authname><surname>Kindlmann</surname><given-name>Pavel</given-name><initials>P.</initials><afid>113093441</afid><afid>60016605</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55205749500</author-url><authid>55205749500</authid><authname>Kindlmann P.</authname><surname>Kindlmann</surname><given-name>Pavel</given-name><initials>P.</initials><afid>113093441</afid><afid>60016605</afid></author><authkeywords>Biodiversity | Natura 2000 | Post-communist countries | Šumava national park</authkeywords><intid>1535570133</intid><source-id>17244</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928744583"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928744583?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928744583&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928744583&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0736574815000398"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928744583</prism:url><dc:identifier>SCOPUS_ID:84928744583</dc:identifier><eid>2-s2.0-84928744583</eid><dc:title>The effects of PBDE-209 exposure during pregnancy on placental ET-1 and eNOS expression and the birth weight of offspring</dc:title><dc:creator>Du P.</dc:creator><prism:publicationName>International Journal of Developmental Neuroscience</prism:publicationName><prism:issn>07365748</prism:issn><prism:eIssn>1873474X</prism:eIssn><prism:volume>43</prism:volume><prism:pageRange>86-91</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijdevneu.2015.03.011</prism:doi><pii>S0736574815000398</pii><dc:description>© 2015 Elsevier Ltd. Decabrominated diphenyl ether (PBDE-209) is a persistent organic pollutant. Gestational exposure to PBDE-209 can accumulate in pregnant women and fetuses via the placenta and umbilical cord, affecting perinatal outcome. In this study, pregnant Sprague-Dawley (SD) rats were randomly divided into five groups and intragastrically administered peanut oil (vehicle) 1, 5 and 10. mg/kg by body weight (b.w.) of PBDE-209, or nothing (control) from day 0 (G0) to day 21 (G21) gestation, respectively. Placental samples were collected on G21 by cesarean section. The mRNA and protein expressions of ET-1, eNOS and iNOS in the placenta were examined using qRT-PCR and Western blot, respectively. Total nitric oxide (NO) in the placenta was measured using a specific ELISA kit. Compared with the control and vehicle groups, the mRNA expression of ET-1 and iNOS in the placenta was gradually and significantly increased after exposure to increasing concentrations of PBDE-209 (P&lt;. 0.05), while the mRNA level of eNOS in the placenta was gradually and significantly reduced after exposure to increasing concentrations of PBDE-209 (P&lt;. 0.05). The expression trends of ET-1, eNOS and iNOS proteins were consistent with those of mRNA expression. Interestingly, the production of total NO was significantly increased after exposure to 5 and 10. mg/kg b.w. PBDE-209 (P&lt;. 0.05). Finally, the birth weight of the offspring rats was significantly reduced after maternal exposure to 5 and 10. mg/kg b.w. PBDE-209 compared with the control and vehicle groups (P&lt;. 0.05). These results suggest that PBDE-209 exposure during pregnancy upregulates ET-1 and iNOS expression, but decreases eNOS expression in the placenta, as well as reduces the birth weight of offspring.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110099118</affiliation-url><afid>110099118</afid><affilname>The Third Affiliated Hospital of Guangzhou Medical University</affilname><name-variant>Third Affiliated Hospital of Guangzhou Medical University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002593</affiliation-url><afid>60002593</afid><affilname>Southern Medical University</affilname><name-variant>Southern Medical University</name-variant><affiliation-city>TongHe</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55938683500</author-url><authid>55938683500</authid><authname>Du P.</authname><surname>Du</surname><given-name>Peili</given-name><initials>P.</initials><afid>110099118</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56610916700</author-url><authid>56610916700</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhihua</given-name><initials>Z.</initials><afid>110099118</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56611193200</author-url><authid>56611193200</authid><authname>Du L.</authname><surname>Du</surname><given-name>Lili</given-name><initials>L.</initials><afid>110099118</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55938804300</author-url><authid>55938804300</authid><authname>Zhang H.</authname><surname>Zhang</surname><given-name>Huili</given-name><initials>H.</initials><afid>110099118</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56507586400</author-url><authid>56507586400</authid><authname>Zhou Y.</authname><surname>Zhou</surname><given-name>Yanmei</given-name><initials>Y.</initials><afid>110099118</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56611006500</author-url><authid>56611006500</authid><authname>Sun W.</authname><surname>Sun</surname><given-name>Wen</given-name><initials>W.</initials><afid>110099118</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55880772800</author-url><authid>55880772800</authid><authname>Xiao X.</authname><surname>Xiao</surname><given-name>Xue</given-name><initials>X.</initials><afid>110099118</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55938415000</author-url><authid>55938415000</authid><authname>He Y.</authname><surname>He</surname><given-name>Yutian</given-name><initials>Y.</initials><afid>110099118</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55938743600</author-url><authid>55938743600</authid><authname>Sun B.</authname><surname>Sun</surname><given-name>Bin</given-name><initials>B.</initials><afid>110099118</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:9249938100</author-url><authid>9249938100</authid><authname>Yu Y.</authname><surname>Yu</surname><given-name>Yanhong</given-name><initials>Y.</initials><afid>60002593</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7405453766</author-url><authid>7405453766</authid><authname>Chen D.</authname><surname>Chen</surname><given-name>Dunjin</given-name><initials>D.</initials><afid>110099118</afid></author><authkeywords>ENOS | ET-1 | NO | PBDE-209 | Placenta</authkeywords><intid>1785840322</intid><source-id>16147</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924914634"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924914634?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924914634&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924914634&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0268005X15000892"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924914634</prism:url><dc:identifier>SCOPUS_ID:84924914634</dc:identifier><eid>2-s2.0-84924914634</eid><dc:title>Development of shrikhand premix using microencapsulated rice bran oil as fat alternative and hydrocolloids as texture modifier</dc:title><dc:creator>Gupta P.</dc:creator><prism:publicationName>Food Hydrocolloids</prism:publicationName><prism:issn>0268005X</prism:issn><prism:volume>48</prism:volume><prism:pageRange>220-227</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodhyd.2015.02.028</prism:doi><pii>S0268005X15000892</pii><dc:description>© 2015 Elsevier Ltd. A premix of shrikhand (Indian dessert) was prepared using skim milk powder, skim milk curd, sucrose and microencapsulated rice bran oil (RBO) as fat alternative. RBO was microencapsulated using spray drying under the optimized conditions of air inlet temperature (135°C), feed rate (15mL/h) and solid content (17%) in emulsion. Hicap-100 (modified starch) was found to provide best encapsulation (62.83±0.57%) to RBO as compared to that of gum arabic and maltodextrin as wall material. The size and shape of microencapsulated oil was checked using SEM and thermal stability was evaluated using DSC. Addition of 1% α-tocopherol to RBO before microencapsulation enhanced its oxidative stability. The premix was used to prepare shrikhand and compared with market sample with respect to composition, texture, colour and sensory profile. Addition of blend of xanthan and gellan gum (80:20) improved the texture of prepared shrikhand to the level of market shrikhand.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006361</affiliation-url><afid>60006361</afid><affilname>Mumbai University Institute of Chemical Technology</affilname><name-variant>University Institute of Chemical Technology</name-variant><affiliation-city>Mumbai</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56553581000</author-url><authid>56553581000</authid><authname>Gupta P.</authname><surname>Gupta</surname><given-name>Pradeep Kumar</given-name><initials>P.K.</initials><afid>60006361</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55331491300</author-url><authid>55331491300</authid><authname>Jadhav S.</authname><surname>Jadhav</surname><given-name>Swati B.</given-name><initials>S.B.</initials><afid>60006361</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202911852</author-url><authid>7202911852</authid><authname>Singhal R.</authname><surname>Singhal</surname><given-name>Rekha S.</given-name><initials>R.S.</initials><afid>60006361</afid></author><authkeywords>Microencapsulation | Premix | Rice bran oil | Shrikhand | Spray drying</authkeywords><intid>535218594</intid><source-id>22597</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926622015"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926622015?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926622015&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926622015&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0016718515000809"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926622015</prism:url><dc:identifier>SCOPUS_ID:84926622015</dc:identifier><eid>2-s2.0-84926622015</eid><dc:title>'There's no future here': The time and place of children's migration aspirations in Peru</dc:title><dc:creator>Crivello G.</dc:creator><prism:publicationName>Geoforum</prism:publicationName><prism:issn>00167185</prism:issn><prism:volume>62</prism:volume><prism:pageRange>38-46</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.geoforum.2015.03.016</prism:doi><pii>S0016718515000809</pii><dc:description>© 2015 Elsevier Ltd. This article examines young Peruvians' aspirations and the role of migration in their imagined futures, from a generational perspective. The data come from Young Lives, a long-term study of childhood poverty combining survey and qualitative approaches with children and their parents. The paper uses a biographical approach that sees migration as part of individual biographies as well as social structures and life course processes. The aim is to deepen understanding of the social contexts in which aspirations for and by children are generated, paying close attention to family migration histories, dynamic household contexts, and children's migration networks. The analysis focuses on the time-spaces of migration aspirations, showing the way past, present and future are interconnected. It also emplaces aspirations by focusing on the way aspirations by and for children are constituted in and through particular places. The conclusion reflects on the role of poverty and argues that 'aspirations' are about much more than abstract 'futures'; they orient actions in the present and say a great deal about young people's current realities and relationships.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9846766900</author-url><authid>9846766900</authid><authname>Crivello G.</authname><surname>Crivello</surname><given-name>Gina</given-name><initials>G.</initials><afid>60026851</afid></author><authkeywords>Aspirations | Children | Generation | Latin america | Migration | Poverty</authkeywords><intid>1535483881</intid><source-id>28611</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923013467"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923013467?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923013467&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923013467&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X14000153"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923013467</prism:url><dc:identifier>SCOPUS_ID:84923013467</dc:identifier><eid>2-s2.0-84923013467</eid><dc:title>Culture and emotion regulation</dc:title><dc:creator>Ford B.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>3</prism:volume><prism:pageRange>1-5</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2014.12.004</prism:doi><pii>S2352250X14000153</pii><dc:description>© 2014 Elsevier Ltd. While anthropological research has long emphasized cultural differences in whether emotions are viewed as beneficial versus harmful, psychological science has only recently begun to systematically examine those differences and their implications for emotion regulation and well-being. Underscoring the pervasive role of culture in people's emotions, we summarize research that has examined links between culture, emotion regulation, and well-being. Specifically, we focus on two questions. First, how does culture lead individuals to regulate their emotions? And second, how does culture modulate the link between emotion regulation and well-being? We finish by suggesting directions for future research to advance the study of culture and emotion regulation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025038</affiliation-url><afid>60025038</afid><affilname>UC Berkeley</affilname><name-variant>University of California</name-variant><affiliation-city>Berkeley</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35093849100</author-url><authid>35093849100</authid><authname>Ford B.</authname><surname>Ford</surname><given-name>Brett Q.</given-name><initials>B.Q.</initials><afid>60025038</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7801461623</author-url><authid>7801461623</authid><authname>Mauss I.</authname><surname>Mauss</surname><given-name>Iris B.</given-name><initials>I.B.</initials><afid>60025038</afid></author><intid>1534904666</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926188626"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926188626?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926188626&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926188626&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005796715000480"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926188626</prism:url><dc:identifier>SCOPUS_ID:84926188626</dc:identifier><eid>2-s2.0-84926188626</eid><dc:title>Therapist competence in global mental health: Development of the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale</dc:title><dc:creator>Kohrt B.</dc:creator><prism:publicationName>Behaviour Research and Therapy</prism:publicationName><prism:issn>00057967</prism:issn><prism:eIssn>1873622X</prism:eIssn><prism:volume>69</prism:volume><prism:pageRange>11-21</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.brat.2015.03.009</prism:doi><pii>S0005796715000480</pii><dc:description>© 2015 The Authors. Lack of reliable and valid measures of therapist competence is a barrier to dissemination and implementation of psychological treatments in global mental health. We developed the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale for training and supervision across settings varied by culture and access to mental health resources. We employed a four-step process in Nepal: (1) Item generation: We extracted 1081 items (grouped into 104 domains) from 56 existing tools; role-plays with Nepali therapists generated 11 additional domains. (2) Item relevance: From the 115 domains, Nepali therapists selected 49 domains of therapeutic importance and high comprehensibility. (3) Item utility: We piloted the ENACT scale through rating role-play videotapes, patient session transcripts, and live observations of primary care workers in trainings for psychological treatments and the Mental Health Gap Action Programme (mhGAP). (4) Inter-rater reliability was acceptable for experts (intraclass correlation coefficient, ICC(2,7)=0.88 (95% confidence interval (CI) 0.81-0.93), N=7) and non-specialists (ICC(1,3)=0.67 (95% CI 0.60-0.73), N=34). In sum, the ENACT scale is an 18-item assessment for common factors in psychological treatments, including task-sharing initiatives with non-specialists across cultural settings. Further research is needed to evaluate applications for therapy quality and association with patient outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108095156</affiliation-url><afid>108095156</afid><affilname>Transcultural Psychosocial Organization (TPO) Nepal</affilname><name-variant>Transcultural Psychosocial Organization (TPO)</name-variant><affiliation-city>Kathmandu</affiliation-city><affiliation-country>Nepal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025286</affiliation-url><afid>60025286</afid><affilname>George Washington University School of Medicine and Health Sciences</affilname><name-variant>George Washington University School of Medicine and Health Sciences</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101870245</affiliation-url><afid>101870245</afid><affilname>Research and Development</affilname><name-variant>Research and Development</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002494</affiliation-url><afid>60002494</afid><affilname>McGill University</affilname><name-variant>McGill University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031331</affiliation-url><afid>60031331</afid><affilname>London School of Hygiene &amp; Tropical Medicine</affilname><name-variant>London School of Hygiene and Tropical Medicine</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112834212</affiliation-url><afid>112834212</afid><affilname>Public Health Foundation of</affilname><name-variant>Public Health Foundation of</name-variant><affiliation-city>New Delhi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115118910</affiliation-url><afid>115118910</afid><affilname>Sangath Center</affilname><name-variant>Sangath Center</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506441612</author-url><authid>6506441612</authid><authname>Kohrt B.</authname><surname>Kohrt</surname><given-name>Brandon A.</given-name><initials>B.A.</initials><afid>108095156</afid><afid>60025286</afid><afid>60005200</afid><afid>60008724</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506441612</author-url><authid>6506441612</authid><authname>Kohrt B.</authname><surname>Kohrt</surname><given-name>Brandon A.</given-name><initials>B.A.</initials><afid>108095156</afid><afid>60025286</afid><afid>60005200</afid><afid>60008724</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506441612</author-url><authid>6506441612</authid><authname>Kohrt B.</authname><surname>Kohrt</surname><given-name>Brandon A.</given-name><initials>B.A.</initials><afid>108095156</afid><afid>60025286</afid><afid>60005200</afid><afid>60008724</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506441612</author-url><authid>6506441612</authid><authname>Kohrt B.</authname><surname>Kohrt</surname><given-name>Brandon A.</given-name><initials>B.A.</initials><afid>108095156</afid><afid>60025286</afid><afid>60005200</afid><afid>60008724</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8634127600</author-url><authid>8634127600</authid><authname>Jordans M.</authname><surname>Jordans</surname><given-name>Mark J D</given-name><initials>M.J.D.</initials><afid>108095156</afid><afid>60011520</afid><afid>101870245</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8634127600</author-url><authid>8634127600</authid><authname>Jordans M.</authname><surname>Jordans</surname><given-name>Mark J D</given-name><initials>M.J.D.</initials><afid>108095156</afid><afid>60011520</afid><afid>101870245</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8634127600</author-url><authid>8634127600</authid><authname>Jordans M.</authname><surname>Jordans</surname><given-name>Mark J D</given-name><initials>M.J.D.</initials><afid>108095156</afid><afid>60011520</afid><afid>101870245</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56579713300</author-url><authid>56579713300</authid><authname>Rai S.</authname><surname>Rai</surname><given-name>Sauharda</given-name><initials>S.</initials><afid>108095156</afid><afid>60008724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56579713300</author-url><authid>56579713300</authid><authname>Rai S.</authname><surname>Rai</surname><given-name>Sauharda</given-name><initials>S.</initials><afid>108095156</afid><afid>60008724</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56579877900</author-url><authid>56579877900</authid><authname>Shrestha P.</authname><surname>Shrestha</surname><given-name>Pragya</given-name><initials>P.</initials><afid>108095156</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36100508200</author-url><authid>36100508200</authid><authname>Luitel N.</authname><surname>Luitel</surname><given-name>Nagendra P.</given-name><initials>N.P.</initials><afid>108095156</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37003929800</author-url><authid>37003929800</authid><authname>Ramaiya M.</authname><surname>Ramaiya</surname><given-name>Megan K.</given-name><initials>M.K.</initials><afid>60008724</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:49864503500</author-url><authid>49864503500</authid><authname>Singla D.</authname><surname>Singla</surname><given-name>Daisy R.</given-name><initials>D.R.</initials><afid>60002494</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402495238</author-url><authid>7402495238</authid><authname>Patel V.</authname><surname>Patel</surname><given-name>Vikram</given-name><initials>V.</initials><afid>60031331</afid><afid>112834212</afid><afid>115118910</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402495238</author-url><authid>7402495238</authid><authname>Patel V.</authname><surname>Patel</surname><given-name>Vikram</given-name><initials>V.</initials><afid>60031331</afid><afid>112834212</afid><afid>115118910</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402495238</author-url><authid>7402495238</authid><authname>Patel V.</authname><surname>Patel</surname><given-name>Vikram</given-name><initials>V.</initials><afid>60031331</afid><afid>112834212</afid><afid>115118910</afid></author><authkeywords>Competence | Culture | Global health | Measurement | Psychotherapy | Training</authkeywords><intid>535407475</intid><source-id>12127</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928881104"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928881104?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928881104&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928881104&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928881104</prism:url><dc:identifier>SCOPUS_ID:84928881104</dc:identifier><eid>2-s2.0-84928881104</eid><dc:title>Dual-port distal gastrectomy for the early gastric cancer</dc:title><dc:creator>Kashiwagi H.</dc:creator><prism:publicationName>Surgical Endoscopy and Other Interventional Techniques</prism:publicationName><prism:issn>09302794</prism:issn><prism:eIssn>14322218</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1321-1326</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00464-014-3827-9</prism:doi><dc:description>© 2014, The Author(s). Background: Although recent trends in laparoscopic procedures have been toward minimizing the number of incisions, four or five ports are normally required to complete laparoscopic gastrectomy because of the complexity of this procedure. Multi-channel ports, such as the SILS port (Covidien, JAPAN), are now available and are crucial for performing single-incision laparoscopic surgery (SILS) or reduced port surgery (RPS). We carried out reduced port distal gastrectomy (RPDG) using a dual-port method with a SILS port. Methods: Ten patients who were diagnosed as early stage gastric cancer were offered the RPDG. Mean age and body mass index (BMI) were 68.1 and 21.4, respectively. No distant metastasis or regional lymph node swelling was seen in any case. A 5-mm flexible scope (Olympus, JAPAN) and SILS port were used and a nylon ligature with a straight needle, instead of a surgical instrument, was available to raise the gastric wall. Results: The average operative time was 266.9 ± 38.3 min and blood loss was 37.8 ± 56.8 ml. Patients recovered well and experienced no complications after surgery. All patients could tolerate soft meals on the first day after surgery and the average hospital stay was 8.1 days. Past conventional LAG cases were evaluated to compare the short-term outcome and no difference was seen in the mean operative time or operative blood loss. The length of hospital stay after surgery was shorter for the RPDG group than the conventional operation group (p &lt; 0.0001). Interestingly, the trend of serum CRP elevation after surgery was lower in the RPDG group than the conventional LAG group (p = 0.053). Conclusions: Although the benefits of RPS have not been established, this type of surgery may be expected to have some advantages. Cosmetic benefits and shorter hospital stays are clear advantages. Less invasiveness can be expected according to the trend of serum CRP elevation after RPDG.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101886946</affiliation-url><afid>101886946</afid><affilname>Shounai-Amarume Hospital</affilname><name-variant>Shounai City Hospital</name-variant><affiliation-city>Yamagata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16316038200</author-url><authid>16316038200</authid><authname>Kashiwagi H.</authname><surname>Kashiwagi</surname><given-name>Hiroyuki</given-name><initials>H.</initials><afid>101886946</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:49961708900</author-url><authid>49961708900</authid><authname>Kumagai K.</authname><surname>Kumagai</surname><given-name>Kenta</given-name><initials>K.</initials><afid>101886946</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6504452213</author-url><authid>6504452213</authid><authname>Monma E.</authname><surname>Monma</surname><given-name>Eiji</given-name><initials>E.</initials><afid>101886946</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:49961944500</author-url><authid>49961944500</authid><authname>Nozue M.</authname><surname>Nozue</surname><given-name>Mutsumi</given-name><initials>M.</initials><afid>101886946</afid></author><authkeywords>Laparoscopic distal gastrectomy | Multi-channel port | Reduced port surgery</authkeywords><intid>535862026</intid><source-id>19196</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925779034"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925779034?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925779034&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925779034&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0273230015000380"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925779034</prism:url><dc:identifier>SCOPUS_ID:84925779034</dc:identifier><eid>2-s2.0-84925779034</eid><dc:title>Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the negative exponential model</dc:title><dc:creator>Fry J.</dc:creator><prism:publicationName>Regulatory Toxicology and Pharmacology</prism:publicationName><prism:issn>02732300</prism:issn><prism:eIssn>10960295</prism:eIssn><prism:volume>72</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>49-57</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yrtph.2015.02.010</prism:doi><pii>S0273230015000380</pii><dc:description>© 2015 The Authors. One possible contributor to the reported rise in the ratio of adenocarcinoma to squamous cell carcinoma of the lung may be differences in the pattern of decline in risk following quitting for the two lung cancer types. Earlier, using data from 85 studies comparing overall lung cancer risks in current smokers, quitters (by time quit) and never smokers, we fitted the negative exponential model, deriving an estimate of 9.93. years for the half-life - the time when the excess risk for quitters compared to never smokers becomes half that for continuing smokers. Here we applied the same techniques to data from 16 studies providing RRs specific for lung cancer type. From the 13 studies where the half-life was estimable for each type, we derived estimates of 11.68 (95% CI 10.22-13.34) for squamous cell carcinoma and 14.45 (11.92-17.52) for adenocarcinoma. The ratio of the half-lives was estimated as 1.32 (95% CI 1.20-1.46, p&lt;. 0.001). The slower decline in quitters for adenocarcinoma, evident in subgroups by sex, age and other factors, may be one of the factors contributing to the reported rise in the ratio of adenocarcinoma to squamous cell carcinoma. Others include changes in the diagnosis and classification of lung cancer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101665820</affiliation-url><afid>101665820</afid><affilname>P N Lee Statistics and Computing Ltd</affilname><name-variant>P.N. Lee Statistics and Computing Ltd</name-variant><affiliation-city>Sutton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54418683800</author-url><authid>54418683800</authid><authname>Fry J.</authname><surname>Fry</surname><given-name>John S.</given-name><initials>J.S.</initials><afid>101665820</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8041763000</author-url><authid>8041763000</authid><authname>Lee P.</authname><surname>Lee</surname><given-name>Peter N.</given-name><initials>P.N.</initials><afid>101665820</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602828037</author-url><authid>6602828037</authid><authname>Forey B.</authname><surname>Forey</surname><given-name>Barbara A.</given-name><initials>B.A.</initials><afid>101665820</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55348331900</author-url><authid>55348331900</authid><authname>Coombs K.</authname><surname>Coombs</surname><given-name>Katharine J.</given-name><initials>K.J.</initials><afid>101665820</afid></author><authkeywords>Cessation of smoking | Histological type | Lung cancer | Meta-analysis | Negative exponential model | Review | Smoking | Statistical models</authkeywords><intid>1535346302</intid><source-id>25176</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926430022"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926430022?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926430022&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926430022&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015001975"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926430022</prism:url><dc:identifier>SCOPUS_ID:84926430022</dc:identifier><eid>2-s2.0-84926430022</eid><dc:title>Atherosclerosis in HIV patients: A different disease or more of the same?</dc:title><dc:creator>Bittencourt M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>333-334</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.03.037</prism:doi><pii>S0021915015001975</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013877</affiliation-url><afid>60013877</afid><affilname>Hospital das Clinicas da FMUSP</affilname><name-variant>Universidade de São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36117675900</author-url><authid>36117675900</authid><authname>Bittencourt M.</authname><surname>Bittencourt</surname><given-name>Márcio Sommer</given-name><initials>M.S.</initials><afid>60008088</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56048659100</author-url><authid>56048659100</authid><authname>Peixoto D.</authname><surname>Peixoto</surname><given-name>Driele</given-name><initials>D.</initials><afid>60013877</afid></author><authkeywords>Atherosclerosis | Atherosclerotic plaque | CD4 | Coronary artery disease | HAART | HIV | Non-calcified plaque</authkeywords><intid>35455007</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84919933653"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84919933653?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84919933653&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84919933653&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814614019712"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84919933653</prism:url><dc:identifier>SCOPUS_ID:84919933653</dc:identifier><eid>2-s2.0-84919933653</eid><dc:title>Effect of heat treatment on the n-3/n-6 ratio and content of polyunsaturated fatty acids in fish tissues</dc:title><dc:creator>Schneedorferová I.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>176</prism:volume><prism:pageRange>205-211</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2014.12.058</prism:doi><pii>S0308814614019712</pii><dc:description>© 2014 Elsevier Ltd . All rights reserved. The aim of this study was to compare the effect of different heat treatments (pan-frying, oven-baking, and grilling) on the contents of polyunsaturated fatty acids (PUFAs) in fish tissue. Four fish species were examined: pike, carp, cod, and herring. High performance liquid chromatography, coupled with electrospray ionization and mass spectrometric detection (HPLC/ESI/MS), was employed for determination of intact lipid molecules containing n-3 and n-6 PUFAs. Although mostly non-polar lipids (triacylglycerols, TGs) were present in the fish tissue, the PUFAs were present preferentially in the phospholipid fraction. Omnivorous fish species (carp, herring) contained more TGs than did predatory ones (pike, cod). Higher amounts of PUFAs were detected in the marine species than in the freshwater ones. The impact of heat treatments on the lipid composition in the fish tissue seems to be species-specific, as indicated by multivariate data analysis. Herring tissue is most heat-stable, and the mildest heat treatment for PUFA preservation was oven-baking.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026381</affiliation-url><afid>60026381</afid><affilname>Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic</affilname><name-variant>Academy of Sciences of the Czech Republic</name-variant><affiliation-city>Ceske Budejovice</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009424</affiliation-url><afid>60009424</afid><affilname>Jihoceska Univerzita v Ceskuch Budejovicich</affilname><name-variant>University of South Bohemia</name-variant><affiliation-city>České Budějovice</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60058192</affiliation-url><afid>60058192</afid><affilname>Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic</affilname><name-variant>Czechoslovak Academy of Sciences</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56287290300</author-url><authid>56287290300</authid><authname>Schneedorferová I.</authname><surname>Schneedorferová</surname><given-name>Ivana</given-name><initials>I.</initials><afid>60026381</afid><afid>60009424</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56287290300</author-url><authid>56287290300</authid><authname>Schneedorferová I.</authname><surname>Schneedorferová</surname><given-name>Ivana</given-name><initials>I.</initials><afid>60026381</afid><afid>60009424</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23494056800</author-url><authid>23494056800</authid><authname>Tomčala A.</authname><surname>Tomčala</surname><given-name>Aleš</given-name><initials>A.</initials><afid>60026381</afid><afid>60058192</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23494056800</author-url><authid>23494056800</authid><authname>Tomčala A.</authname><surname>Tomčala</surname><given-name>Aleš</given-name><initials>A.</initials><afid>60026381</afid><afid>60058192</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004605546</author-url><authid>7004605546</authid><authname>Valterová I.</authname><surname>Valterová</surname><given-name>Irena</given-name><initials>I.</initials><afid>60058192</afid></author><authkeywords>Fish tissue | GC/MS | Heat treatment | HPLC/MS | n-3 PUFA | n-6 PUFA</authkeywords><intid>34391604</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226772"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226772?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226772&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226772&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226772</prism:url><dc:identifier>SCOPUS_ID:84930226772</dc:identifier><eid>2-s2.0-84930226772</eid><dc:title>Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE&lt;sup&gt;-/-&lt;/sup&gt; mice and angiogenesis</dc:title><dc:creator>Escudero P.</dc:creator><prism:publicationName>British Journal of Pharmacology</prism:publicationName><prism:issn>00071188</prism:issn><prism:eIssn>14765381</prism:eIssn><prism:volume>172</prism:volume><prism:issueIdentifier>12</prism:issueIdentifier><prism:pageRange>2946-2960</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bph.13098</prism:doi><dc:description>© 2015 The British Pharmacological Society. Background and Purpose Abdominal aortic aneurysm (AAA) is a degenerative vascular disease associated with angiogenesis. Bexarotene is a retinoid X receptor (RXR) ligand with anti-angiogenic activity. Statins also exert anti-angiogenic activity and activate PPARs. Because RXR ligands form permissive heterodimers with PPARs and a single anti-angiogenic drug may not be sufficient to combat the wide array of angiogenic factors produced during AAA, we evaluated the effect of combined low doses of bexarotene and rosuvastatin in a mouse model of AAA. Experimental Approach The effect of the combined treatment was investigated in a murine model of angiotensin II-induced AAA in apoE&lt;sup&gt;-/-&lt;/sup&gt; mice. This combination therapy was also evaluated in in vivo (Matrigel plug assay) and in vitro (endothelial cell differentiation assay) models of angiogenesis as well as the underlying mechanisms involved. Key Results Co-treatment with bexarotene plus rosuvastatin reduced aneurysm formation, inflammation and neovascularization compared with each single treatment. In HUVEC, the combination of suboptimal concentrations of bexarotene and rosuvastatin inhibited angiotensin II-induced morphogenesis, proliferation and migration. These effects were accompanied by diminished production of pro-angiogenic chemokines (CXCL1, CCL2 or CCL5) and VEGF, and seemed to be mediated by RXRα/PPARα and RXRα/PPARγ activation. This combined therapy reduced the activation of members of the downstream PI3K pathway (Akt/mTOR and p70S6K1) in vivo and in vitro. Conclusions and Implications The combination of RXR agonists with statins at low doses synergistically interferes with the signalling pathways that modulate inflammation and angiogenesis and may constitute a new and safer therapeutic treatment for the control of AAA.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113116027</affiliation-url><afid>113116027</afid><affilname>Institute of Health Research INCLIVA</affilname><name-variant>Institute of Health Research-INCLIVA</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002644</affiliation-url><afid>60002644</afid><affilname>Universitat de ValEncia</affilname><name-variant>Universitat de València</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015415</affiliation-url><afid>60015415</afid><affilname>Hospital Clinico Universitario de Valencia</affilname><name-variant>Hospital Clinico Universitario</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015415</affiliation-url><afid>60015415</afid><affilname>Hospital Clinico Universitario de Valencia</affilname><name-variant>Hospital Clinico Universitario</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52563391700</author-url><authid>52563391700</authid><authname>Escudero P.</authname><surname>Escudero</surname><given-name>P.</given-name><initials>P.</initials><afid>113116027</afid><afid>60002644</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52563391700</author-url><authid>52563391700</authid><authname>Escudero P.</authname><surname>Escudero</surname><given-name>P.</given-name><initials>P.</initials><afid>113116027</afid><afid>60002644</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662742100</author-url><authid>56662742100</authid><authname>Navarro A.</authname><surname>Navarro</surname><given-name>A.</given-name><initials>A.</initials><afid>113116027</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37076821700</author-url><authid>37076821700</authid><authname>Ferrando C.</authname><surname>Ferrando</surname><given-name>C.</given-name><initials>C.</initials><afid>113116027</afid><afid>60015415</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37076821700</author-url><authid>37076821700</authid><authname>Ferrando C.</authname><surname>Ferrando</surname><given-name>C.</given-name><initials>C.</initials><afid>113116027</afid><afid>60015415</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56663146700</author-url><authid>56663146700</authid><authname>Furio E.</authname><surname>Furio</surname><given-name>E.</given-name><initials>E.</initials><afid>113116027</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602238644</author-url><authid>6602238644</authid><authname>Gonzalez-Navarro H.</authname><surname>Gonzalez-Navarro</surname><given-name>H.</given-name><initials>H.</initials><afid>113116027</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12143463500</author-url><authid>12143463500</authid><authname>Juez M.</authname><surname>Juez</surname><given-name>M.</given-name><initials>M.</initials><afid>60015415</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201640965</author-url><authid>7201640965</authid><authname>Sanz M.</authname><surname>Sanz</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>113116027</afid><afid>60002644</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201640965</author-url><authid>7201640965</authid><authname>Sanz M.</authname><surname>Sanz</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>113116027</afid><afid>60002644</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602220198</author-url><authid>6602220198</authid><authname>Piqueras L.</authname><surname>Piqueras</surname><given-name>L.</given-name><initials>L.</initials><afid>113116027</afid></author><intid>1036082881</intid><source-id>20084</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925721209"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925721209?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925721209&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925721209&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515000730"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925721209</prism:url><dc:identifier>SCOPUS_ID:84925721209</dc:identifier><eid>2-s2.0-84925721209</eid><dc:title>The effects of Pilates exercise training on physical fitness and wellbeing in the elderly: A systematic review for future exercise prescription</dc:title><dc:creator>Bullo V.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>75</prism:volume><prism:pageRange>1-11</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.002</prism:doi><pii>S0091743515000730</pii><dc:description>© 2015 Elsevier Inc. This systematic review aims to summarize the effects of Pilates exercise training (PET) in elderly population on physical fitness, balance and fall prevention, and its effects on mood states, quality of life and independence in the daily living activities. Methods: Keyword "Pilates" associated with "elderly", "aging" and "old subjects" were identified as terms for the literature research in MEDLINE, Embase, PubMed, Scopus, PsycINFO and SPORTDiscus. Only studies published in peer-reviewed journals written in English language were considered. A meta-analysis was performed and effect sizes (ES) calculated. Results: 10 studies were identified (6 RCTs and 4 uncontrolled trials); age ranged from 60 to 80. years. Overall, PET showed large ES to improve muscle strength (ES. = 1.23), walking and gait performances (ES. = 1.39), activities of daily living, mood states and quality of life (ES. = 0.94), moderate to high effect on dynamic balance (ES. = 0.77), small effects on static balance (ES. = 0.34) and flexibility (ES. = 0.31), while a small effect on cardio-metabolic outcomes (ES. = 0.07). Conclusions: PET should be taken into account as a way to improve quality of life in the elderly, due to the imparted benefits of fall prevention, physical fitness, and mood states. In this context, physicians might include PET as a tool for exercise prescriptions for the elderly.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000481</affiliation-url><afid>60000481</afid><affilname>Universita degli Studi di Padova</affilname><name-variant>University of Padova</name-variant><affiliation-city>Padua</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023222</affiliation-url><afid>60023222</afid><affilname>Medical University of South Carolina</affilname><name-variant>Medical University of South Carolina</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56574330500</author-url><authid>56574330500</authid><authname>Bullo V.</authname><surname>Bullo</surname><given-name>V.</given-name><initials>V.</initials><afid>60000481</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35331605300</author-url><authid>35331605300</authid><authname>Bergamin M.</authname><surname>Bergamin</surname><given-name>M.</given-name><initials>M.</initials><afid>60000481</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55910920000</author-url><authid>55910920000</authid><authname>Gobbo S.</authname><surname>Gobbo</surname><given-name>S.</given-name><initials>S.</initials><afid>60000481</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35769746500</author-url><authid>35769746500</authid><authname>Sieverdes J.</authname><surname>Sieverdes</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60023222</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36868368700</author-url><authid>36868368700</authid><authname>Zaccaria M.</authname><surname>Zaccaria</surname><given-name>M.</given-name><initials>M.</initials><afid>60000481</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56574379700</author-url><authid>56574379700</authid><authname>Neunhaeuserer D.</authname><surname>Neunhaeuserer</surname><given-name>D.</given-name><initials>D.</initials><afid>60000481</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506610351</author-url><authid>6506610351</authid><authname>Ermolao A.</authname><surname>Ermolao</surname><given-name>A.</given-name><initials>A.</initials><afid>60000481</afid></author><authkeywords>Elderly | Fall prevention | Physical fitness | Pilates | Review</authkeywords><intid>535349002</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924041801"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924041801?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924041801&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924041801&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167577X15002761"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924041801</prism:url><dc:identifier>SCOPUS_ID:84924041801</dc:identifier><eid>2-s2.0-84924041801</eid><dc:title>Design of cell niches for the regulation of stem cell fate in central nervous tissue regeneration</dc:title><dc:creator>Li L.</dc:creator><prism:publicationName>Materials Letters</prism:publicationName><prism:issn>0167577X</prism:issn><prism:eIssn>18734979</prism:eIssn><prism:volume>148</prism:volume><prism:pageRange>96-98</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.matlet.2015.02.079</prism:doi><pii>S0167577X15002761</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Cell therapy based on biomaterials and stem cells has made outstanding performance in central nervous tissue engineering. To stimulate stem cell behavior and obtain maximum functional recovery, researchers have paid great effort to elucidate the function of stem cell microenvironments. However, optimum scaffold conditions vary among biomaterials and cells. During the development in scaffolds, stem cells detect different aspects of scaffold signals and change their behavior accordingly, where as the synergism of scaffold biochemical and geometric properties are usually neglected by current reports. To provide a reference for scaffold designs based on specific types of biomaterials and stem cells, we performed this review to make discussion on the function of the geometric properties of scaffolds with reference to the corresponding biomaterials.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001187</affiliation-url><afid>60001187</afid><affilname>Chonbuk National University</affilname><name-variant>Chonbuk National University</name-variant><affiliation-city>Jeonju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56394814400</author-url><authid>56394814400</authid><authname>Li L.</authname><surname>Li</surname><given-name>Li Ming</given-name><initials>L.M.</initials><afid>60003970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402604146</author-url><authid>7402604146</authid><authname>Han M.</authname><surname>Han</surname><given-name>Min</given-name><initials>M.</initials><afid>60003970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005558286</author-url><authid>7005558286</authid><authname>Khang G.</authname><surname>Khang</surname><given-name>Gilson</given-name><initials>G.</initials><afid>60001187</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56535997700</author-url><authid>56535997700</authid><authname>Tabata Y.</authname><surname>Tabata</surname><given-name>Yasuhiko</given-name><initials>Y.</initials><afid>60011001</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7404475089</author-url><authid>7404475089</authid><authname>Gao J.</authname><surname>Gao</surname><given-name>Jian Qing</given-name><initials>J.Q.</initials><afid>60003970</afid></author><authkeywords>Central nervous system | Neural differentiation | Scaffold | Stem cell</authkeywords><intid>35081486</intid><source-id>28697</source-id></entry></search-results>
